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Prologue
This thesis is about improving the quality of healthcare for patients with mental 
health problems, such as depression and schizophrenia, by implementing 
knowledge into practice. ‘Quality Improvement’ can be defined as the ‘combined 
and unceasing efforts of everyone -healthcare professionals, patients and their 
families, researchers, payers, planners and educators- to make the changes that 
will lead to better patient outcomes (health), better system performance (care) and 
better professional development (learning)’.1 Here we focus on how to achieve this 
‘improvement’ in mental healthcare, and the factors and interventions which 
contribute to improvement.  
One of the most critical issues in mental health services today is the gap between 
what is known about effective treatment and what is provided to and experienced 
by consumers in routine care.2,3 Every year over a third of the total European 
population suffers from mental disorders.4 Although overall rates of mental 
disorders have not increased since 2005, quality of care and treatment did not 
improve either; less than one-third of all cases receive any treatment, suggesting a 
considerable level of unmet needs.4 This implementation gap, ‘the gap between 
what can and should be and what exists is so large, that . . . it constitutes a 
chasm’.5
Practice guidelines can help to close this gap by providing concise, evidence-
based recommendations. Guidelines summarize existing knowledge, synthesizing 
the scientific evidence, clinical expertise and the expertise of healthcare users. 
The rationale for developing guidelines is their expected contribution to ‘evidence-
based’ practice and thus outcomes of healthcare for patients and societies.6,7
Studies have found that practice guidelines for somatic conditions have been 
effectively implemented to some extent, leading to measurable improvements in 
healthcare, although the impact on health outcomes is less obvious.8 In mental 
healthcare the body of research on guidelines implementation is still limited.9 This 
thesis reports on research concerning guideline development and implementation 
in mental health. Guideline implementation studies in depression and severe 
mental illness care are presented, with a focus on a frequently used 
implementation method in the Netherlands, the Quality Improvement Collaborative 
(QIC).
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In this introduction the implementation gaps for depression and schizophrenia are 
discussed, as well as the guidelines for both disorders and implementation barriers 
and strategies. At the end, an outline of this thesis will be described. 
The implementation gap for depression and schizophrenia
The quality of depression care 
Depression (major depressive disorder [MDD]) is a highly prevalent disorder 
across all regions of the world, with average lifetime and 12-month prevalence 
estimates of 14.6% and 5.5% in high-income countries and 11.1% and 5.9% in 
low-income countries.10 In the Netherlands lifetime and 12-month estimates of 
depression are 18.7% and 5.2%11 and across Europe the average 12-month 
prevalence rate is 6.9%.4 In the last 10 years no clear changes in overall rates of 
mental disorders were found.4,11 In the Netherlands, the first wave of the 
Netherlands Mental Health Survey and Incidence Study (NEMESIS 1) showed that 
new depressive episodes had a median duration of three months, 63% of those 
with a new episode recovered within six months and 76% within 12 months. 
Almost 20% of affected patients had not recovered in 24 months.12 Although many 
patients recover from depression, for a proportion of patients it is a chronic illness, 
characterized by high rates of symptom recurrence and sustained functional 
impairment.13
 In 1990 depression was the fourth leading cause of worldwide Disability-
Adjusted Life Years (DALYs), the sum of life years lost due to premature mortality 
and years lived with disability adjusted for severity.14 It is projected to be cause 
number two by 2020.15 European per capita cost of mood disorders in 2010 was 
estimated at €113.4 billion on average, varying by country.16 The socio-economic 
costs of depression for societies, not just the healthcare system, are considerable, 
approximately 1% of gross domestic product. Most costs are incurred outside the 
healthcare system because they are related to productivity losses, lost leisure 
opportunities and premature mortality.17
The science-to-service gap for depression is rather substantial. International 
comparisons showed that treatment adequacy rates for anxiety disorders and 
depressive episodes in Belgium, France, Germany, Italy, the Netherlands and 
Spain were similar to those found in the United States of America (USA)18. In the 
USA a national representative survey conducted in 1996 showed that, although 
53.8% of respondents with at least one 12-month mental disorder received any 
mental healthcare, only 14.3% received care that could be considered consistent 
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with evidence-based treatment recommendations.18 A later study of Wang et al.19
showed that treatment adequacy in specialty care is better than in the general 
medical sector, with rates of patients receiving a minimal threshold of treatment 
adequacy of 48.3% versus 12.7%. Unmet need for treatment is greatest in
traditionally underserved groups, including elderly persons, racial-ethnic minorities, 
those with low incomes, those without insurance, and residents of rural areas.19 In 
Europe the rates were 57.4% and 23%, respectively.20
In the Netherlands, as in most western countries, primary care is the key supplier 
of mental healthcare. About 21% of the patients in primary care suffer from 
depression or depressive symptoms.21 Around 42% of the primary care patients 
with a confirmed Composite International Diagnostic Interview (CIDI) diagnosis of 
depressive disorder, are treated in accordance with primary care guidelines.22 For
patients with an anxiety disorder, this percentage is 27%, whereas half of the 
patients with both depression and anxiety disorder receive guideline-concordant 
care.22 There seems to be room for improvement in terms of reducing both 
overtreatment of mild cases and undertreatment of more severely depressed 
patients. 
Clinical audits strongly suggested overtreatment of mild depression with 
antidepressants in primary care. Differentiation of subgroups based on severity 
criteria is not routine practice since a clear relation between antidepressant 
medication and the severity of depression does not seem to be present.23 Around 
50% of the patients diagnosed with depression by the primary care physician 
receive antidepressant medication or benzodiazepines in the first consultations.24
Other research has shown that more than 70% of the patients diagnosed with 
depression by the primary care physician are treated with antidepressant 
medication, whereas in more than 50% of these cases antidepressants were the 
only treatment.25 These high prescription rates do not seem to be in line with 
patients’ preferences, which lend towards psychological treatment rather than 
medication.26 Researchers and depression experts conclude therefore that 
patients with mild depression presenting in primary care could profit more from 
effective interventions such as self-help or physical exercise.27,28 Despite 
numerous policy incentives to strengthen the capacities of primary care in the 
Netherlands, primary care physicians still refer more patients to specialized mental 
healthcare care than to psychologists and social workers in primary care.21,29
These referral rates to specialty mental healthcare have risen over the last years.30
 Chapter 1: Introduction 
10
with evidence-based treatment recommendations.18 A later study of Wang et al.19
showed that treatment adequacy in specialty care is better than in the general 
medical sector, with rates of patients receiving a minimal threshold of treatment 
adequacy of 48.3% versus 12.7%. Unmet need for treatment is greatest in
traditionally underserved groups, including elderly persons, racial-ethnic minorities, 
those with low incomes, those without insurance, and residents of rural areas.19 In 
Europe the rates were 57.4% and 23%, respectively.20
In the Netherlands, as in most western countries, primary care is the key supplier 
of mental healthcare. About 21% of the patients in primary care suffer from 
depression or depressive symptoms.21 Around 42% of the primary care patients 
with a confirmed Composite International Diagnostic Interview (CIDI) diagnosis of 
depressive disorder, are treated in accordance with primary care guidelines.22 For
patients with an anxiety disorder, this percentage is 27%, whereas half of the 
patients with both depression and anxiety disorder receive guideline-concordant 
care.22 There seems to be room for improvement in terms of reducing both 
overtreatment of mild cases and undertreatment of more severely depressed 
patients. 
Clinical audits strongly suggested overtreatment of mild depression with 
antidepressants in primary care. Differentiation of subgroups based on severity 
criteria is not routine practice since a clear relation between antidepressant 
medication and the severity of depression does not seem to be present.23 Around 
50% of the patients diagnosed with depression by the primary care physician 
receive antidepressant medication or benzodiazepines in the first consultations.24
Other research has shown that more than 70% of the patients diagnosed with 
depression by the primary care physician are treated with antidepressant 
medication, whereas in more than 50% of these cases antidepressants were the 
only treatment.25 These high prescription rates do not seem to be in line with 
patients’ preferences, which lend towards psychological treatment rather than 
medication.26 Researchers and depression experts conclude therefore that 
patients with mild depression presenting in primary care could profit more from 
effective interventions such as self-help or physical exercise.27,28 Despite 
numerous policy incentives to strengthen the capacities of primary care in the 
Netherlands, primary care physicians still refer more patients to specialized mental 
healthcare care than to psychologists and social workers in primary care.21,29
These referral rates to specialty mental healthcare have risen over the last years.30
Chapter 1: Introduction 
11
The quality of schizophrenia care 
Schizophrenia is one of the main chronic severe mental illnesses (SMI), 
characterized by fundamental disturbances in thinking, perception and emotions.31
Schizophrenia usually starts in young adulthood. Life expectancy is reduced by 
approximately 10 years, mostly as a consequence of suicide, and only a minority 
of those affected fully recover.31 Different prevalence rates have been reported 
internationally. In a systematic review, published in 2005, its median lifetime 
prevalence was estimated at 4.0/1,0032 and not 1%, as reported in the Diagnostic 
and Statistic Manual of Mental Disorders, fourth edition.33 In the Netherlands, with 
a population of 16.6 million, approximately 120,000 persons (around 0.7%) have a 
diagnosis of schizophrenia.34
Even though schizophrenia is not highly prevalent, it is among the most costly 
illnesses worldwide. The European per capita cost of psychotic disorders in 2010 
was estimated at €93.9 billion on average.16 According to the Global Burden of 
Disease Study, schizophrenia was the 26th leading cause of worldwide DALYs.14
In addition to the direct burden, there is considerable burden on patients’ relatives. 
Most people with schizophrenia receive community-based care.34 Treatment goals 
are to identify the illness as early as possible, treat the symptoms, provide skills to 
patients and their families, maintain the improvement over a period of time, 
prevent relapses and reintegrate the ill persons into the community so that they 
can lead a life as normal as possible.31
In the management of schizophrenia the science-to-service gap is substantial. 
Despite the fact that a number of interventions have been proven effective, 
services research shows indisputably that people with this serious mental disorder 
are likely to receive few if any of these effective interventions35 and many receive 
low quality of care, such as inappropriately high doses of neuroleptics.2  
 One of the first gap studies in the USA, the Schizophrenia Patient Outcomes 
Research Team (PORT) study, found that patients in two large state public mental 
health programs were unlikely to receive most of the indicated evidence-based 
treatments. The rates at which patients’ treatment conformed to the 
recommendations were modest at best, generally below 50%.36
 An analysis of the difference between actual care and guideline 
recommendations performed just before the release of the Dutch schizophrenia 
guidelines in 2005 reported a considerable science-to-practice gap.37 Although 
best-practices exist in Dutch mental healthcare, patients generally either did not 
receive the effective interventions as recommended in the guidelines, or not in a 
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sufficient number of sessions and within an appropriate timeframe. Moreover, 
good coordination of care appeared hard to come by.37
 In 2005, the first Quality Assessment of Regional Treatment Systems for 
Schizophrenia (QUARTS assessment), a structured interview with Dutch 
stakeholders, showed that an estimated 25-50% of patients were offered care 
according to the guidelines.34
In this thesis, we report on evaluations of efforts to address these science-to-
service gaps for patients with depression or schizophrenia, and improve clinical 
processes and outcomes as well as efficiency of care. 
Multidisciplinary guidelines as strategies for quality improvement 
A practice guideline is:
 a document with recommendations, aimed at improving the quality of care, 
based on systematic summaries of scientific research, on weighing the 
advantages and disadvantages of the various options for care, completed 
by the expertise and experiences of healthcare professionals and 
healthcare users.38,p.9
Guidelines can be considered as tools to translate research results and new 
insights to clinical practice with the ultimate aim of improving processes and 
outcomes of healthcare. The recommendations in practice guidelines describe the 
goal of improvement (optimal clinical practice) and might also be seen as a 
method for improving practice7,39 and reduce practice variation.40 Nevertheless, it 
is now widely understood that practice guidelines usually do not implement 
themselves. Interventions to translate guidelines and enhance their uptake in 
clinical practice are usually needed.  
Different types of practice guidelines exist. Multidisciplinary guidelines, unlike 
monodisciplinary guidelines, are documents simultaneously developed by all 
professional groups involved in the care for a specific patient group. Healthcare 
consumers and carers may also be involved in the development. A 
multidisciplinary guideline encompasses several elements of the care process and 
is not restricted to the care of one specific professional group, moment or location. 
It is an overarching document and different disciplines feel responsible for its 
implementation. In monodisciplinary guidelines, mostly one professional group is 
addressed.41
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 In mental health in the Netherlands, multidisciplinary guidelines have become 
the most important type of guidelines, since most mental healthcare by definition 
needs a multidisciplinary approach. Their developmental process follows a 
rigorous approach, according to the internationally accepted criteria of the 
Appraisal of Guidelines for Research & Evaluation instrument.42
Practice guidelines on depression 
The Dutch multidisciplinary guideline for depression was released in 2005 and was 
revised in 2010.43,44 The 2005 version served as the basis for the research in this 
thesis. For patients with a first episode of mild depression, the Dutch guideline 
working group recommended clinicians to consider no treatment, neither 
psychotherapy nor antidepressant medication, in the first three months. The 
working group did recommend one of the following interventions: information, 
psycho-education, bibliotherapy or self-help, problem solving treatment and follow-
up visits for monitoring in all cases. In case of a mild to moderate depressive 
episode of more than three months, or if the first step treatment interventions did 
not show sufficient response, or in case of a severe or recurrent depression, 
treatment in terms of psychotherapy and/or antidepressant medication was 
indicated, according to the guidelines.43
Internationally, various American and European guidelines provide similar basic 
principles of treatment, which include individualizing the treatment plan, preparing 
the patient for potential long-term treatment, providing measurement-based care, 
and treating to remission.45 In a review of six guidelines, mild depression had the 
most variance in treatment recommendations; some, but not all, guidelines 
suggest that it may resolve with exercise or watchful waiting, but psychotherapy or 
antidepressants could be used if initial efforts fail. Moderate and severe major 
depressions carry broadly similar recommendations among the guidelines. First 
choice treatment recommendations for moderate depressive disorder included 
antidepressant therapy, psychotherapy, and a combination of both. Severe 
depression may require the combination of an antidepressant and an 
antipsychotic, electroconvulsive therapy, or a combination of an antidepressant 
and psychotherapy.45,46 Hegarty et al.47 found considerable variation in 
recommendations on screening, use of self-help and the length of antidepressant 
treatment in primary care guidelines for depression. 
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Stepped care 
The recommendations described above all refer to a ‘stepped care’ approach for 
the allocation of depression treatment. In a stepped care approach evidence-
based treatment options are ranked by their degree of intensity, looking at the 
impact on the patient’s life, the length of treatment, the setting (primary care or 
specialty care) and the costs, as well as combinations of these criteria.48-50
Patients start to step in at the appropriate intensity level which matches their 
(severity) profile. Stepped care models have the potential to improve efficiency and 
effectiveness of depression care.51-53 Also, the implementation of a stepped care 
model can lead to better collaboration and integration, involving all partners across 
primary and secondary care, and making them aware of their individual 
contributions to the shared approach.53  
In the revised version of the multidisciplinary guideline (2010) this ‘stepped care 
approach’ was recommended as the basic principle for the organization of 
depression care. 44 It was made explicit in a series of four algoritms targeting 
patients with a first mild depressive episode of no longer than three months, 
patients with a mild depressive episode longer than three months or a recurrent 
mild depression, patients with a first moderate or severe depression, and patients 
with a recurrent moderate or severe depression. Although there are indications 
that a stepped care approach for depression can be cost-effective and acceptable 
to patients, good evidence is hard to generate due to methodological pitfalls and 
has been lacking until now. 
Practice guidelines on schizophrenia
The first Dutch evidence-based multidisciplinary guideline for schizophrenia was 
published in 2005 at the same time as the depression guideline. 54 Its revised 
version was published in 2012. The first guideline was developed by 
representatives of consumer and carer organizations and a range of professional 
organizations. It incorporated recommendations concerning diagnosis and 
treatment of schizophrenia. The recommended interventions included: assertive 
community treatment (ACT) or its adapted version functional assertive community 
treatment (FACT), cognitive behavioural therapy (CBT), psycho-education (PE), 
family interventions (FI), individual placement support (IPS), and pharmacotherapy 
(PHth).54
Internationally, a number of schizophrenia guidelines of average good quality 
exist.55 Besides treatment with antipsychotics, guidelines also recommend 
different psychosocial interventions: cognitive behavioural therapy (CBT), 
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community-based treatment (adapted to the conditions of the respective mental 
health system), family interventions (including psycho-education) and vocational 
rehabilitation or supported employment. In addition, some guidelines also 
recommend several psychosocial interventions such as case management, 
reinforcement techniques, cognitive training, compliance therapy and social skills 
training. Recommendations across different international guidelines largely 
correspond, whereas discrepancies or vagueness exist in areas due to newly 
emerging evidence (drug choice) or still restricted evidence (duration of 
antipsychotic treatment).55
The multidisciplinary guidelines for depression and schizophrenia were the first of 
a set of guidelines to be released in 2005 by the National Steering Group for 
Multidisciplinary Guideline Development in Mental Health.56 The work and lessons 
learned by the steering group are presented in part one of this thesis. For both 
guidelines, Quality Improvement Collaboratives (QICs) were organized from 2005 
onward to implement relevant recommendations. The studies evaluating these 
projects are presented in part two of the thesis. 
Factors influencing guideline implementation
A range of factors can help or hinder the implementation of evidence-based 
interventions, innovations or guideline recommendations.57,58 According to 
Wensing et al.59 influencing factors might be related to: individuals (cognitions, 
motivations, routines), the social context (teams and networks), organizations 
(structure, culture and available means), and the broader societal context 
(professionalization, financial incentives, regulations and laws). The attributes of 
evidence summarized in guidelines may as well affect compliance in practice.58,60
Better compliance is associated with: the health topic (acute care guidelines are 
better followed than chronic care guidelines), the quality of the evidence, the 
compatibility of the recommendations with existing values, less complexity of the 
decision-making needed, more concrete description of the desired performance, 
and fewer new skills and organizational change needed to follow the 
recommendations.58,60 In a meta-review of 12 systematic reviews on factors 
influencing guideline implementation, complexity of a guideline was found to be 
the most frequently described. Guidelines, which are easy to understand, can 
easily be tried out and do not require specific resources, seemed to have a higher 
probability of being used.58
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Barriers to guideline implementation in depression care
In depression care many of these barriers have been identified as well. Smolders 
et al.61 reported no associations between practice characteristics and guideline-
concordant care, and one professional characteristic of primary care physicians 
related to higher rates of overall guideline adherence: a stronger confidence in 
depression identification, being able to distinguish depression from unhappiness. 
Perceived time limitations were associated with a decrease of the probability of 
delivering appropriate non-pharmacological care; no practice-related or 
professional-related factors were associated with appropriate pharmacological 
care and depression identification and less perceived barriers for implementation 
were associated with referral to specialized mental healthcare.61
Patient-related factors, other than clinical factors, play an important role as well. 
Prins et al.62 reported that patient education level, accessibility of care and 
patients’ perceived needs for care are more strongly associated with the delivery 
of guideline-concordant care for anxiety or depression than clinical need factors.  
 Organizational factors impacting on depression management, such as quality 
improvement capabilities and information technology infrastructures (reminder 
systems, use of electronic medical records), communication and coordination 
tasks are relevant in implementing evidence-based practices and need to be better 
measured and understood.63
 In terms of guideline attributes, significant limitations have been identified in the 
relevance and applicability of current depression guidelines to primary care.47 A
lack of agreement with the guideline recommendation, mostly related to a lack of 
applicability, is one of the barriers for primary care physicians to follow the 
guidelines.64 On the other hand, the fact that guidelines in the Netherlands were 
developed by working groups of both primary care physicians and specialists 
might explain the relatively high rates of treatment adequacy for depression and 
anxiety in the general medical setting.20
 However, more studies are needed on patient and physician factors influencing 
guideline implementation in order to establish to what extent mental health 
guidelines can contribute to improving outcomes.9 
In our evaluations of quality improvement collaboratives, in part two of the thesis 
we aim to identify factors associated with guideline implementation and 
improvement. 
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Guideline implementation strategies
There are many different theories and approaches to change. Overall, research on 
these different approaches is still scarce and none of the approaches is superior 
for all changes in all settings.60,65 What has become clear over the past decades of 
research is that effective implementation of complex innovations requires: (1) a 
thorough preparation and planning and a systematic approach based on a 
comprehensive understanding of the barriers and facilitators to change; (2) a 
multifaceted strategy combining different strategies, targeting different levels of 
care provision and tailored to specific settings and target groups (doctor, team 
practice, hospital, wider environment); and (3) evaluation of the implementation 
process and outcomes.60,65,66 Most guidelines, both in general as in mental 
healthcare, need well-developed, well-executed and sustained implementation 
programs,67 and even such programs usually have only a moderate effect on 
performance in terms of care improvement (around 8-10%68).
Implementation strategies are: ‘targeted activities to realize the introduction of a 
specific method or product or to enhance a specific change’.69,p.4 They can be 
categorized in different ways, the Cochrane Effective Practice and Organisation of 
Care Group (EPOC) being considered as the most accepted one (Box 1). These 
interventions may be combined, overlap, or one intervention may contain elements 
from several categories.39 Over the last decades numerous studies have been 
published about the effectiveness of a range of these strategies to disseminate 
and implement clinical guidelines.70
In mental health, despite an increasing number of psychiatric guidelines, there is 
only a small number of implementation studies of such guidelines. A systematic 
review of 18 studies, of which eight studies addressed depression and two 
schizophrenia, showed that some of these studies reported modest and temporary 
effects of guideline implementation on the process of care and patient outcome.9
The most common setting was primary care (12 studies), one study was 
conducted in a general hospital and only five studies were based within specialist 
mental healthcare settings.10 Strategies used in the studies were: ongoing support 
and feedback, specific psychological models to overcome implementation barriers 
or social marketing techniques.9
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Box 1. EPOC categories of implementation strategies (adapted from Thorsen & Mäkelä39) 
1. Interventions orientated toward health professionals:
a. Distribution of educational materials (including clinical practice guidelines).
b. Conferences: small-group conferences (active participation), or big-group conferences (passive 
participation).
c. Local consensus processes: discussions to agree that the clinical problem is important and the 
approach to manage the problem is appropriate.
d. Outreach visits: use of a trained person who meets with providers to provide information. 
e. Local opinion leaders: using providers nominated by their colleagues as ‘educationally influential.’ 
f. Patient-mediated interventions: information from or given directly to patients by others; e.g. 
mailings.
g. Audit and feedback: information or summary of clinical performance over a specified period of 
time.
h. Reminders: manual or computerized intervention, that prompts to perform a clinical action.
i. Peer review.
2. Financial interventions:
a. Provider intervention (fee-for-service, capitation, provider salaried service, direct or indirect 
financial rewards, penalties, changes in reimbursable available products).
b. Patient interventions (premium, co-payment, user-fee, patient 
incentives/grants/allowance/penalties).
3. Organizational interventions:
a. Structural interventions (changes in the settings/site of service delivery, telemedicine, changes in 
medical records systems (e.g. changing from paper to computerized records).
b. Staff-oriented interventions (revision of professional roles, multidisciplinary teams, case 
management or integration of services, skill mix interventions, improve provider satisfaction with 
the conditions of work).
c. Patient-oriented interventions (facilitating individual patient participation).
4. Regulatory interventions:
a. Changes in medical liability.
b. Management of patient complaints.
c. Accreditation.
d. Licensure.
Guideline implementation for depression in primary care 
According to Gilbody,71 simple guideline implementation and educational 
strategies are ineffective for improving depression in primary care. Instead, more 
complex strategies are needed incorporating clinician education, an enhanced role 
of the nurse for case management or telephone medication counseling and a 
larger degree of integration between primary and secondary care. Overall there is 
some evidence that guideline-concordant care is associated with improved 
depression outcomes, but this still has to be better demonstrated.62
 In the USA a range of studies has been published on the implementation of so-
called guideline-based models and protocols. In these studies the interventions to 
be implemented are derived from existing guidelines. A range of such projects 
have shown to improve detection and treatment of depression in primary care,72
improve depression outcomes,73 reduce suicide risk,74 prevent relapse of 
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symptoms and improve work outcomes.73,75 Several rigorous, controlled trials have 
demonstrated that depression care is amenable to treatment models designed
specifically for managing chronic illnesses,76 such as the Chronic care Model 
(CCM) developed by Wagner.77,78 These effective models are based on the 
principles of ‘collaborative care’,79–82 ‘stepped care’,53 ‘disease management’,83 or 
combinations of these.51,83,84 The components described in the CCM are central to 
all of these models: use of evidence-based practice guidelines, practice 
reorganization to meet the needs of chronically ill patients, patient education, and 
expert systems or multidisciplinary approaches to care.78 Overall in the USA, multi-
component system level interventions have led to a modest increase in recovery 
from depression in primary care.85
 In Europe one of the early guideline implementation studies was the Hampshire 
Depression Project performed in 2000 in which an educational package (including 
seminars, demonstration videotapes, small group discussion, guidance of 
educators for nine months) was offered to primary care physicians to improve their 
recognition of depression.86 The conclusion of the authors that education did not 
increase the sensitivity and specificity of physicians’ recognition of depression 
must have added to the growing common notion that guideline implementation 
needs a package of strategies tailored to specific implementation problems. 
 In the Netherlands a large program to improve primary mental healthcare was 
launched in 2001 by the Dutch College of General Practitioners (NHG) and the 
Dutch National Association of General Practitioners (LHV). This program included 
the development of a range of products to support the primary care physicians: 
guidelines, educational materials, software modules. The primary healthcare 
regions were responsible for the improvement projects and national funding, 
quality improvement training, and meetings for consultations with coordinators 
were organized. The effect study showed no impact of the program in terms of 
self-reported mental health performance, while perceived barriers to optimal care 
decreased. Participation in the improvement interventions was not associated with 
any of these outcomes.87
Guideline implementation in schizophrenia care 
Also in schizophrenia care, implementation of guidelines has followed the pattern 
observed in general healthcare: moving gradually from passive diffusion to system 
reengineering based on complex electronic records, decision supports, and 
Wagner’s CCM.88 Similar initiatives were undertaken as described above for 
depression management; based on the CCM components, several efforts were 
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undertaken in the USA to implement evidence-based interventions. This happened 
on a large scale, rather than in small demonstration projects.88
 The largest implementation program was the Texas Medication Algorithm 
Project (TMAP) directed at the development, implementation and evaluation of an 
algorithm-driven disease management program for adults with major psychiatric 
disorders. The program included a medication algorithm, a patient/family 
educational program, ongoing physician training and consultation, a medical 
documentation system with routine assessment of symptoms and side effects, and 
prompting by on-site clinical coordinators.89
 Another large and well researched program was the National Implementing 
Evidence-Based Practices Project,90 which contained a multi-faceted strategy 
containing written material, web-based resources, training experiences, and 
consultation opportunities, packaged as implementation toolkits and addressing a 
range of stakeholders.90 Outcomes were measured in terms of fidelity to the 
evidence-based practice model. More than half of the participating sites showed 
high fidelity implementation of one of five evidence-based interventions at the end 
of two years.91
These examples show that depression and schizophrenia guidelines, although not
always implemented explicitly, have served to design a vast number of large 
quality improvement studies. This thesis adds to this body of literature by 
presenting new knowledge on a specific quality improvement method, the Quality 
Improvement Collaborative (QIC). 
A multifaceted implementation strategy: Quality Improvement Collaboratives 
A quality improvement collaborative (QIC) is a multifaceted package of 
implementation strategies that seeks to implement evidence-based practice 
through the sharing of experience and knowledge of others in a similar setting over 
a short period of time.92-95 QICs combine implementation strategies from the 
EPOC categories in box 1, mostly from categories 1 (interventions orientated 
toward health professionals) and 3 (organizational interventions).  
 A QIC brings together groups of physicians from different healthcare 
organizations to work in a structured way to improve one aspect of the quality of 
their service. It involves them in a series of meetings to learn about best practice in 
the area chosen, about quality methods and change ideas, and to share their 
experiences of making changes in their own local setting.96  
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Drawn from the literature, Hulscher et al.97 defined a QIC as an: 
 organized, multifaceted approach to quality improvement that involves five 
essential features: (1) there is a specified topic; (2) clinical experts and 
experts in quality improvement provide ideas and support for improvement; 
(3) multi-professional teams from multiple sites participate; (4) there is a 
model for improvement (setting targets, collecting data and testing 
changes); and (5) the collaborative process involves a series of structured 
activities.97,p.9
Different types of collaboratives exist, the most frequently used being the 
Breakthrough Series (BTS) developed by the Institute for Healthcare Improvement 
(IHI) in 1995 to help healthcare organizations make ‘breakthrough’ improvements 
in quality while reducing costs.94,95,98 The driving vision behind the BTS model is 
this:
 sound science exists on the basis of which the costs and outcomes of 
current healthcare practices can be greatly improved, but much of this 
science lies fallow and unused in daily work. There is a gap between what 
we know and what we do.98,p.1
The rationale behind the IHI’s thinking was to combine subject matter experts in 
specific clinical areas with application experts who could help organizations select, 
test, and implement changes on the front line of care.98 The steps in the BTS 
model follow a particular order (Box 2). 
Box 2. Steps in the Institute for Healthcare Improvement’s Breakthrough Series (BTS) 
Collaborative Model94
1. Sponsoring organization identifies topics where a significant gap exists between best and typical 
practice.
2. The Institute for Healthcare Improvement (IHI) then assembles an expert panel.
3. Expert panel prepares a package of ideas for closing the gap.
4. IHI recruits participating teams to be part of the collaborative.
5. Participants engage in prework: forming local improvement team, development of goals and
measurements, and characterizing current practice.
6. During a collaborative’s life, usually six to 12 months, teams from participating organizations attend 
three learning sessions in which they learn about ideas for better practice and improvement methods
that they implement between sessions.
7. Between learning sessions, teams share experiences and maintain contact through such mechanisms 
as conference calls and Internet e-mail listservs while submitting progress reports.
8. The lessons learned are spread through a national meeting (congress) and reports.
Studying the components of the QIC improvement model, Schouten99 has
identified three dominant categories of theories underlying the assumptions and 
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hypotheses of the model: (1) Rogers’ theory of diffusion of innovation,100
describing how innovations spread in social networks; (2) social influence 
theories101 about how mechanisms such as role modeling and social comparison 
contribute to this process; and (3) the total quality management (TQM) or 
‘continuous quality improvement’ (CQI102), which emphasizes leadership, a culture 
of continuous cycles of measurement and improvement of performance.   
 From the start in 1996, QICs were used in different clinical areas (e.g. cesarean 
section rates, cardiac surgery) and organizational contexts (e.g. intensive care, 
reducing delays and wait times in operation rooms) and have been adopted by 
numerous large and small healthcare systems and individual clinics. From 1998 
onward, IHI started to launch QICs in chronic care by incorporating the model for 
delivering chronic illness care developed by Wagner into the BTS model. In more 
than 50 healthcare systems for diabetes, congestive heart failure, depression and 
asthma, the chronic illness BTS represented a feasible method of improving the 
quality of care.103 In one of these collaboratives, focusing at improving depression 
care, the BTS model appeared to be a viable method of disseminating evidence-
based care.104
 In the Netherlands, just as in the USA,104 the United Kingdom,105 and other 
western countries, collaboratives have had a central place in the general and 
mental health reform policies. In 2004 the Ministry of Health, Welfare and Sport in 
the Netherlands started an ambitious national program to improve health and 
social care services, ultimately comprising 10 programs costing €100 million106.
The programs were organized by sectors (cure, care, prevention, mental 
healthcare) or specific subjects or conditions (dementia, diabetes). At the same 
time, the release of the multidisciplinary guidelines became important moments for 
national funding bodies to initiate QIC projects, expecting that these would help 
clinicians to implement the guideline recommendations. From 2004 onward, 
guideline based QIC projects for depression, anxiety disorders, schizophrenia and 
Attention-Deficit/Hyperactivity Disorder (ADHD) were launched and funded by the 
Healthcare Insurance Board (CVZ),107,108 the Healthcare Insurance Innovation 
Fund (Innovatiefonds Zorgverzekeraars),109 and ZonMw, the Netherlands 
organization for Health Research and Development, which also provided grants for 
evaluation studies of some of the mental health QICs.
This popularity of the QIC method was not yet based on scientific grounds. It was 
only in 2008 that a systematic review of the effectiveness of the quality 
improvement collaborative was published, showing positive but limited results. 110
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The review included a total of 72 studies, amongst which 60 uncontrolled reports. 
Of these, 50 reports were based on the BTS. Conclusions on effectiveness could 
not be drawn from these reports owing to the lack of adequate reporting 
procedures on data collection, analysis, and objective evaluations.110 The review's 
update in 2009 was based on 10 controlled studies (including two randomized 
controlled trials), out of which three reported a positive effect, five studies reported 
positive effects on some of the effect parameters and two showed no significant 
effect. ‘Process of care’ parameters more often showed ‘positive results’ than 
patient outcomes, probably because of the chosen timeframe.97 None of the 
included studies was about mental healthcare topics. In addition to reviewing the 
effectiveness of QICs, the authors developed a long list of probable determinants 
of success based on the literature and expert-opinions, but found little empirical 
information on the impact of these factors within the collaborative and teams 
studied in the review.97 The authors concluded that the evidence underlying the 
QIC is still limited and the effects cannot be predicted with great certainty. Also, 
more research is needed to study probable determinants of success or failure and 
to improve our understanding of how and why QICs work.97  
In summary, despite their popularity, little is known about the cost-effectiveness of 
quality improvement collaboratives or about specific components that enhance 
effectiveness and sustained impact.110 This is even more the case for its use in 
mental healthcare, for which virtually no research has been done into the potential 
of the QIC method to implement guidelines and help clinicians improve the quality 
of care. 
Purpose, research questions and structure of this thesis 
Purpose 
Implementation of evidence-based mental healthcare based on guidelines is a 
goal of many healthcare providers, mental health organizations, policy makers and 
funding bodies. There is a lack of knowledge about effective implementation 
strategies in mental health, both in primary care as in the specialty care setting. 
Large investments have been made in the Netherlands to organize QICs as a 
multifaceted strategy to implement guideline recommendations and improve the 
quality of care and patient outcomes. This thesis was designed to define the 
impact of the QIC method on the implementation of guideline recommendations for 
depression and schizophrenia in two different care settings and to draw lessons 
for future quality improvement programs in the mental health setting. 
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Research questions 
The following research questions were phrased for the research presented in this 
thesis.
1. What are the activities, results and implementation lessons learned from the 
Dutch multidisciplinary guideline program? 
2. What is the effectiveness of organizational strategies aiming to improve 
evidence-based care for patients with severe mental illness?
3. What is the impact of a depression QIC on quality indicators in primary care?  
4. What are the perceptions of the clinicians participating in a depression QIC on 
the implementation of stepped care for depression into their daily routines?
5. What is the effectiveness of a depression QIC on antidepressant prescription 
rates by primary care physicians? 
6. What is the cost-effectiveness of care according to the depression QIC 
compared to usual care? 
7. What is the impact of a schizophrenia QIC on quality indicators in secondary 
mental healthcare organizations? 
Structure of the thesis
The thesis consists of two parts. In part I, research questions 1 and 2 are 
answered by presenting studies on two types of implementation strategies in 
mental healthcare: (a) guidelines as strategies directed at healthcare professionals 
and (b) organizational strategies directed at changing the delivery of care within 
mental health institutions according to guideline recommendations. In part II we 
focus on research questions 3-7 relating to the effectiveness of QIC strategy on 
changing care as a multifaceted strategy combining both professional and 
organizational strategies.  
Part I: Strategies for quality improvement in mental healthcare 
In chapter 2 we present a narrative overview of multidisciplinary guideline 
development in mental health in the Netherlands. This chapter provides an in-
depth insight into multidisciplinary guideline development in mental health during 
the last decade in the Netherlands. It describes the national guideline program, the 
actors involved, the guideline method and activities, and the products and lessons 
learned on three central topics: the methodology of developing multidisciplinary 
guidelines, service user and carer involvement and dissemination and 
implementation. 
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the last decade in the Netherlands. It describes the national guideline program, the 
actors involved, the guideline method and activities, and the products and lessons 
learned on three central topics: the methodology of developing multidisciplinary 
guidelines, service user and carer involvement and dissemination and 
implementation. 
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In chapter 3 we present a study of systematic reviews of organizational strategies 
to implement change and improve quality and outcomes of care for patients with 
severe mental illness. To provide a comprehensive overview of the research we 
searched for systematic literature reviews published in English during 2000 to 
2007 in PubMed, PsycINFO, CINAHL, EMBASE, and the Cochrane Central 
Register of Systematic Reviews. The quality of the studies was assessed and they 
were categorized using an existing taxonomy of six broad categories of strategies 
for organizational change.
Part II: The impact of the quality improvement collaborative on improving 
mental health
In chapter 4 we present a quality improvement report of the depression QIC and its 
impact on process and outcome indicators. The goal of the QIC was to implement 
a stepped care model for depression in primary care, based on guidelines. This 
model had been derived from guideline recommendations by a national expert 
team. The rationale for this model, its components and influencing factors are 
reported. 
Chapter 5 consists of a qualitative study into the perspectives of clinicians 
participating in the QIC on quality improvement in primary depression care. In
order to understand how clinicians participating in the depression QIC have 
implemented a stepped care approach for depression in a QIC context, group 
interviews with eight primary care teams were conducted. Qualitative analysis was 
supplemented using concepts of the normalization process theory (NPT). 
Chapter 6 presents the findings of a quasi-experimental evaluation of the 
depression QIC on antidepressant prescribing by primary care physicians. The 
goal of the study was to determine the effectiveness of the depression QIC in 
terms of change in professional performance, notably antidepressant prescribing. 
In the study, three years depression performance data extracted from the 
electronic medical records (EMRs) of the primary care practices participating in the 
QIC were compared to the data of non-participating colleagues extracted from the 
database of the Dutch National Information Network of General Practice (Landelijk 
Informatie Netwerk Huisartsenzorg).
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In chapter 7 an economic evaluation of the depression QIC is presented. To study 
the cost-effectiveness of the depression QIC, a cost-effectiveness study was 
performed comparing clinical outcomes and costs of patients treated by primary 
care physicians who participated in the depression QIC to matched controls 
selected from the primary care cohort of the Netherlands Study of Depression and 
Anxiety (NESDA), an eight-year longitudinal study to investigate the course of 
depression and anxiety disorders in five regions in the Netherlands.  
Chapter 8 covers the quality improvement report of the schizophrenia QIC, with a 
similar design as chapter 4. This chapter provides information on the impact of the 
QIC on schizophrenia process and outcome indicators in secondary care. The 
goal of the QIC was to implement the evidence-based interventions recommended 
in the multidisciplinary guideline and to improve the continuity of care for patients 
with schizophrenia. In addition, influencing factors are reported. 
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Abstract 
From 1999 until 2009 the National Steering Group for Multidisciplinary Guideline 
Development in Mental Health led a national guideline program in the Netherlands. 
Ten service user and carer groups and 30 professional organizations were 
involved. Within the program 13 practice guidelines and a range of other 
deliverables, such as patient versions, checklists and implementation materials, 
were produced. Lessons learned included the methodology of developing 
guidelines, service user and carer involvement, and the dissemination and 
implementation of the guidelines. There are important future challenges such as 
following a strict and transparent methodology, adhering to process management, 
improving integration of the service user and professional perspectives, and 
bridging the gap between guideline and practice. 
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Background 
In the last decade the Netherlands has been one of the leading countries in the 
field of guideline development. In the late 1980s a revolutionary shift in the 
healthcare system in the direction of more market-driven competition was initiated 
by the government. In order to assure the high quality of healthcare, stakeholders 
such as service user and professional organizations, health insurance companies, 
the inspectorate and the Ministry of Health, Welfare and Sport invested in a 
national program for the development of quality methods and instruments, such as 
standards, guidelines, quality assessment and improvement. From 1995, 
healthcare funding was placed almost entirely in the hands of for-profit healthcare 
insurance companies, who commissioned care from privately organized healthcare 
providers, but were almost fully reimbursed by the national government on their 
mental healthcare expenses. 
 In the 1980s the first systematically developed guidelines were published, 
following the example of the National Institutes of Health in the USA.1 Two 
institutes were pioneering in this area: the Dutch Institute for Healthcare 
Improvement (CBO), which published its first guideline on blood transfusion in 
1982, and the Dutch College of General Practitioners (Nederlands Huisartsen 
Genootschap, NHG), which produced its first guideline on diabetes in 1989. The 
goals of the CBO program were to develop criteria for quality assessment of 
hospital performance and to reduce unwanted variation in professional 
performance.1 The NHG guidelines aimed to support education and training and to 
develop the profession of the primary care physician.2 Before 1990 there was 
hardly any guideline development in psychiatry.3 The first ‘guideline’, the ‘onset of 
a protocol for the care of patients with suicide attempts in general hospitals’, was 
published in 1991.4,5 The Netherlands Psychiatric Association (NVvP) published its 
first monodisciplinary guidelines in 1998 on pharmacotherapy in bipolar disorder, 
schizophrenic psychoses and anxiety disorders. Other monodisciplinary 
psychiatric guidelines followed (see Table 1). 
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Table 1. Monodisciplinary guidelines for psychiatrists published by the Netherlands Psychiatric 
Association 
Guideline Year of publication
Depressive disorder 1994*
Pharmaco therapy in bipolar disorders 1998
Anti psychotics in schizophrenic psychoses 1998
Pharmaco therapy in anxiety disorders 1998
Patient education 1999
Psychiatric reporting 2002
Delirium, revision in 2011 2004
Psychiatric assessment, revision in 2011 2004
Bipolar disorders 2008
Coercive hospitalization and treatment 2008
Autism spectrum disorders in children 2008
Psychiatric consultation 2008
Electroconvulsive therapy 2009
Help with suicide of psychiatric patients 2009
Psychiatric reporting for legal court 2011
Drivers license assessment 2011
Car driving in autism 2011
Oppositional Defiant Disorder + Conduct Disorders (ODD/CD) 2011
Pediatric Delirium Planned 
Autism in adults Planned in 2012
* The first depression guideline was published by the CBO and was called a multidisciplinary guideline, 
despite its strong monodisciplinary character. 
 From the mid 1990s, the Ministry of Health, Welfare and Sport was concerned 
about the disparate and diverse guideline activities, and encouraged evidence-
based guideline development by funding large development programs, thereby 
instituting a shift from monodisciplinary to multidisciplinary guidelines. The first 
program was led by the National Association of Medical Specialists (OMS), the 
umbrella organization of various specialist societies.1 Because a single body of 
guidelines on mental health did not emerge spontaneously, the Ministry gave a 
strong top-down steer to multidisciplinary guideline development by installing the 
National Steering Group for Multidisciplinary Guideline Development in Mental 
Health in 1999 (NSGMH). It received a budget to lead a national guideline 
program in mental health until 2009, and involved around ten service user and 
carer groups and approximately 30 professional organizations. The activities and 
lessons learned during the ten years’ existence of the NSGMH were multiple.
 In this paper we present these activities, results and lessons learned on three 
components of the guideline program that we consider of special interest for the 
international audience: the methodology of developing multidisciplinary guidelines, 
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service user and carer involvement and dissemination and implementation. Our 
information is based on selected publications and reports found after a structured 
search of electronic databases, an Internet search of relevant Dutch journals and 
websites and papers retrieved from the authors’ archives.
Methodology of developing multidisciplinary guidelines 
The NSGMH was set up as an informal network of five professional organizations. 
Two separate committees addressed the issues of service user participation and 
implementation. The NSGMH selected the guideline topics and it appointed 
independent and authoritative chairs of the Guideline Development Working 
Groups (GDGs). The other members of the GDGs were appointed by the boards 
of the professional and service user organizations involved with the specific 
disorder. Two or three members of a technical team, working in the CBO, the 
Trimbos Institute or the National Centre of Expertise for Nurses (LEVV), were 
added to each GDG. 
 The mental health guidelines were developed according to the principles of 
evidence-based medicine procedures6 promoted by the Evidence-Based Guideline 
Development Platform (EBRO), a Dutch network initiated by the Dutch Cochrane 
Centre and CBO in 1997.7,8 The scope of the guidelines as well as the clinical 
questions to be answered by the guidelines were defined by the GDGs. Based on 
the questions, literature searches were performed by an information specialist and 
the reviewing and writing tasks were divided among the GDG members, 
professionals as well as technical team members. GDG members received some 
training and a small fee for their tasks. 
The format of the guidelines 
The guidelines were presented in a fixed format with specific headings for each 
topic or clinical question: (1) ‘Literature review’, ending in one or more 
‘Conclusions’, including level of evidence, (2) ‘Other considerations’ describing the 
translation of the evidence to recommendations for clinical practice as discussed 
within the GDG – these considerations could refer to the patient perspective, 
availability of services, costs and other organizational aspects influencing the 
content and applicability of the recommendations, and (3) ‘Recommendations’, 
providing practical answers or advice regarding the clinical questions posed. 
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External review and endorsement of the guidelines
After finalizing a draft of a guideline, copies were sent for comments to the boards 
of all organizations involved and to the Committee of Service User Participation, 
who also assessed the quality of the participation process and the patient-
centredness of the guideline recommendations. The comments were discussed in 
the final GDG meeting and amendments to the guidelines were made. The final 
version of the guideline, including an overview of the amendments based on the 
comments received, was returned to the professional organizations for formal 
endorsement or approval. After this process of endorsement, which could take 6
months to 1 year, the guidelines had legal implications according to Dutch law, 
being part of the professional norms and standards for individual clinicians 
established by the professional organizations. 
Multidisciplinary guidelines 
Thus far, 13 mental health guidelines have been developed and disseminated, 
including three updated versions (see Table 2). Two more guidelines (one on 
suicidal behaviour and one on heroin addiction) were developed following the 
formal abolition of the NSGMH in 2009, still using its infrastructure but having 
different funding. For four guidelines (on anxiety disorders, depression, 
schizophrenia and ADHD), additional funding to develop patient versions was 
received. Other products, derived from some of the guidelines, consisted of 
national mental healthcare programs (for anxiety disorders, depression, ADHD in 
young people and eating disorders) and online decision aids for patients (for 
anxiety disorders, depression and ADHD in young people9), published on the 
‘Dutch national healthcare portal’ (www.kiesbeter.nl).
Table 2. Multidisciplinary guidelines in mental health published from 2003 – 2011 
Guideline Year of publication Commissioner
Anxiety disorders 2003 + 2009 NSGS
Depressive disorders 2005 + 2009 NSGS + ZonMw
Schizophrenia 2005 + 2010 NSGS + ZonMw
ADHD in children 2005 NSGS
Eating disorders 2006 NSGS
Personality disorders 2008 NSGS
Interventions following disasters 2007 NSGS
Alcohol disorders 2009 NSGS
Domestic violence 2009 NSGS
Anxiety disorders in the elderly 2009 NSGS
Depressive disorders in the elderly 2009 NSGS
Depressive disorders in children 2009 NSGS
Somatically unexplained complaints and somatoform disorders 2010 NSGS
Suicidal behaviour 2011 ZonMw
Heroin addiction 2011 NVvP
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Innovation of the methodology
In 2006 the Ministry of Health, Welfare and Sport commissioned a new guideline 
program, not restricted to mental healthcare, aiming at the innovation of the 
guideline methodology.10 The update of the anxiety and depression guidelines was 
one of three pilot projects to experiment with innovative elements, such as having 
two guidelines revised by one GDG, involving healthcare professionals from the 
work setting and from healthcare insurance companies, and introducing a digital 
project environment and a budget impact analysis of the updated guidelines. The 
goals of the pilot were to create a process of ‘living guidelines’ and a streamlined 
update process to be repeated on a yearly basis as well as to enlarge the scope of 
the guidelines and make them usable in the work and health insurance setting. 
The plan was to have the updates completed within 1 year. This plan appeared to 
be too ambitious, but most of the other elements were viewed quite positively by 
the participants. Digital sharing and archiving of documents was seen as a 
success, but online interactive communication was considered too anonymous 
and cold if it was not balanced out with telephone conferences and face-to-face 
meetings. Another drawback was the available budget, which did not allow for in-
depth working procedures for the two guidelines and demanded very rigorous 
project management.10
Lessons learned 
Evaluations of the multidisciplinary guideline program led to the identification of 
several bottlenecks and possible solutions.11,12 First, in terms of topic selection, a 
structured process and assessment of topics had been lacking. New topics 
occasionally arose, unfortunately sometimes when the budget had already been 
allocated. This led to the suggestion that agenda setting and topic selection, as 
well as the decision about which professional and service user groups to involve in 
a GDG, need to be nationally organized and structured.11,12 Secondly, descriptions 
of roles and tasks were unclear in many GDGs. This resulted in mismatched 
expectations and delays in the process. Apart from rigorous project and process 
management by a project manager, a clear division of tasks among the technical 
team (for reviewing the evidence), a facilitator with good knowledge of the topic 
(for writing the drafts) and the expert members of the GDG (for discussing and 
deciding on the recommendations) was considered an important improvement.10-12
A third bottleneck was that the members of the GDGs were selected as 
representatives of their organizations and did not feel able to freely express their 
own point of view. This hampered discussions within the group, especially when 
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the represented organization was poorly organized, the evidence was weak, or 
when the recommendation was expected to have important consequences in 
practice.12 In several instances, nurses and allied healthcare professionals were 
provided with additional support to help them develop the ‘professional 
perspective’ of their organization as they did not always have the same body of 
knowledge to which to refer. Finally, it was suggested that the process of external 
review and endorsement should be improved, for instance by organizing 
stakeholder involvement from the start and by ensuring that the developmental 
processes were transparent and adhered to.11,12 
Service user and carer involvement
Service user and carer participation was a central element of the NSGMH’s
multidisciplinary guideline program. The vision was that ‘a guideline should, in an 
ideal world, contribute to the empowerment of the patient, making him or her better 
equipped for an active role in the treatment process’.13 This vision resulted in an 
extensive plan for service user involvement, and the production of a series of 
deliverables, such as a literature review on guideline participation14, two 
questionnaires for gathering guideline input on patient experiences and 
preferences15 and a scientific evaluation in which both service users and 
professionals were asked about the participation process in some of the GDGs.16
These products aimed to improve service user and carer participation in the 
development and implementation of guidelines in mental health. 
Methods of involvement 
Different formal methods of involving service users and carers were applied.17 In 
the first edition of the schizophrenia guideline, service users and carers formed a 
‘topic group’, addressing specific questions concerning the service user 
perspective, mainly about how to inform and address the patient properly. This 
group was supported by one of the professionals in the GDG, who wrote the 
patient perspective chapter, the largest chapter of the guideline. In the guidelines 
on depression and anxiety disorders, primary qualitative research was carried out 
among service users to identify experiences of care.18,19 In the guideline on 
personality disorders, a survey among service users and carers was performed 
with input from the three service users and carers in the GDG.20 The results of 
these research projects were discussed within the GDGs and resulted in either a 
separate chapter on the patient perspective or in the integration of the results in 
the guideline. 
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knowledge to which to refer. Finally, it was suggested that the process of external 
review and endorsement should be improved, for instance by organizing 
stakeholder involvement from the start and by ensuring that the developmental 
processes were transparent and adhered to.11,12 
Service user and carer involvement
Service user and carer participation was a central element of the NSGMH’s
multidisciplinary guideline program. The vision was that ‘a guideline should, in an 
ideal world, contribute to the empowerment of the patient, making him or her better 
equipped for an active role in the treatment process’.13 This vision resulted in an 
extensive plan for service user involvement, and the production of a series of 
deliverables, such as a literature review on guideline participation14, two 
questionnaires for gathering guideline input on patient experiences and 
preferences15 and a scientific evaluation in which both service users and 
professionals were asked about the participation process in some of the GDGs.16
These products aimed to improve service user and carer participation in the 
development and implementation of guidelines in mental health. 
Methods of involvement 
Different formal methods of involving service users and carers were applied.17 In 
the first edition of the schizophrenia guideline, service users and carers formed a 
‘topic group’, addressing specific questions concerning the service user 
perspective, mainly about how to inform and address the patient properly. This 
group was supported by one of the professionals in the GDG, who wrote the 
patient perspective chapter, the largest chapter of the guideline. In the guidelines 
on depression and anxiety disorders, primary qualitative research was carried out 
among service users to identify experiences of care.18,19 In the guideline on 
personality disorders, a survey among service users and carers was performed 
with input from the three service users and carers in the GDG.20 The results of 
these research projects were discussed within the GDGs and resulted in either a 
separate chapter on the patient perspective or in the integration of the results in 
the guideline. 
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Lessons learned 
In different evaluations of two of the participation processes (for the schizophrenia 
and eating disorders guidelines) positive as well as negative experiences of 
service users and professionals have been reported.16,21 Positive comments were 
given on the good social skills of the service users involved. Good support, 
preferably having someone assigned to the service users to help them formulate 
the patient perspective and discuss it within the GDG, and a clear description of 
the participatory tasks, were facilitating factors. The tasks of service users were, 
according to some, not to select and assess the literature but rather to help 
establish the clinical questions and the conclusions. In one of the GDGs, 
discussions between service users and professionals about the inclusion and 
quality of certain studies led to negative comments in the press after the release of 
the guideline, because the final version was not in accordance with the 
perspectives of a particular service user organization. Another important factor for 
acceptance of the guideline by service users is proper integration of the service 
user input in the final products and attractive summaries of guidelines for service 
users. However, funding was available for only a few topics to produce patient 
versions. 
Overall, developing evidence-based guidelines, in terms of the integration of the 
clinical expertise with the best available research evidence and patient values, 
was not an easy thing to achieve, which is in line with what is found in the 
literature.22 One of the first evaluation reports concluded that although the mental 
health guidelines paid attention to service user input, as long as the medical 
perspective dominated the process and the evidence-based rules for guideline 
development were applied, significant input from service users into the content of 
the guidelines was difficult, because their experiences and preferences were 
considered to be of a lower level of evidence.16 A more recent report on service 
user involvement within and outside mental health advocated a more structured 
process and systematic approach to participation as well as the development of 
methods to make the activities and effects of service user involvement more 
transparent.21
Dissemination and implementation 
From the start of the multidisciplinary guideline program, guideline implementation 
received explicit attention and was embedded in the NSGMH’s Committee on 
Implementation. This committee consisted of delegates of the professional 
organizations involved in the guideline program. The committee produced several 
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deliverables, such as an overview of implementation strategies23, a checklist for 
assessing the attributes of guidelines for successful implementation24, and a paper 
presenting the results of interviews with opinion leaders from different professional 
disciplines about the expected facilitators and barriers for guideline 
implementation.25 Another activity of this committee was the development of a set 
of indicators for monitoring the performances of psychiatrists, psychotherapists 
and psychologists on depression and anxiety disorders.26 This set was the only 
one to be developed by the NSGMH. It was published separately from the 
guidelines. There is no information about the use of these indicators in daily 
practice, as well as of any other indicators linked to the guidelines. 
Strategies
The guidelines were for sale as booklets via the Trimbos Institute and freely 
available (in Dutch only) via the NSGMH website (www.GGZrichtlijnen.nl), the 
CBO (www.cbo.nl) and the websites of professional societies such as the 
Netherlands Psychiatric Association (www.nvvp.net). Congresses, publications, 
and educational programs were other strategies to raise awareness among 
clinicians about the guidelines. Implementation programs, directed at changing 
existing routine into care according to guidelines, were no part of the guideline 
program but were initiated by either the professional organizations (accreditation 
and auditing), service user organizations (limited dissemination of service user 
versions or other promotion), the mental health institutions (education, integrated 
care systems and care pathways based on guidelines) and the CBO and Trimbos 
Institute (through a series of ‘quality improvement collaboratives’ (QICs), see 
below). 
 Over the last decade, two important practice developments have provided 
impetus for the implementation of guidelines in an indirect way: the introduction of 
integrated care systems and care pathways, and the large-scale launch of quality 
improvement collaboratives. The first instruments are mostly organizational 
translations of guidelines, but also contain practice-based descriptions of care. In 
the Netherlands around 75% of the mental health organizations have developed 
these instruments for specific patient groups and based the redesign of their care 
processes on them.27,28 The QICs have also become very popular in the 
Netherlands, especially within the Ministry of Health, Welfare and Sport. QICs are 
quality improvement projects, using multifaceted strategies to rapidly improve 
performance and outcomes. QICs generally have five essential features: (1) a 
focus on a specific topic with gaps between best and current practice; (2) clinical 
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experts providing ideas and support for improvement; (3) participation of
multidisciplinary teams from multiple sites; (4) a model for improvement (setting 
targets, collecting data and testing changes); and (5) a collaborative process with 
a series of structured activities in a given time frame.29,30 In the Netherlands the 
government has sponsored different large QIC programs over the last decade. 
Mental health QICs were directed at implementing guidelines on depression, 
anxiety disorders, schizophrenia and ADHD. All of them have led to improvements 
in the quality of care through guideline recommendations being implemented at 
the local level.31
Reception and uptake 
Multiple factors can influence the uptake of guidelines in daily practice, including 
the characteristics of guidelines themselves. Relevant technical characteristics of 
guidelines have been identified in the literature, such as having: (1) concrete aims 
and objectives, (2) sufficient evidence, (3) a clear structure and attractive lay-out, 
(4) clear and specific recommendations that take into account the norms and 
values of the target users, and (5) applicability in different settings.32
 Before the publication of the first multidisciplinary guideline, a qualitative 
research project reported that the new guidelines were welcomed by professionals 
because they were expected to structure the negotiation and relationships with 
service users, and with other healthcare professionals, to give access to scientific 
information and to strengthen the position of the allied health professions in the 
multidisciplinary field.25 After the publication of the first guidelines in 2003 and 
2005, many professionals thought the guidelines contained clear 
recommendations, a good scientific base, showed a good fit with daily work while 
leaving enough space for individual choice.33 Later, in 2008, a survey among 400 
psychiatrists, psychotherapists, psychologists, nurses and creative therapists 
showed that 91% of the respondents knew about the existence of the guidelines 
(among primary care physicians this was 73%) and two thirds of the respondents
indicated they possessed one or more of the guidelines.34 However, only 28% of 
the respondents reported intentionally using them in daily practice. Reasons for 
not using the guidelines were their poor applicability to problems encountered in 
daily practice and a lack of skills and time to apply them. There were quite large 
differences between the professional groups, psychiatrists being by far the most 
familiar with the content and use of the guidelines (89%) compared with 56% of 
social workers. This relatively high awareness of guidelines among psychiatrists is 
in line with the results of medical audits by the Netherlands Psychiatric 
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Association. Although the survey had limitations, a relevant outcome was that 
respondents who had participated in a quality improvement project such as a 
Breakthrough project or attended training or education used the guidelines more 
often.34
 A more fundamental issue for some professionals was the use of the Diagnostic 
and Statistical Manual of Mental Disorders (DSM) diagnosis as the starting point 
for guideline development. For instance the concept of schizophrenia as the basis 
for guidelines and treatment was considered ‘harmful’ and ignored ‘the relationship 
between a patient’s life history and the onset of symptoms and the possible link 
between the symptoms’.35 Romme35 concludes that ‘we do not yet know enough to 
draw up treatment guidelines and that from a scientific or ethical point of view the 
DSM cannot be regarded as the gold standard: for such treatment guidelines.’
 In line with this argument is the recurrent discussion about the narrow focus of 
the guidelines – that they give much attention to medical issues, such as symptom 
reduction, and much less to the perspective of the non-medical professions, and to 
issues such as the contexts and causes of symptoms.33,34 As a consequence, the 
guidelines limit recommendations about effective treatment to interventions based 
on evidence generated by randomized controlled trials. In the field of the 
psychological treatments, interventions other than cognitive and behavioural 
therapies such as person-centred psychotherapy are not reviewed because they 
lack sufficient evidence.33,34,36 
 To some, the lack of applicability was caused by the gap between the guideline 
recommendations and daily practice. Clinicians complained about the poor 
integration of the different multidisciplinary perspectives, leaving uncertainty 
among users about the roles and tasks of the different professions during the care 
process and the collaboration needed at different points.16,34 Other complaints are 
that the guidelines do not sufficiently respond to the problems encountered in daily 
practice37, to the expertise of professionals and existing best practice27,38, to 
specific patient characteristics, such as sex-related factors39 or to the information 
needs of specific disciplines.33 Finally, a common critique from virtually all 
professionals and service users, regardless of their background, was directed at 
the format of the guidelines: the books were too voluminous and lacked practical 
summaries, simple monodisciplinary instructions, algorithms, and service user 
versions.16,33,34 
 The dissemination and uptake of the service user versions of the guidelines 
have also been evaluated. Service user representatives indicated that these 
products were hardly known by the larger audience and virtually unused in the 
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consultations between service users and professionals. However, they do have a 
function as background literature for service user representatives.40
Conclusion and future directions 
In this paper we presented the national multidisciplinary guideline program in the 
Netherlands of the last 10 years, initiated by the Ministry of Health, Welfare and 
Sport and steered by a national group in which psychiatrists, psychotherapists, 
psychologists, primary care physicians, nurses, service user and carers closely 
collaborated. The evidence-based method of guideline development was 
introduced to almost 30 professional organizations, service users were part of 
each guideline project and attention was given to the implementation of the 
guidelines among different user groups. From 1999 until 2010, 13 guidelines and 
many more products were produced. Some of the projects were evaluated, as well 
as the program itself. Considering these achievements one can conclude that the 
program has been a success. 
 Summarizing the lessons learned, we can conclude that in terms of the 
guideline development methodology, an internationally accepted method has been 
developed and implemented over the last decade. Guideline development needs 
to be a transparent, evidence-based process with strict division of tasks and roles 
among the technical team and the professionals as well as having rigorous 
process and project management in order to prevent delays and mismatched 
expectations. Service user and carer participation has been an interesting learning 
experience, with a range of participatory methods applied, and experiencing 
difficulties in integrating service user input in an evidence-based guideline.
Dissemination of the guidelines, in terms of professionals becoming aware of 
them, has occurred during the last decade, although the academic professions 
have been more exposed to guidelines compared with the allied health 
professions or service users and carers. Still, coming from a situation in mental 
health in which there was virtually no familiarity with or acceptance of guidelines, 
this can be considered a real transformation. It is the implementation of the 
guidelines that will need the most of our attention in the coming years. This means 
a search for new formats of guidelines, lean methods of development and 
innovative implementation strategies, making optimal use of the enormous 
possibilities of information technology. But the biggest challenge will be to bridge 
the evidence – practice gap, in terms of developing guidelines that really offer 
meaningful information to professionals and service users, and inversely making 
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professionals and service users sensitive to using evidence in daily decision 
making. 
 These topics will be on the agenda of the new Guideline Network in Mental 
Health, a follow-up of the NSGMH, which was abolished in 2009 when direct 
government funding of the guideline program ended, and will be replaced by a 
new infrastructure, initiated and led by the professional organizations. This new 
organization, a formal collaboration of service user and professional organizations 
and the national centre of expertise in mental health (Trimbos Institute), will have 
to deal with these issues in a changing policy environment since the Ministry of 
Health, Welfare and Sport has announced the foundation of a national institute for 
quality of care in the coming years. This institute will co-ordinate, steer and monitor 
a national quality agenda, in close collaboration with professionals, service users 
and other stakeholders. After all, it is the quality initiatives from the healthcare 
providers themselves that will remain the crucial driver for change, with 
encouragement and support from national policy makers and funding bodies. 
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Abstract
Objective: To provide a comprehensive overview of the research on 
organizational changes aimed at improving healthcare for patients with severe 
mental illness and to learn lessons for mental health practice from the results. 
Method: We searched for systematic literature reviews published in English during 
2000 to 2007 in PubMed, PsycINFO, CINAHL, EMBASE, and the Cochrane 
Central Register of Systematic Reviews. Three reviewers independently selected 
and assessed the studies’ quality. Studies involving changes of who delivers 
healthcare, how care is organized, or where care is delivered were included. We 
categorized the studies using an existing taxonomy of 6 broad categories of 
strategies for organizational change. 
Results: A total of 21 reviews were included. Among these, 17 had reasonably
good methodological quality. Almost all reviews included or intended to include 
randomized controlled trials (RCTs), 6 reviews did not identify studies that met 
eligibility criteria. Multidisciplinary teams and integrated care models had been 
reviewed most frequently (a total of 15 reviews). In most studies, these types of 
changes showed better outcomes in terms of symptom severity, functioning, 
employment, and housing, compared with conventional services. Different results 
were found on cost savings. Other types of organizational changes, such as 
changing professional roles or introducing quality management or knowledge 
management, were much less frequently reviewed. Very few reviews looked at 
effects of organizational changes on professional performance.
Conclusions: There is a fairly large body of evidence of the positive impact of 
multidisciplinary teams and integrated care changes on symptom severity, 
functioning, employment, and housing of people with severe mental illness, 
compared with conventional services. Other strategies, such as changes in 
professional roles, quality or knowledge management, have either not been the 
subject of systematic reviews or have not been evaluated in RCTs. There is still a 
lack of insight in the so-called black box of change processes and the impact of 
change on professional performance. 
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Introduction
The challenges posed by chronic illnesses are especially pertinent to mental 
healthcare, as the prevalence and costs of chronic mental illness are growing and 
a clear perspective on their management is lacking.1 Chronic mental illness 
includes schizophrenia and related disorders, bipolar disorder, and depression 
with psychotic features. Schizophrenia is the most frequently diagnosed disorder 
among patients with severe mental illness, affecting 1% of the Canadian 
population. Though the incidence is low, the prevalence is high owing to lifelong 
chronicity. Globally, nearly 3% of the total burden of human disease is attributed to 
schizophrenia.2 In addition to persons with schizophrenia, many others are 
disabled by serious mental illnesses. Based on data from the National Comorbidity 
Study, Wang et al3 estimated that 5% of the US population is so affected. The 
cooccurrence of substance use disorder and severe mental illness, although 
frequently underdetected, is most common and clinically significant, affecting 
between 15% and 60% of individuals.4,5
In the past decades, better knowledge was acquired of the services that can help 
people with severe mental illness to lead satisfying lives. The evidence, taken in its 
entirety, points to the value of treatment approaches combining specific 
pharmacological treatment with specific psychosocial treatments, including 
psychological interventions (particularly cognitive-behavioural therapy), family 
interventions, supported employment, assertive community treatment, integrated 
treatment for dual disorders, and skills training.6 Studies also suggest that the 
provision of mental healthcare for patients with severe mental illness demands a 
better integration of treatment, rehabilitation, and support services at the clinical 
team level. Integration at this level can increase the effectiveness for patients with 
severe mental illness, while treatment integration at the organizational or system 
level seems less promising in terms of clinical effectiveness.7
 Despite this growing evidence base, the gap between what works and what is 
provided in routine mental health setting is still large, owing to various barriers.8
Although guidelines for the treatment of schizophrenia and bipolar disorders are 
available in many western countries, they have only marginally incorporated 
recommendations concerning psychosocial interventions and effective community 
treatment approaches.9 Widespread implementation of evidence-based care 
models for people with severe mental illness has generally failed until now.10
Patients experience problems at a system level, such as separate administrative 
divisions and funding pools and arbitrary service divisions, leading to 
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fragmentation of services, nonadherence, and dropout from treatment programs. 
This is especially the case for severely mentally ill patients with a comorbid 
substance abuse problem.4,5
There is a large body of research on how to implement guidelines and care 
models in routine daily practice, mainly from outside mental healthcare settings, 
which has provided relevant insights. Education targeted at consumers or health 
professionals is not always effective at changing healthcare practices and 
improving patient outcomes. In most cases, multifaceted strategies are needed, 
incorporated in a longer time multi-level approach, targeting patients, 
professionals, financing and regulatory systems, and care organizations.11-13
Further, implementation experts believe that tailoring of guidelines and care 
models to individual and locally relevant organizational factors is needed.14 For 
instance, in some settings it may be most helpful to set up multidisciplinary teams 
of care providers, while in other settings a specific treatment may have to be 
provided in another place, for example outside the hospital. There is no single 
solution to all implementation problems; however, it can be instructive to learn from 
experiences in other settings. While our general knowledge on effective transfer of 
evidence to practice is growing, there is less information on these issues in the 
area of specialized mental healthcare. 
 This article reviews the research evidence on organizational changes, aiming to 
improve evidence-based care for patients with severe mental illness. We focused 
on systematic reviews because they have a lower risk of biased results, compared 
with individual studies, even if these were RCTs.15 In a recent review of reviews, 
focusing on various healthcare settings, numerous organizational changes were 
found to improve professional performance, patient outcomes, and efficiency of 
services in many healthcare settings.16 We wondered whether such interventions 
would also be effective in the care for severe mental illness. 
Method 
Expecting the most relevant implementation literature to be only recently reviewed, 
we performed a search of systematic literature reviews, published in English 
during 2000 to 2007, in PubMed, PsycINFO, CINAHL, EMBASE, and the 
Cochrane Central Register of Systematic Reviews. 
Combinations of search terms related to the following keywords were used: severe 
mental illnesses, schizophrenia, bipolar disorder, organizational interventions, 
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meta-analysis, or systematic reviews. Organizational changes were defined 
according to the Cochrane Effective Practice and Organisation of Care Group 
definition as interventions that involve a change in the service delivery of 
healthcare. This change involves who delivers healthcare, how care is organized, 
or where care is delivered.17 A taxonomy of existing organizational interventions 
was used (Box 1). 
Box 1. A taxonomy of organizational changes to improve patient carea 
Revision of professional roles: substitution of tasks from one professional by the other or by a 
supplementation of a set of tasks by a new team member
Multidisciplinary teams: clinical teams or collaborations of multiple professional disciplines
Integrated care services: organized systems for care delivery to patients with specific diseases, who 
receive care according to a protocol, which covers the spectrum from screening to education, 
treatment, and monitoring. Also labeled as disease management programs or integrated care 
pathways. Case management has been included in this category.
Knowledge management: optimal organization of knowledge within an organization. In practice, it 
mainly refers to the use of information and communication technology to support patient care, such 
as computerized medical record-keeping.
Quality management: a group of approaches characterized by a focus on customers, continuous 
efforts to improve, performance measurement and supportive leadership and culture. Total quality 
management, continuous quality improvement, and business redesign are included in this category.
Changes in setting: a change in the location of care delivery.
aDerived from Wensing et al16
Three reviewers independently assessed the eligibility of studies, based on a 
screening of titles and abstracts. All selected reviews were appraised by 2 
reviewers independently, using a structured data extraction form containing 
questions about the focus of the review, the search strategy, the methodological 
quality, and the main results. The form also contained 6 quality assessment 
questions that focused on the reviews information about the search strategy and 
the intended assessment and analysis of the eligible articles. We based these 6 
questions on those used in other reviews of reviews (Box 2). 
Part I – Strategies for quality improvement in mental healthcare 
58
Box 2. Quality assessment questions for included reviewsa
Is the search strategy described (search terms)?
Was the search for evidence reasonably comprehensive (relevant databases, reference lists in 
included articles, authors and [or] experts contacted)?
Were the criteria for deciding which studies to include in the review reported (types of studies, 
participants, interventions, outcomes)?
Was bias in the selection of articles avoided (explicit selection criteria used, independent screening 
of full text by at least 2 reviewers)?
Were the criteria for assessing the validity of the studies that were reviewed reported?
Last point: Were the methods used to combine the findings of the relevant studies reported (to 
reach a conclusion)?
aDerived from Oxman42
We valued each quality question as follows: a positive answer received 1 point; a 
cannot tell or partial answer received 0.5 points; and a negative answer received 
0 points. We added up the total number of points for each of the 6 questions to 
calculate the total score for each review. Substantial differences of opinion among 
reviewers throughout the process were resolved by returning to the relevant 
literature and by discussion. The studies were ordered and described according to 
6 broad categories of strategies for organizational change, looking at the most 
important characteristics of the organizational change that was implied (Box 2). 
Where possible, effect sizes were expressed in terms of average effect size, odds 
ratio, relative risk (categorical outcome data), weighted mean difference, 
standardized mean differences (for continuous data), number needed to treat, or 
percentage of studies with improvements. In case of a meta-analysis, a significant 
effect or a nonsignificant effect was recorded. Where quantitative summary 
measures of effectiveness were not performed, the range of effects across studies 
was used. 
Results
Description of studies 
A total of 21 reviews were included.4,5,18-36 The most relevant reasons to exclude 
papers were that they did not: focus on severe mental illness, study an 
organizational change, or have a method section describing their review methods 
(Figure 1). Of the included reviews, 17 reviews scored 4 to 6 points regarding 
methodological quality. Four articles received a lower score, owing to a lack of 
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information on all our quality criteria. Almost all reviews included only controlled 
trials or RCTs. Six reviews did not find any eligible studies. We still included these 
in our review and assessed their search strategy and the quality of the intended 
assessment procedures described.19,20,24,25,27,33 The maximum number of studies 
included in a single review was 26. The mean number of studies per review was 
11, excluding the reviews with no studies. 
Figure 1. Flow chart of included studies 
Potentially relevant articles 
identified and screened on basis 
of title and abstract (n=662)
Articles excluded: did not meet 
inclusion criteria on design, 
problems, setting, or intervention 
(n=624)
Articles retrieved for more 
detailed evaluation (n=38)
Articles excluded: did not meet 
inclusion criteria on  description 
of methodology, patient category 
or intervention
Total number of 
articles included 
in review (n=24)
Total number of 
studies included 
in review (n=21)
Effectiveness of the revision of professional roles
One review was included in this category but found no eligible studies (Table 1). 
The review aimed to assess several strategies including the role of nurses 
prescribing medication. 
Table 1. Studies examining the revision of professional roles (n=1) 
Study, n, type, 
years searched
Quality 
score
Focus and (or) comparison Type of outcomes
found:
Methods and main 
results 
Muralidharan et
al.33
n=0, RCTs, 
up to 2006
5,5 Containment strategies for 
managing acutely disturbed 
people, including changes in 
patient-staff ratios, tasks of 
nurses and locked wards. 
Patient outcomes*
Costs
no studies included
* Patient outcomes can be: engagement with treatment (lost to follow up, leaving the study early), clinical 
outcomes (death, mental state, symptoms, social and cognitive functioning), adverse effects, (clinical, 
violence, criminal behaviour), quality of life, burden on relatives, satisfaction with care, employment 
status, homelessness and service use ( admissions to hospital, mean days in inpatient care). 
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Effectiveness of multidisciplinary teams 
Seven reviews were included in this category (Table 2). Three reviews assessed a 
well-defined and -researched multidisciplinary team approach, namely, the ACT 
program.18,21,28 The main goal of ACT is to prevent hospitalization in patients at 
risk for relapse through provision of comprehensive integrated community 
services.18 The model prescribes that patients are assigned to one 
multidisciplinary team with a fixed caseload and a high staff to patient ratio that 
enables more intensive contact. It delivers all services when and where needed by 
the patient, 24 hours a day, 7 days a week. Most ACT programs that were 
investigated appear to adhere to some degree to the standards for ACT care 
processes and professional behaviour, but also deviate from the specifications in 
some way.28 Although a lot of research on ACT exists, active ingredients of these 
programs have not been identified so far. The positive effects could be due to 
improved medication compliance, continuity of caregivers, 24-hour coverage, site 
of and intensity of services, or a combination of these elements.18
Table 2. Studies examining the effectiveness of multidisciplinary teams (n=7) 
Study, n, type, 
years searched
Quality 
score
Focus Type of outcomes
found:
Methods performed and main 
results 
Bustillo et al.18 ,
n=18, RCTs, 
1966-2000
2 Assertive Community 
Treatment and Supported 
Employment programs for 
people with schizophrenia 
versus control. 
Patient outcomes*
Costs
Narrative review.
ACT: reduction of time spent in 
hospital: PSI 14/24 = 58%, 
improved housing stability: PSI 
9/13 = 69%, modest effects on 
functioning, different results on 
cost savings: PSI 1/2=50%.
Supported Employment: 
significant increased rates of 
competitive employment: 
unweighted mean 65% vs 26%, 
no beneficial effects on re-
hospitalization.
Coldwell et al.21,
n=10, 6 RCTs
and
4 observational 
studies,
up to 2003
5 Assertive Community 
Treatment for homeless 
severely mentally ill 
compared to standard 
case management
Patient outcomes Meta-analysis
ACT favours housing: WMD 
37%, CI 18-55% and symptom 
severity: WMD=26%, CI 7-44%. 
No difference in hospitalization: 
WMD=10%, CI -7-27%.
Kirsch et al.28,
n=16,
9 experimental or 
quasi-
experimental and
7 non-
experimental,
1990-2003
3 Looking at employment 
outcomes of Assertive 
Community Treatment
Patient outcomes, 
focused on 
employment 
outcomes
Narrative review
ACT has better employment 
outcomes in RCTs: PSI = 6/7, 
compared to usual treatment, 
especially in teams including a 
vocational specialist. 
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services.18 The model prescribes that patients are assigned to one 
multidisciplinary team with a fixed caseload and a high staff to patient ratio that 
enables more intensive contact. It delivers all services when and where needed by 
the patient, 24 hours a day, 7 days a week. Most ACT programs that were 
investigated appear to adhere to some degree to the standards for ACT care 
processes and professional behaviour, but also deviate from the specifications in 
some way.28 Although a lot of research on ACT exists, active ingredients of these 
programs have not been identified so far. The positive effects could be due to 
improved medication compliance, continuity of caregivers, 24-hour coverage, site 
of and intensity of services, or a combination of these elements.18
Table 2. Studies examining the effectiveness of multidisciplinary teams (n=7) 
Study, n, type, 
years searched
Quality 
score
Focus Type of outcomes
found:
Methods performed and main 
results 
Bustillo et al.18 ,
n=18, RCTs, 
1966-2000
2 Assertive Community 
Treatment and Supported 
Employment programs for 
people with schizophrenia 
versus control. 
Patient outcomes*
Costs
Narrative review.
ACT: reduction of time spent in 
hospital: PSI 14/24 = 58%, 
improved housing stability: PSI 
9/13 = 69%, modest effects on 
functioning, different results on 
cost savings: PSI 1/2=50%.
Supported Employment: 
significant increased rates of 
competitive employment: 
unweighted mean 65% vs 26%, 
no beneficial effects on re-
hospitalization.
Coldwell et al.21,
n=10, 6 RCTs
and
4 observational 
studies,
up to 2003
5 Assertive Community 
Treatment for homeless 
severely mentally ill 
compared to standard 
case management
Patient outcomes Meta-analysis
ACT favours housing: WMD 
37%, CI 18-55% and symptom 
severity: WMD=26%, CI 7-44%. 
No difference in hospitalization: 
WMD=10%, CI -7-27%.
Kirsch et al.28,
n=16,
9 experimental or 
quasi-
experimental and
7 non-
experimental,
1990-2003
3 Looking at employment 
outcomes of Assertive 
Community Treatment
Patient outcomes, 
focused on 
employment 
outcomes
Narrative review
ACT has better employment 
outcomes in RCTs: PSI = 6/7, 
compared to usual treatment, 
especially in teams including a 
vocational specialist. 
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Study, n, type, 
years searched
Quality 
score
Focus Type of outcomes
found:
Methods performed and main 
results 
Marshall et al.31,
n=7, 1 on
integrated teams,
up to 2002
6 7 comparisons including 
integrated team versus 
standard care to improve 
outcome in first episode 
psychosis.
Patient outcomes 
Costs
Narrative review, data on 
relevant comparison derived 
from 1 study. Numbers of 
people leaving the study early 
were significantly lower in the 
integrated treatment group, by 
one year: RR 0.59, CI 0.4-0.8 
and by two years: RR 0.64, CI 
0.5-0.8. functioning, user 
satisfaction and compliance with 
treatment were better in the 
intervention group. 
Mitchell32, n=7,
1 RCT and 1
pragmatic 
controlled trial for 
chronic mentally 
ill patients,
up to 2001
4 Monthly case-
conferencing and regular 
consultations between a 
primary care physician
and an outpatient-based 
team
Patient outcomes
Professional 
behaviour 
Costs
Narrative review
Sign. decrease in mean number 
of unmet needs: 0.57 vs 1.62 (p 
< 0.001), sign. increase in mean 
number of met needs: 2.62 vs 
1.60 (p < 0.001 ). Less 
readmissions: 27% vs 64%, (p 
0.002). During intervention more 
contact with health services: 
community psychiatric nurse 
71% vs 30%, social worker 48% 
vs 26%, occupational therapist 
48% vs 2% (p < 0.01). Client 
satisfaction better on scale 1-4.
low is better 1.86 vs 2.23.
Simmonds et
al.34,
n=5, RCTs and
quasi- controlled 
trials, up to 1998
5,5 Community mental health 
team (CMHT) 
management
Patient outcomes
Costs
Meta-analysis
Sign. benefits with respect to 
deaths by suicide or suspicious 
circumstances: OR 0.32, CI 
0.09-1.12. Sign. smaller 
proportion dropped out of CMHT
management early: OR 0.61, CI 
0.45-0.83. Less costs for people 
treated with CMHT 
management. 
Simpson35, n=12,
RCTs and 7 other 
comparative 
studies,
1966-2001
5 Users involved in health 
service and healthcare 
delivery by a team as 
providers or trainers of 
service providers.
Process measures 
of involvement, 
outcomes for 
involved users and 
their patients
Narrative review, no numeric 
data.
Users spent more time in 
contact with patients and less 
time on telephone and office 
work. No effects in clinical 
outcomes, some improvement in 
quality of life, social functioning, 
reported life problems, burden to 
the family, less admissions to 
hospital
* Patient outcomes can be: engagement with treatment (lost to follow up, leaving the study early), clinical 
outcomes (death, mental state, symptoms, social and cognitive functioning), adverse effects, (clinical, 
violence, criminal behaviour), quality of life, burden on relatives, satisfaction with care, employment 
status, homelessness and service use ( admissions to hospital, mean days in inpatient care). 
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One review actually found a reduced time spent in hospital and improved housing 
stability but modest effects on functioning, and different results on cost savings.18
This review showed that programs that more closely resemble the original ACT 
model tend to have a more reliable effect on hospitalization. More recent studies 
tend to show no differences among study groups, potentially as a result of 
enriched packages of high-quality clinical case management as control conditions. 
Another review looked at the effect of ACT on a subpopulation of homeless 
mentally ill individuals and found significant improvements in rates of 
homelessness and levels of psychiatric symptom severity. No differences were 
found in reducing hospitalization for this population.21 Another review looked at 
employment outcomes and found the ACT model to be superior to usual 
treatment.28 The studies that did not include a vocational specialist were more 
mixed in their results, suggesting that a vocational specialist may have a positive 
impact on outcomes.
 Multidisciplinary community mental health teams are widely recognized generic 
care teams offering a range of interventions. Although they have a much lower 
profile than the assertive community teams, one review found that they show 
positive effects on deaths, leaving care early, hospitalization, and costs.34
 Another multidisciplinary team approach consists of early intervention for 
patients with prodromol symptoms or patients with first episode psychosis. Teams 
provide integrated care and are considered alternatives to standard psychiatric 
care. One review showed that, owing to insufficient data, there was little evidence 
to support the introduction of either specialized teams or standard care for this 
patient group. This might change in the near future, as several large studies are 
still ongoing.31
Collaboration among primary care physicians and specialists in multidisciplinary 
teams in improving functional outcomes for chronic mentally ill patients was 
investigated in 2 small studies included in one of the reviews.32 The studies 
showed a modest positive impact that did not occur in physically chronically ill 
patient groups. The arrangements with the primary care physician consisted of 
monthly case-conferencing and regular consultations with an outpatient-based 
team.32
 One review looked at the effects of involving patients as employees in service 
delivery teams, mostly as case managers.35 Current or former users of mental 
health services owing to serious mental illness were added to the professional 
team. They received training, support, and payment to learn necessary 
organizational and interpersonal skills. Some studies indicated benefits for clients 
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of user employees, such as improvement in quality of life, social functioning, and 
burden to the family. No serious disadvantages were found. 
Effectiveness of integrated care services
Eight reviews assessing integrated care services were included (Table 3).
Integration of mental health and housing services
Supported housing schemes involve self-contained apartments located in a shared 
building or site with office-based professional workers available during office hours 
to support tenants, to maintain the tenancy, or to prevent homelessness. One 
review aimed to assess the effectiveness of supported housing schemes for 
people with severe mental illness living in the community but did not find eligible 
studies.20
Integration of vocational rehabilitation and mental health services
Two reviews focused on programs integrating treatment and approaches to 
improve the employment status of people with severe mental illness.37 Models 
entitled Prevocational Training, Supported Employment, and a modification of the 
latter model, namely, Individual Placement and Support, were assessed. In 
Prevocational Training, participants undergo a period of preparation, such as 
working in a sheltered environment or receiving some form of pre-employment 
training, before they are encouraged to seek competitive employment. Supported 
Employment is a place-then-train approach that attempts to place clients 
immediately in competitive employment, with less than a month of preparation. 
Patients then receive on-the-job training. A modification of the Supported 
Employment program is the Individual Placement and Support model. This model 
is usually integrated within mental health settings so that participants have access 
to healthcare providers and vocational specialists. The treatment team 
collaborates with the participants' coworkers and supervisors. Both reviews found 
that Supported Employment programs, including Individual Placement and 
Support, are superior to conventional types of rehabilitation.36 Prevocational 
training was not found to be superior to standard care. Owing to methodological 
limitations, little evidence was found that vocational programs improved symptoms, 
quality of life, or social functioning.37
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Table 3. Studies examining the effectiveness of integrated care services (n=8) 
Study, n, type, 
years searched
Quality 
score
Focus Type of outcomes
found:
Main results 
Brunette et al.4,
n=10, controlled 
studies,
not reported
1.5 Programs for people with 
severe mental illness and 
co-occurring substance use 
disorders, integrating 
mental health treatment, 
substance abuse 
interventions, housing and 
other support at different 
levels of integration. 
Patient outcomes* Narrative review
Improved retention: 
PSI 7/8 = 87,5%,
Improved housing: 
PSI 3/4 = 75%,
Substance abuse improved: 
PSI 5/10 = 50%. 
Chilvers et al.20,
n=0, randomized
or quasi- RCTs,
up to 2006
5,5 Supported housing 
schemes compared with 
outreach support schemes 
or standard care
Patient outcomes
Professional 
satisfaction
Costs
No studies included
Crowther et al.22,
n=18 RCTs,
up to 1998
5,5 Varieties of work 
rehabilitation programs, 
Supported Employment 
and Individual Placement 
and Support versus 
Prevocational Training. 
Patient outcomes, 
mainly employment 
outcomes
Costs
Meta-analysis
Supported Employment is 
superior to Pre-vocational 
Training, 34% of clients 
employed in the Supported 
Employment group, versus 
12% in Pre-vocational training, 
ARR= 0.76, CI 0.69-0.84. 
No major differences in clinical 
outcomes and costs.
Drake et al.23 ,
n=26, controlled 
studies, 
1994-2003
1,5 Integrated care packages 
with mental health and 
substance abuse 
professionals in the same 
team 
Patient outcomes Narrative review, no numeric 
data
Greater treatment progress 
and decreased drug/alcohol 
use outcomes in all relevant 
studies (n=4), other outcomes 
similar.
Hickling et al.25,
n=0, RCTs, 
up to 2001
5,5 Treating psychosis in open 
general medical wards
Patient outcomes 
Costs
No studies included
Joy et al. 26,
n=0, RCTs, 
up to 2006
5,5 Mother and baby units for 
the treatment of perinatal 
psychosis 
Patient outcomes 
(mother and child)
No studies included
Jeffery et al. 5 ,
n=6, RCTs,
up to 1998
6 Substance misuse 
treatment programs 
combined with psychiatric 
care versus psychiatric 
care alone and different 
types of integrated 
treatment programs versus 
non-integrated programs 
and each other. All
programs for people with 
problems of both substance 
misuse and serious mental 
illness.
Patient outcomes Meta-analysis
Number of people lost to 
evaluation: no difference 
between the combined 
program and standard care at 
6 months: OR 0.99, CI 0.58-
1.67. People lost to treatment: 
no clear difference between 
integrated and non-integrated 
program: OR 0.38, CI 012-
1.23 and no difference 
between ACT vs other 
program: OR 1.66, CI 0.77-
3.58.
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Study, n, type, 
years searched
Quality 
score
Focus Type of outcomes
found:
Main results 
Twamley et al.36,
n=11, RCTs,
up to 2002
4 Work rehabilitation 
programs, Supported 
Employment and Individual 
Placement and Support
Patient outcomes 
only 
employment 
measures
Meta-analysis
Better outcomes compared to 
conventional services in terms 
of achieving competitive work: 
WMD based on 5 studies: 
0.79, increased chance of 
obtaining competitive work: 
OR 4.14.
* Patient outcomes can be: engagement with treatment (lost to follow up, leaving the study early), clinical 
outcomes (death, mental state, symptoms, social and cognitive functioning), adverse effects, (clinical, 
violence, criminal behaviour), quality of life, burden on relatives, satisfaction with care, employment 
status, homelessness and service use ( admissions to hospital, mean days in inpatient care). 
Integrated services for dual diagnoses
Three reviews looked at integrated services for dual-diagnoses patients.4,5,23 One 
review looked into the effects of integrated and nonintegrated treatment programs 
within psychiatric care, as opposed to standard psychiatric care. One of the 
6 included studies compared the ACT model with any other integrated care model. 
No evidence was found that integrated care produced better or worse outcomes.5
Another review of integrated care for dual-diagnoses patients included studies that 
explicitly assessed the impact of organizational and structural changes. These 
studies focused on mental health and substance abuse clinicians as joint 
members of the same ACT team, without specifying the clinical intervention given 
by these teams.23 The review reported mainly positive effects on patient outcomes; 
no outcomes at the level of professional practice were reported. 
 Because dual diagnoses are associated strongly with unstable housing and 
homelessness, residential programs have emerged as a popular intervention 
strategy. A third review investigated the effects of integrated residential programs 
for people with dual disorders, looking at the effects associated with different 
levels of integration.4 Among 10 controlled studies, all with major methodological 
difficulties, 9 suggested positive effects of residential dual-diagnosis programs that 
integrate and modify mental health and substance abuse treatment approaches. 
Greater levels of integration were associated with better engagement and 
retention in treatment. The specific structures and components of the programs 
varied among the studies and little can be said about which are most effective.4 
Integration of psychiatric and medical services in general hospital
One review aimed to assess the impact of integrated care for mothers with a 
perinatal psychosis and their children. Mother and baby units are common in the 
United Kingdom, but no RCTs could be found that suggest the efficacy of this type 
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of care, compared with inpatient care for mothers without any attachment to a 
mother and patient unit.27 Another review assessed the evidence for the benefits 
of open general medical wards to treat people with psychosis, compared with 
specialist psychiatric units. This model, requiring the integration of psychiatric 
treatment procedures into services provided by nurses and doctors of conventional 
hospital wards, can be especially relevant to countries with limited psychiatric 
inpatient care. No studies met inclusion criteria.25
Effectiveness of knowledge management
No reviews were included in this category. 
Effectiveness of quality management
One review assessed the value of outcome measurement and needs assessment 
tools in everyday routine care and the feedback they provide to clinicians and 
clinical teams in improving the management and outcome of patients with 
schizophrenia and related disorders. Although in the United Kingdom numerous 
policy initiatives are aimed at the introduction of outcomes measurement tools, no 
RCTs were found on this topic (Table 4). 
Table 4. Studies examining the effectiveness of quality management (n=1) 
Study, n, type, 
years searched
Quality 
score
Focus Type of outcomes
found:
Main results 
Gilbody et al. 24,
n=0, RCTs,
up to 2002
6 Standardized instruments to 
help clinicians make decisions 
about treatment for persons 
with schizophrenia and to 
assess subsequent therapeutic 
impact.
Patient outcomes*
Professional outcomes 
(acceptability, adapting 
treatment plan)
Costs
No studies included
* Patient outcomes can be: engagement with treatment (lost to follow up, leaving the study early), clinical 
outcomes (death, mental state, symptoms, social and cognitive functioning), adverse effects, (clinical, 
violence, criminal behaviour), quality of life, burden on relatives, satisfaction with care, employment 
status, homelessness and service use ( admissions to hospital, mean days in inpatient care). 
Effectiveness of changes in setting of care provision
We found 4 reviews on these types of changes (Table 5). 
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Table 5. Studies examining the effectiveness of changes in setting (n=4) 
Study, n, type, 
years searched
Quality 
score
Focus Type of 
outcomes found:
Main results 
Catty et al.19,
n=0, RCTs, 
up to 2006
6 Non-medical day 
centre care for people 
with severe mental 
illness
Patient outcomes
Costs
No studies included
Joy et al.26,
n=5 RCTs, 
up to 2006
6 Crisis intervention at 
home compared to 
standard hospital 
based crisis 
intervention
Patient outcomes
Costs
Meta-analysis
Persons with home based crisis 
intervention were more likely to stay in 
care for at least a year (NNT 13, CI 7 
tot 130). Repeated hospital 
admissions ARR=0.72 (95% CI 0.54-
0.97). Favourable outcomes on 
burden on families.
Costs: home based care found to be 
significantly cheaper (PSI 2/2 =100%)
Marshall et al. 29
n=8, RCTs,
3 trials 
concerning 
individuals with 
schizophrenia,
up to 2000
6 Day treatment 
programs, day care 
centres or transitional 
day hospital care 
versus out-patient 
care for people with 
psychiatric disorders
Patient outcomes
Costs
Meta-analysis
Day treatment group data showed a 
trend favouring day treatment in terms 
of improved mental state: RR 1.85 CI 
0.99-3.46 at 18-24 months. Insufficient 
evidence in terms of other outcomes. 
Also insufficient evidence that day 
care centres are superior to out-
patient care. Mental state outcomes at 
3 months: WMD 0.31, CI -0.20-0.82. 
Some inconclusive data on costs, 
suggesting day care centres may be 
more expensive. Only one trial on 
transitional day hospitals. Insufficient 
evidence to show superiority over out-
patient care. Mental state outcomes at 
12 months: WMD 0.17, CI -0.39-0.73. 
Marshall et al.30,
n=9, RCTs,
up to 2000
6 Day hospital versus 
inpatient care for 
people with acute 
psychiatric disorders
Patient outcomes
Costs
Meta-analysis
Combined data suggests that acute 
day hospitals may reduce inpatient 
admissions by about 23%. 
No effects on social functioning and 
burden on carers. 
Day hospital care 20.9-36.9% cheaper 
than inpatient care (PSI 4/5=80%). 
* Patient outcomes can be: engagement with treatment (lost to follow up, leaving the study early), clinical 
outcomes (death, mental state, symptoms, social and cognitive functioning), adverse effects, (clinical, 
violence, criminal behaviour), quality of life, burden on relatives, satisfaction with care, employment 
status, homelessness and service use ( admissions to hospital, mean days in inpatient care). 
Day hospitals and day centres
Two reviews looked at the impact of day hospitals or day centres as alternatives to 
outpatient care.19 One review focused on day care centres, psychiatric day 
hospitals offering continuing care to patients with severe mental disorders.29 Day 
centres were not superior to outpatient care in terms of engagement with care, 
admission rates, clinical outcomes, patient satisfaction, or costs. A second review 
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unsuccessfully looked for RCTs of nonmedical day centres, offering long-term 
support for the chronically ill, as an alternative to outpatient departments and day 
hospitals run by health professionals.19 The authors suggest that British policy 
makers’ recent emphasis on this type of day care is not matched by robust 
evidence concerning their effectiveness in meeting clinical and social needs. 
Changes in acute care setting  
Two reviews investigated different forms and settings of care for people with acute 
psychiatric problems.30 Marshall found 9 studies showing better patient outcomes 
of psychiatric day hospitals, compared with acute inpatient care, at probably lower 
costs. The number of days in hospital are the same; however, patients spend more 
of these days in the cheaper day facility. Another review studied the effect of crisis 
intervention at home, compared with in hospital.26 Crisis intervention was not 
investigated in a pure form but integrated in a package of community care. The 
authors suggest that a well-organized team, using a crisis intervention ethos, may 
provide care that is more acceptable to patients and their families and less 
burdensome for the families than if the individual was admitted to standard 
hospital care. The authors conclude that crisis intervention at this moment is
widely implemented without good evidence. 
Discussion 
Main findings 
The goal of this review was to provide an evaluation of the effectiveness of 
organizational strategies aimed at the transfer of evidence to practice and at 
improving care for patients with severe mental illness. We also intended to provide 
recommendations for mental health physicians. We found 21 systematic reviews 
published from 2000 to 2007 and analyzed them according to an existing 
framework for organizational change strategies.17 We assessed the overall quality 
of the reviews as moderately good. Only 2 reviews allowed observational designs 
to be included; 13 reviews restricted their study to RCTs. Summarizing, our main 
findings were:
 There is a fairly good body of evidence in the field of severe mental illness care 
that shows that organizational change leads to improved patient outcomes. Most 
evidence referred to changes in multidisciplinary teams, integrated care services, 
and changes in service setting. Specific organizational models have been 
particularly well elaborated and shown effective in terms of patient outcomes, such 
Part I – Strategies for quality improvement in mental healthcare 
68
unsuccessfully looked for RCTs of nonmedical day centres, offering long-term 
support for the chronically ill, as an alternative to outpatient departments and day 
hospitals run by health professionals.19 The authors suggest that British policy 
makers’ recent emphasis on this type of day care is not matched by robust 
evidence concerning their effectiveness in meeting clinical and social needs. 
Changes in acute care setting  
Two reviews investigated different forms and settings of care for people with acute 
psychiatric problems.30 Marshall found 9 studies showing better patient outcomes 
of psychiatric day hospitals, compared with acute inpatient care, at probably lower 
costs. The number of days in hospital are the same; however, patients spend more 
of these days in the cheaper day facility. Another review studied the effect of crisis 
intervention at home, compared with in hospital.26 Crisis intervention was not 
investigated in a pure form but integrated in a package of community care. The 
authors suggest that a well-organized team, using a crisis intervention ethos, may 
provide care that is more acceptable to patients and their families and less 
burdensome for the families than if the individual was admitted to standard 
hospital care. The authors conclude that crisis intervention at this moment is
widely implemented without good evidence. 
Discussion 
Main findings 
The goal of this review was to provide an evaluation of the effectiveness of 
organizational strategies aimed at the transfer of evidence to practice and at 
improving care for patients with severe mental illness. We also intended to provide 
recommendations for mental health physicians. We found 21 systematic reviews 
published from 2000 to 2007 and analyzed them according to an existing 
framework for organizational change strategies.17 We assessed the overall quality 
of the reviews as moderately good. Only 2 reviews allowed observational designs 
to be included; 13 reviews restricted their study to RCTs. Summarizing, our main 
findings were:
 There is a fairly good body of evidence in the field of severe mental illness care 
that shows that organizational change leads to improved patient outcomes. Most 
evidence referred to changes in multidisciplinary teams, integrated care services, 
and changes in service setting. Specific organizational models have been 
particularly well elaborated and shown effective in terms of patient outcomes, such 
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as Assertive Community Treatment, Supported Employment, and Community 
Mental Health Teams. 
 Conversely, specific organizational change strategies, such as revision of 
professional roles, knowledge management (better use of information technology), 
and quality management (continuous quality improvement, performance 
measurement), have not been included in systematic reviews of RCTs. Therefore 
it is difficult to assess their impact. 
 The studies focused mostly on patient outcomes, a few also on cost-
effectiveness. Consequently, measures of professional and organizational 
performance were hardly studied, so that the implementation processes remained 
a so-called black box. Therefore, it is difficult to provide guidance to health 
professionals, managers, and policy makers regarding how to implement a specific 
organizational model in their daily work environment. 
Limitations 
Although we searched systematically in various databases, relevant publications 
might have been missed. Our review contained only recent reviews of 
organizational interventions; earlier work has not been assessed. However, a 
screening of the older review literature gave us the same impression: health 
services research in severe mental illness has mainly focused on different models 
of case management, integrated care, or multidisciplinary care teams. Apart from 
older reviews, we also missed the nonreviewed literature on quality improvement 
strategies. 
As for the analysis of included studies, we focused on the most important findings 
of each review, but inevitably this implies that other results were ignored. Also, we 
have no clear impression of the overlap in studies across the reviews. We 
observed that many studies and reviews did not report on professional or 
organization performance, although it was likely that these had changed if the 
intervention improved patient outcomes. This implies that our insight into the 
behavioural and organizational processes, which led to improved patient 
outcomes, remained very limited.  
Implications for practice and research
In this review, we looked at existing research from a knowledge transfer or quality
improvement perspective. Our first finding affirms the work of other authors,7 that 
organizational models directed at better multidisciplinary team work and integration 
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of care services can improve health outcomes for patients with severe mental 
illness. The strong attention given to these strategies in chronic mental illness is a 
logical one, as psychiatric rehabilitation by its nature is a multidisciplinary effort 
owing to the many competencies required for its implementation.38 Our overview of 
the review literature stresses the importance for researchers, physicians, and 
mental health organizations to look at the benefits of evidence-based models such 
as ACT and Supported Employment for their specific settings and practices. 
Developers of clinical practice guidelines in different countries could stimulate the 
implementation of these interventions by incorporating recommendations of 
integrated care and effective models for collaboration into the guidelines. The 
strength and content of these recommendations shall depend on contextual 
factors, such as the quality of care as usual provided and the so-called benefit trap 
or financial disincentives to return to work in each particular country.39
 Another finding of this review is that other implementation strategies have a 
smaller body of good-quality evidence. This is in line with the results of an earlier 
review.16 The evaluation of strategies such as routine outcome measurement, 
financial incentives, the use of information technology, and patient involvement to 
get widespread implementation of effective treatment programs is only beginning 
in the severe mental illness setting.23 There is a need for studies into these 
strategies, because they are initiated in all Western healthcare settings and much 
is expected of them by patients, physicians, managers, and policy makers. 
Strategies to disseminate and implement a specific guideline, technology, or 
treatment program generally have mixed effects: sometimes they work, sometimes 
they do not. A better insight into the factors underlying this variation could help to 
generalize study findings to other settings and to develop more effective 
implementation interventions. Although we found good evidence of integrated care 
and multidisciplinary teams for better patient outcomes, information on 
professional and organizational performance as intermediate outcomes is hardly 
available. Many smaller qualitative studies on implementation issues have been 
published; however, most is of poor methodological quality. This lack of insight into 
the black box of implementation processes implies that managers and physicians
wanting to spread effective care models for this patient group are left in the dark 
when it comes to selecting effective elements of care models and to picking 
strategies that can lead to successful implementation. 
 There is obviously a need for good quality implementation research in the area 
of severe mental illness. RCTs are the design of choice if one wants to make 
robust generalizable conclusions. Other approaches can also be informative to 
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local quality improvement projects and to physicians who are trying to bridge the 
gap between their daily practices and scientific evidence, provided they use 
multilevel measures of implementation efforts and outcomes.13,40 For good-quality 
improvement projects and research to happen, Fixen41 has proposed that 
healthcare providers and researchers create partnerships, set mutually beneficial 
implementation agendas, and create communities of practice, where the 
integration of innovations is facilitated. These communities of practice could 
function as self-sustaining learning communities. Of course, this proposal needs 
testing before wide-scale implementation can be recommended. 
 The National Implementing Evidence Based Practices Project is an example of 
a descriptive study that investigated the implementation of 5 psychosocial 
practices in the United States’ chronic mental health settings.41 Supported 
Employment, ACT, and integrated dual-disorder treatments were 3 of these 
practices. In this study, the primary outcome was professional and organizational 
performance in terms of model fidelity. The study looked at differences of model 
fidelity among the evidence-based practices and at the degree of implementation 
over time within each evidence-based practice. In the near future, data on 
predictors of successful implementation, barriers, and facilitators will be spread by 
the research group, so that these experiences will become useful to others.
Conclusions
This review assessed the impact of organizational strategies to improve care for 
people with severe mental illness. From our work, we draw 2 conclusions: 
 There is a fairly large body of evidence on the impact of several well-known 
organizational strategies used to improve care for people with severe mental 
illness. These strategies comprise multidisciplinary teams, integrated care, 
and changes in care setting. The impact of other applied strategies, such as 
quality or knowledge management strategies, have either not been subjected 
to systematic reviews or have not been evaluated in RCTs.  
 There is a lack of insight in the black box of change processes and the impact 
of change on process and professional performance. This is hindering 
knowledge transfer to other settings of daily practice. The authors suggest a 
future implementation research agenda comprising both experimental and 
observational study designs, depending on the questions. The research 
agenda should focus on a wider range of improvement strategies and include 
multilevel measures, such as data about patient outcomes, the impact on 
professional performance (adherence to clinical guidelines), organizational 
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performance (waiting times, continuity of care), and the reach and long-term 
effects of the interventions.
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Abstract 
Background: Improving the healthcare for patients with depression is a priority 
health policy across the world. Roughly, two major problems can be identified in 
daily practice: (1) the content of care is often not completely consistent with 
recommendations in guidelines and (2) the organization of care is not always 
integrated and delivered by multidisciplinary teams.
Aim: To describe the content and preliminary results of a quality improvement 
project in primary care, aiming at improving the uptake of clinical depression 
guidelines in daily practice as well as the collaboration between different mental 
health professionals. 
Method: A Depression Breakthrough Collaborative was initiated from December 
2006 until March 2008. The activities included the development and 
implementation of a stepped care depression model, a care pathway with two 
levels of treatment intensity: a first step treatment level for patients with non-
severe depression (brief or mild depressive symptoms) and a second step level for 
patients with severe depression. Twelve months data were measured by the 
teams in terms of one outcome and several process indicators. Qualitative data 
were gathered by the national project team with a semi-structured questionnaire 
amongst the local team coordinators. 
Results: Thirteen multidisciplinary teams participated in the project. In total 
101 health professionals were involved, and 536 patients were diagnosed. Overall 
356 patients (66%) were considered non-severely depressed and 180 (34%) 
patients showed severe symptoms.
 The mean percentage of non-severe patients treated according to the stepped 
care model was 78%, and 57% for the severely depressed patient group. The 
proportion of non-severely depressed patients receiving a first step treatment 
according to the stepped care model, improved during the project, this was not the 
case for the severely depressed patients. The teams were able to monitor 
depression symptoms to a reasonable extent during a period of 6 months. Within 
3 months, 28% of monitored patients had recovered, meaning a Beck Depression 
Inventory (BDI) score of 10 and lower, and another 27% recovered between 3 and 
6 months. 
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Conclusions and discussion: A stepped care approach seems acceptable and 
feasible in primary care, introducing different levels of care for different patient 
groups. Future implementation projects should pay special attention to the quality 
of care for severely depressed patients. Although the Depression Breakthrough 
Collaborative introduced new treatment concepts in primary and specialty care, the 
change capacity of the method remains unclear. Thorough data gathering is 
needed to judge the real value of these intensive improvement projects. 
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Introduction
Policies aiming to create an evidence-based mental healthcare system, offering 
appropriate care to patients and delivering better outcomes, have not been 
successful until now. According to the European Study of the Epidemiology of 
Mental Disorders (ESEMED) conducted in six western countries including the 
Netherlands, of all patients treated for an anxiety disorder or a depressive 
disorder, 57% were treated appropriately in secondary care and only 23% 
received the right treatment in primary care.1
 Major depressive disorder (MDD)2 is a prevalent condition worldwide: 
12 months prevalence of MDD ranges from 4 to 10% and a lifetime prevalence of 
15 to 17%.3-6 In the Netherlands Mental Health Survey and Incidence Study 
(NEMESIS)6,7 a median duration of a new depressive episode of 3 months was 
found, 63% of those with a new episode had recovered within 6 months and 76% 
in 12 months. Almost 20% of those affected had not recovered in 24 months.8
Primary care is the key supplier of care to patients, because of the high 
prevalence of patients with depression or depressive feelings in primary care of
around 21%.9 Despite policy incentives to strengthen the capacities of primary 
care, primary care physicians (PCPs) still refer more patients to a more expensive 
form of care in specialty care than to psychologists and social workers in primary 
care.9,10 
Two depression guidelines are actually available to Dutch physicians, 
recommending effective interventions for different subgroups of patients. The 
Multidisciplinary Guideline for Depressive Disorder, adopted in 2005 by a range of 
professional organizations in specialized mental health, and the depression 
guideline adopted by PCPs in 2003.11,12 Following depression guidelines can be of 
value to professionals as applying the effective interventions recommended in 
guidelines can lead to better outcomes for patients and to lower costs to society.13-
18 Unfortunately, the uptake of the depression guideline recommendations in Dutch 
daily practice has been slow. A study looking into evidence-based depression care 
in 1999 concluded that previous depression guideline editions were considered to 
be too globally formulated, giving insufficient tools to physicians for decision 
support in daily practice.19-22 Other implementation barriers can be related to 
characteristics of the professionals and the patients, and environmental factors 
such as a lack of support from peers or superiors, insufficient staff or time, and 
poor collaboration between professionals.18,23 
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 The effective treatments proposed in the most recent depression guidelines, to 
be published in the Netherlands in the spring of 2009, range from less intensive 
interventions like psycho-education or self help intervention (individual or group 
courses), problem solving treatment (PST), and physical exercise (running 
therapy), to more intensive treatments such as cognitive behavioural therapy, 
pharmacotherapy and electroconvulsion therapy. Considering the heterogeneous 
course of MDD, the selection of the appropriate intervention and the organization 
of depression care needs to be built on careful timing and paced appropriately. 
Goals of treatment should be to avoid over-treatment in those with a favourable 
prognosis and to prevent the development of chronic symptoms in those 
depressed individuals with an unfavourable prognosis (under-treatment). 
Overtreatment of minor and mild-major depressions is seen in primary care where 
antidepressant drugs are prescribed to 68% of the patients, regardless of the 
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One of the methods to overcome barriers and improve the content and 
organization of care is the Breakthrough Series Collaborative, because of its ability 
to enhance the rate of diffusion of existing science into clinical practice, by using 
multi-institutional or multisite work groups.31-35 In this article, we present the 
content and results of a part of a large Breakthrough Collaborative project 
targeting better outcomes for patients suffering from depression. The information 
presented is directed at the improvements for adult patients in primary care. The 
collaborative was initiated by the Netherlands Institute of Mental Health and 
Addiction (http://www.trimbos.nl), operated from December 2006 to April 2008, and 
was funded by a national health insurers fund, as part of the depression initiative 
program.36
 In the remainder of this article, we describe the problems in depression care 
targeted by the participants in this project, the improvement principles and goals, 
the improvement method, the methods used to collect and analyze the data, and 
the impact on key outcome and process indicators. In the discussion, the results 
are interpreted and compared to similar work, giving suggestions for future quality 
improvement projects. 
Methods 
Improvement principles and goals 
A national expert team of depression opinion leaders and project coordinators was 
set in place. They developed a project plan, containing improvement principles, 
goals and suggestions for improvement ideas. The overall improvement principle 
was the implementation of a stepped care approach. In a stepped care approach 
evidence-based treatment options are ranked by their degree of intensity, looking 
at the impact on the patient’s life, the length of treatment, the setting (primary care 
or specialty care) and the costs, as well as combinations of these criteria.37-39
Patients start to step in at the appropriate intensity level, which matches their 
(severity) profile. Stepped care models have the potential to improve efficiency and 
effectiveness of depression care.40-42 Also, the implementation of a stepped care 
model can lead to better collaboration and integration, involving all partners across 
primary and secondary care, and making them aware of their individual 
contributions to the shared approach.38,38,42,43 
 A pragmatic stepped care model was developed (Figure 1), consisting of a 
depression care pathway with two levels of treatment intensity: a first step 
treatment level for patients with mild depressive symptoms and a second step 
treatment level for patients with severe depressive symptoms. 
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Figure 1. Stepped care depression model 
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P76
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Appoint to patient group
Patient group 1:
Symptoms not severe
Patient group 2:
Symptoms severe *
Treatment pathway level 1
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- Watchful waiting
- Psycho-education
- Self-help, group or individual
- Counseling
- Brief psychotherapy, 8 sessions
- Physical exercise
- Other
Monitoring
1 BDI per 6 weeks
Treatment pathway level 2
DSM-IV assessment
Start treatment within 1 month
Psycho-education
Depression treatment
- Antidepressants
- Psychotherapy: GT, CGT, IPT
- Other
Drop-out reduction
Monitoring
1 BDI per 6 weeks
* Severe symptoms in this model are:
Symptoms duration longer than 6 months or
Insufficient response to treatment pathway level 1 after 3 months or
Suicidal ideation, psychotic features, high level of social dysfunctioning,
inability to normal role taking (work, self care, taking care of others).
The stepped care model was based on previous projects in Dutch mental 
healthcare and on the (inter)national literature.37,38 Professionals applying all the 
elements of the stepped care depression model, needed to implement the 
following changes in their practices: 
1. Stepped diagnostics. Depressive episodes were diagnosed as usual, with 
PCPs using the ICPC coding system for new cases. Differentiation between 
patients with non-severe depressive symptoms (patient group 1 in Figure 1) 
and patients with severe symptoms (patient group 2 in Figure 1) had to be 
made, based on a set of severity criteria (see text at the bottom of Figure 1). 
For severely depressed patients a DSM-IV assessment was indicated. 
2. Stepped treatment. Implementation of a treatment pathway with two 
treatment levels: a first step level consisting of interventions for first, mild 
depressive episodes with a duration up to 3 months (treatment pathway 
level 1 in Figure 1) and a second step level mainly consisting of 
antidepressant medication and effective psychotherapeutic interventions 
(treatment pathway level 2 in Figure 1). 
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3. Monitoring and evaluation of the treatment plan. The course of symptoms and 
treatment progress were to be monitored in both pathways using the Beck 
Depression Inventory (BDI).
Derived from this stepped care model a set of SMART goals was formulated; goals 
that are specific, measurable, attractive, realistic and timely (Box 1). 
Box 1. The SMART goals of the Depression Breakthrough Collaborative 
1. Within 6 months of treatment, 80% of all new patients have a score of 10 or lower on the Beck 
Depression Inventory (BDI). Obligatory goal. 
2. 80% of systematic follow-up visits is according to planning, meaning 1 visit every 6 weeks until the 
scores on the BDI is 10 or lower. Obligatory goal. 
3. Less than 10% of patients with non-severe symptoms receive antidepressants or psychotherapy as a 
first step treatment. 
4. All patients with severe depressive symptoms start treatment within 1 month after diagnosis. 
5. Less than 20% of all patients with severe symptoms, treated with antidepressants, have dropped out of 
treatment within the first 3 months. 
These two instruments, the Stepped Care Depression Model and the set of 
SMART goals, provided the improvement teams with guidance for their 
improvement work. The teams made a selection of goals, developed additional 
local goals if they wished and implemented changes.
Breakthrough method
The Breakthrough method, developed by Berwick and colleagues at the Institute 
for Healthcare Improvement in Boston (http://www.ihi.org), was used as the model 
for change during the collaborative.44 This method was chosen for various 
reasons. Firstly, Breakthrough Collaboratives are attractive projects, creating 
learning opportunities for professionals, offering them knowledge, a model for 
change and permitting them to spend time on testing changes and experimenting 
with new behaviour. Breakthrough Collaboratives can be especially useful for 
microsystem improvements, within small units of care delivery.45 Secondly, these 
projects have become very popular over the last few years within the Dutch 
Ministry of Health, Welfare and Sport which has funded many collaboratives in
different healthcare settings. This positive reputation is only partly based on 
research literature. A recently published systematic review of quality improvement 
collaboratives showed that the underlying evidence is positive but limited, with 
modest effects on outcomes at best.35 In mental healthcare, the Breakthrough 
method had rarely been applied and evaluated. 
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Breakthrough Collaboratives can be considered as a multifaceted 
implementation strategy. Central characteristics of all Breakthrough Collaboratives 
are: the use of guidelines, local multidisciplinary improvement teams consisting of 
professionals and a local team coordinator, a national expert team consisting of 
depression opinion leaders and national project coordinators, data collection and 
continuous feedback loops.34,46 In the Depression Breakthrough Collaborative a 
specific mix of these improvement strategies was offered to the participating teams 
(Box 2). 
Box 2.  Improvement strategies offered during the Depression Breakthrough Collaborative 
 A network of multidisciplinary teams; 
 An expert team, teaching the Stepped Care Model; 
 SMART goal setting, a set of indicators to monitor results and an Excel worksheet;  
 A training for local team coordinators on the Breakthrough method and data collection; 
 Four conference days for all improvement teams for exchange and learning; 
 One conference day for local team coordinators for more intensive exchange with the expert team; 
 Five meetings between local team coordinators, with the expert team present; 
 Team visits of experts and national project coordinators; 
 Telephone contact between local and national coordinators; 
 Written feedback on improvement reports and data charts; 
 A virtual network environment for exchange of best-practices, a Toolkit of instruments and treatment 
protocols, online discussions and links to relevant sites; 
 A two-day training on Problem Solving Treatment for professionals; 
 A workshop workflow improvement. 
A central feature of the Breakthrough Collaboratives is continuous feedback loops 
according to the Nolan model (Figure 2). The model consists of two elements: 
three questions to focus the improvement work and a PLAN-DO-STUDY-ACT
(PDSA) cycle.
 This model, originally developed by Langley and popularized by Nolan, provides 
an overarching framework for testing change ideas that are expected to make 
progressively more complex changes along an improvement ramp. Instead of 
focusing on changing the behaviour of individual providers, the focus is on 
gradually changing organizations into high performing (micro)systems of care.45-47
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Figure 2. The Nolan model for improvement 
1.What are we trying to accomplish?
2. How will we know that a change is 
an improvement?
3. What changes can we test that will 
result in an improvement?
Model for Improvement
Study Do
Act Plan
Data collection and analysis
Quantitative improvement data were collected by the professionals of the 
Breakthrough Collaborative’s teams. Measurements were derived from process 
and outcome indicators, developed by the national expert team to measure goal 
attainment on each of the SMART goals. Data were entered and processed in 
Excel by the local coordinators, who had received training to do so. Periodically, 
the local data were fed back to the teams for discussions and adaptation of 
improvement plans. Aggregation and analysis of all data was done by the expert 
team and data managers of the Trimbos Institute. To maintain privacy, patient data 
were made anonymous before being sent to be processed on a national level. In 
order to monitor the change over time, the team performances of process 
indicators were analyzed as repeated measures of threemonthly data. Teams that 
collected data throughout the improvement year had four terms of 3 months to 
demonstrate change. Other teams, starting to collect data only later, may have 
produced just three sets of data. In addition to the improvement data, qualitative 
data were collected from the local team coordinators, in the last stage of the 
project. For this purpose, a questionnaire was used with items on: characteristics 
of the team, results according to the coordinator, strengths and weaknesses of the 
improvement method, influencing factors, spread and consolidation of results. 
Seven coordinators, reporting on 10 out of 13 teams, returned the completed 
questionnaire. 
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Results
A total of 13 teams participated in the project, consisting of 101 professionals and 
15 managers or staff. The teams all had a multidisciplinary character, including at 
least one or more PCPs, and a psychiatrist or a psychotherapist working in a 
specialized Mental Health Organization. In total, 39 PCPs were involved, 
14 primary care psychologists, 16 social workers, 11 specialised mental health 
nurses, 8 physiotherapists, 6 psychologists or psychotherapists and 
7 psychiatrists. The smallest team consisted of 6 persons, the largest had 
15 members. The teams all had a local team coordinator, responsible for 
supporting the professionals, managing communications within the national 
network, and pushing the local improvement process forward. Most of the team 
coordinators were staff employees in primary care support organizations called 
Regional Support Structures (Regionale Ondersteuning Structuur, ROS).  
 Five hundred and forty-three adult patients were registered by the 13 teams 
during the improvement year. The inclusion ranged from 17 patients in the team 
with the lowest patient number and 93 patients in the team with the highest. All 
teams selected their goals for improvement (see Box 1). SMART goals 1 and 2 
were obligatory for all teams, goals 3 and 4 were selected by 10 teams, goal 5 was 
selected by four teams. 
Diagnostic skills 
PCPs were asked to differentiate between severely depressed and non-severely 
depressed patients. The label severe depression was considered appropriate if the 
patient previously had depressive symptoms lasting 6 months or longer, and/or 
showed an insufficient response to a former treatment and/or reported suicidal 
ideation, psychotic features or a high level of social malfunctioning. Out of the 
543 patients registered during the project, 536 patients were diagnosed to have 
either non-severe or severe depressive symptoms (Figure 3). 
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Figure 3. Number of severe and non-severe depression per team 
 
 
 
Overall 356 patients (66%) were considered non-severely depressed and 180 
(34%) showed severe symptoms according to the primary care physicians. Figure 
3 also shows a large variability between the teams in the proportion of patients in 
each category, with the proportion of severely depressed patients ranging from 2% 
(team 12) to 83% (team 6). The team with the largest patient group (n=93) 
registered 76 non-severe depressed patients (82%) and 17 severe patients (18%). 
 
Stepped care approach 
The overall goal of the improvement teams was the implementation of a stepped 
care model, a depression care pathway with two levels of treatment intensity: a 
first step treatment level for patients with non-severe depressive symptoms and a 
second step level for patients with severe depressive symptoms (Figure 4). 
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Figure 4. Percentage of patients receiving first step treatment according to the stepped care model 
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The teams registered treatment data of a total of 514 patients, 346 (67%) patients 
with a non-severe depression and 168 (33%) patients with a severe depression. 
The overall mean percentage of the non-severe patient group receiving a first step 
treatment according to the stepped care model was 78%, ranging from 53% in the 
worst performing team to 100% in three best performing teams. The mean 
percentage of the severely depressed patient group was 57%, ranging from 25 to 
100% between the teams. The patient groups were extremely small in certain 
teams, thus accounting for these wide ranges. Although the scores in the non-
severe group did not reach the level of 90%, there was a positive trend towards 
this target. This is in line with the reports of the local team coordinators, indicating 
that PCPs did learn to offer patients with few or mild symptoms a brief or first step 
intervention instead of antidepressant treatment, once these first step interventions 
were made available in primary care. 
 According to the stepped care model, all patients with severe symptoms should 
have received psychotherapy or antidepressant treatment within 1 month, either in 
primary or in specialty care. Unfortunately, the improvement teams were not able 
to move good quality treatment for severely depressed patients close to the 
targeted 100%. In total 72 (43%) severely depressed patients did not receive 
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antidepressant treatment or psychotherapy within 1 month or were offered 
treatment options of a too low intensity. This number includes 23 patients who 
were referred to specialty care within 1 month, where they might have received 
proper treatment in time. The team coordinators indicated improvement in terms of 
a growing consciousness amongst professionals of the needs of severely 
depressed patients, better referral procedures and more attention to 
psychotherapy as an alternative for antidepressants. 
Monitoring of depressive symptoms 
The professionals were asked to monitor depressive symptoms with the BDI until 
recovery, defined as a BDI-score of 10 or lower. 
Table 1. Depression symptoms at 6 months 
Non-severely depressed patients (N=91) Severely depressed patients (N=50)
Improved/recovered 75 (83%) / 27 (30%) 44 (88%) /12 (24%)
Stable 3 (3%) 2 (4%)
Worse 13 (14%) 4 (8%)
Table 1 shows that the teams succeeded in following around 70% of their patients 
during a period of 6 months. Repeated BDI monitoring by itself, was conceived to 
be very difficult to organize, especially since integration of the BDI measurements 
in existing ICT systems was lacking. 
 During the project, 477 patients received BDI monitoring at baseline, within 
2 weeks after diagnosis. Four hundred and seventy-four patients (99%) scored 
more than 10, of whom 270 patients (57%) received a follow-up measurement 
within 3 months. Of this group 76 persons (28%) had recovered according to the 
BDI score of 10 or lower. Of the 194 non-recovered patients, 103 patients had 
another follow-up measurement at 6 months (53%). Of this group, another 
28 patients (27%) had recovered, 75 patients (73%) had a BDI score higher than 
10.
Overall, 91 non-severely depressed and 50 severely depressed patients had 
BDI monitoring at baseline and within 3 to 6 months. Seventy five (83%) non-
severely depressed patients improved during that period of whom 27 (30% of the 
total group of 91 patients) recovered. Thirteen non-severely depressed patients 
(14%) worsened with increased scores on the BDI and 3 (3%) remained stable. Of 
the severely depressed group, 44 (88%) patients improved of whom 12 (24% of 
the total group of 50 patients) recovered, 2 (4%) remained stable and 4 (8%)
patients worsened.
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Collaboration and integration
In addition to the data, the comments of the team coordinators on the project were 
asked in a questionnaire. All team coordinators indicated that the project had a 
positive impact on collaboration within primary care. Professionals grew to know 
each other during the project, and as a consequence developed a mutual 
language on depression care, a better understanding of the content and added 
value of each of the different competencies and a more reliable collaborative 
relationship. This was a good basis for a regionally shared approach and 
responsibility in depression care. Teams also reported better collaboration in daily 
practice. Collaboration improved in terms of easier and faster consultation of a 
psychiatrist or psychologist when the patient’s condition was unclear, better 
access to specialty care for primary care patients, and primary care physicians 
staying better informed after referral. Improved collaboration was restricted to the 
professionals in the improvement teams, and did not really spread beyond this 
group. 
Knowledge and guidelines 
Another effect mentioned by the coordinators was improved knowledge of 
depression amongst the professionals and improved competence in terms of 
diagnosing and treating depressive symptoms. Some teams intensively discussed 
the guidelines at the start of the project, whereas other teams considered the 
Depression Breakthrough Collaborative as their knowledge base. 
Strengths and weaknesses of the breakthrough method 
The top-down goal setting appeared to be a success factor in primary care, PCPs 
being in favour of practical tools, standards and clear instructions. Another 
successful element was the outcome monitoring using the BDI. Although hard to 
implement, it shifted the focus of professionals from their own clinical judgements 
to more objective results that could be shared with others. The Toolkit, describing 
the content of interventions in detail (number of sessions needed, topics to inform 
the patient about) served as a fidelity tool for correct development and 
implementation and as a basis for team discussions. 
 Weaknesses of the project, experienced by the team coordinators, were related
to a mismatch between the project’s design and the primary care working culture. 
PDSA cycles were hard to apply and did not fit into the existing culture of primary 
care professionals, who were not used to discussing care processes and reflecting 
on results. Also the website, the main source of information and communication, 
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was of no help to individual professionals, who were not used to virtual project 
environments. Other negative aspects of the project were the obligatory reports 
that needed to be sent to the national expert team and the changing planning of 
conference days and other happenings. 
Influencing factors
Factors facilitating the project were: the presence of a strong local team 
coordinator, enthusiastic team members (particularly the primary care physician as
the key player in the team), financial support for time spent on the project from an 
insurance company, and the embedment of the project within a broader quality 
improvement policy of the Mental Health Organization or primary care health 
centre. Most of the local team coordinators were employed by the so-called 
Regional Support Structures, rather new organizations in Dutch primary care, 
created by the Ministry of Health to help professionals improve the quality of care. 
Some of the healthcare insurance companies reimbursed PCPs for the time spent 
on the project and paid for the team coordinator to support the team. 
Factors hindering the project were: a lack of interest by the management, a lack 
of dedicated time for participating professionals, a lack of patients with new 
depressive symptoms in primary care during the project, and the short length of 
the project’s duration. Most teams felt the time frame of the project was too short 
for real change, especially in smaller teams, with only one PCP. Focusing on a 
longer change period and continuing improvement activities after the project’s 
formal ending, was the way most teams dealt with these frustrations.
Discussion 
Thirteen multidisciplinary teams participated in the quality improvement project. In 
total 101 health professionals were involved, and 536 patients were diagnosed. 
Overall 356 patients (66%) were considered nonseverely depressed and 
180 patients (34%) showed severe symptoms. The mean percentage of non-
severe patients treated according to the model was 78%, and 57% for the severely 
depressed patient group. Compared to numbers mentioned in the literature of 23% 
of patients with anxiety and depression receiving the right treatment in primary 
care, this could be considered as relatively high.1 The proportion of non-severely 
depressed patients receiving the right first step treatment slightly improved during 
the project, but this was not the case for the severely depressed patients. The 
teams were able to monitor depression symptoms to a reasonable extent during a 
period of 6 months. Within 3 months, 28% of monitored patients had recovered, 
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was of no help to individual professionals, who were not used to virtual project 
environments. Other negative aspects of the project were the obligatory reports 
that needed to be sent to the national expert team and the changing planning of 
conference days and other happenings. 
Influencing factors
Factors facilitating the project were: the presence of a strong local team 
coordinator, enthusiastic team members (particularly the primary care physician as
the key player in the team), financial support for time spent on the project from an 
insurance company, and the embedment of the project within a broader quality 
improvement policy of the Mental Health Organization or primary care health 
centre. Most of the local team coordinators were employed by the so-called 
Regional Support Structures, rather new organizations in Dutch primary care, 
created by the Ministry of Health to help professionals improve the quality of care. 
Some of the healthcare insurance companies reimbursed PCPs for the time spent 
on the project and paid for the team coordinator to support the team. 
Factors hindering the project were: a lack of interest by the management, a lack 
of dedicated time for participating professionals, a lack of patients with new 
depressive symptoms in primary care during the project, and the short length of 
the project’s duration. Most teams felt the time frame of the project was too short 
for real change, especially in smaller teams, with only one PCP. Focusing on a 
longer change period and continuing improvement activities after the project’s 
formal ending, was the way most teams dealt with these frustrations.
Discussion 
Thirteen multidisciplinary teams participated in the quality improvement project. In 
total 101 health professionals were involved, and 536 patients were diagnosed. 
Overall 356 patients (66%) were considered nonseverely depressed and 
180 patients (34%) showed severe symptoms. The mean percentage of non-
severe patients treated according to the model was 78%, and 57% for the severely 
depressed patient group. Compared to numbers mentioned in the literature of 23% 
of patients with anxiety and depression receiving the right treatment in primary 
care, this could be considered as relatively high.1 The proportion of non-severely 
depressed patients receiving the right first step treatment slightly improved during 
the project, but this was not the case for the severely depressed patients. The 
teams were able to monitor depression symptoms to a reasonable extent during a 
period of 6 months. Within 3 months, 28% of monitored patients had recovered, 
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meaning a BDI score of 10 and lower, and another 27% recovered between 3 and 
6 months. Collaboration between primary care and specialty care and within 
primary care improved but did not spread beyond the teams. The team 
coordinators indicated that a breakthrough, although still fragile, was being 
achieved in terms of professionals improving their knowledge of depression and 
depression guidelines, learning to use new and less intensive treatments in mild 
cases instead of antidepressant treatment and improving collaboration within and 
between the settings, so that access to specialty care for severely depressed 
primary care patients improved. 
 In total, 39 PCPs identified 536 new cases, a mean of 14 patients per PCP. This 
is lower than expected, considering the national incidence rate of 24 patients in a 
primary care practice of 2300 subscribed patients, suggesting that the PCP did not 
identify all patients with depressive symptoms or did not include all patients who 
were identified.24 The diagnostic performances suggest that the project served as 
a platform for PCPs to change their behaviour and start to differentiate between 
severe and non-severe depressive symptoms. Whether this was done in a reliable 
way, reflecting the true proportions, is not clear. The large variability between the 
PCPs suggests that, apart from epidemiological differences, several professional 
related factors could have influenced the diagnosis. For instance, the sensitivity of 
some of the PCPs to picking up on mild or early depressive symptoms, and their 
ability to discuss their findings with the patient, could have been more or less 
developed. Also, a doctor feeling uncomfortable with a particular label and the 
corresponding treatment level could have adapted the treatment criteria to his own 
perception. 
 The monitoring indicators showed that the teams were able to monitor 
depression symptoms to a reasonable extent during the first 6 months of the 
treatment. This can be considered as a rather big improvement, considering the 
lack of routine, infrastructure and ICT support. When patients had stopped visiting 
the practices, possibly because of diminishing symptoms, continuous monitoring
proved to be problematic. 
The data suggest an improvement ramp pushing the quality of care for patients 
with non-severe depression forward. This is in line with data from a previous 
Depression Breakthrough Collaborative that served as a pilot project. In that 
project, data of precollaborative treatment were compared to the improvement 
data, showing a very sudden drop in unnecessary antidepressant prescriptions for 
non-severely depressed patients from 61 to 11%, during the very first weeks of the 
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collaborative.48 In the current project, no prepost trend can be shown, so nothing 
can be said about the actual change introduced during the collaborative. 
 The recovery rates are in line with the Sequenced Treatment Alternatives to 
Relieve Depression (STAR*D) study, a naturalistic study showing that only one-
third of patients achieves remission with initial treatment and that remission rates 
decline with successive treatment failures.49 The results of our project, although 
not based on research data, confirm the suggestion derived from the scientific 
research into collaboratives, showing modest effects on outcomes at best.35
 Our project also builds on reports of other improvement work in depression care 
that show a positive impact on the quality of care and on patient outcomes. In the 
American version of the Depression Breakthrough Collaborative, the chronic care 
model was implemented, also based on the assumption that depression care is 
fragmented and that there is a gap between guideline recommendations and
actual care.50 The change concepts considered to be essential in the American 
project turned out to be establishing and maintaining a patient register, care 
coordination, diagnostic assessment and pro-active follow-up. Factors facilitating 
that project were: the support of organizational leadership showing the essential 
role of the top management, and a small practice size.50,51 Some of the essential 
change concepts show overlap with the positive experiences in our project 
concerning diagnostic assessment and pro-active follow-up. Still, the stepped care 
approach, introducing different patient categories and corresponding treatment 
levels, with much attention to other than pharmacological approaches, can be 
considered distinctive and of relevance to international readership. 
There are several limitations to this project. Firstly, registration of improvement 
indicators was hampered in various ways and the quality of data gathering during 
the project varied. Although some teams managed to collect most data for their
patients, the overall database showed many missing values. A second limitation 
was the poor insight in the actual implementation of the interventions. The data are 
based on reports of the professionals; it is unclear whether patients actually 
received care according to the protocol or guidelines. Thirdly, the twelve months 
duration of the project; this may have been too short to measure any impact on the 
care processes. 
It is clear that the information derived from these data does not pretend to serve as 
new, generalizable knowledge on causal mechanisms in healthcare, but as a 
mirror for reflection and discussion on processes of change in depression care. 
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Quality improvement is a growing topic of interest to many managers and 
professionals in this sector, also stimulated by policy makers and insurance 
companies. Although changing depression care is on the agenda of many, the 
question of how to go about it is still unanswered. The data presented here may 
help to find some of the answers. Parallel to these quality improvement data, a 
quasi-experimental trial was conducted, comprising rigorous quantitative and 
qualitative process and outcome data-gathering on the patient, the professional 
and the team level, and a comparison between the collaborative study population 
and a care as usual group. The results of that study will be published from 2010 
onwards. 
Conclusions
A stepped care approach seems acceptable and feasible in primary care, 
introducing different levels of care for different patient groups. Although the 
Depression Breakthrough Collaborative introduced new treatment concepts in 
primary and specialty care, the change capacity of the method remains unclear. 
Thorough data gathering is needed to judge the real value of this intensive 
improvement project. 
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Abstract 
Background: Since 2004, ‘stepped care models’ have been adopted in several 
international evidence-based clinical guidelines to guide clinicians in the 
organization of depression care. To enhance the adoption of this new treatment 
approach, a Quality Improvement Collaborative (QIC) was initiated in the 
Netherlands. 
Methods: Alongside the QIC, an intervention study using a controlled before-and-
after design was performed. Part of the study was a process evaluation, utilizing 
semi-structured group interviews, to provide insight into the perceptions of the 
participating clinicians on the implementation of stepped care for depression into 
their daily routines. Participants were primary care physicians, specialist 
physicians, and other healthcare staff from eight regions in the Netherlands. 
Analysis was supported by the Normalisation Process Theory (NPT). 
Results: The introduction of a stepped care model for depression to primary care 
teams within the context of a depression QIC was generally well received by 
participating physicians. All three elements of the proposed stepped care model 
(patient differentiation, stepped care treatment, and outcome monitoring), were 
translated and introduced locally. Physicians reported changes in terms of learning 
how to differentiate between patient groups and different levels of care, changing 
antidepressant prescribing routines as a consequence of having a broader 
treatment package to offer to their patients, and better working relationships with 
patients and colleagues. A complex range of factors influenced the implementation 
process. Facilitating factors were the stepped care model itself, the structured 
team meetings (part of the QIC method), and the positive reaction from patients to 
stepped care. The differing views of depression and depression care within 
multidisciplinary health teams, lack of resources, and poor information systems 
hindered the rapid introduction of the stepped care model. The NPT constructs 
‘coherence’ and ‘cognitive participation’ appeared to be crucial drivers in the initial 
stage of the process. 
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Conclusions: Stepped care for depression is received positively in primary care. 
While it is difficult for the implementation of a full stepped care approach to occur 
within a short time frame, physicians can make progress towards achieving a 
stepped care approach, particularly within the context of a QIC. Creating a shared 
understanding within multidisciplinary teams of what constitutes depression, 
reaching a consensus about the content of depression care, and the division of 
tasks are important when addressing the implementation process.
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Background 
Since 2004, ‘stepped care models’ have been adopted in several international 
evidence-based clinical guidelines on depression globally.1-3 More recently, 
stepped care approaches for depression have been found to be feasible in primary 
care for diverse patient populations. Stepped care approaches can both generate 
well-being and reduce healthcare costs.4-10
The key idea underpinning stepped depression care is that patients with sub-
threshold and mild depression are offered interventions of low intensity, such as 
psycho-education, self help, counseling, physical exercise, or problem-solving 
treatment. Watchful waiting is also valid in this phase. For a patient who does not 
successfully respond to these approaches, or for patients whose symptoms are 
more severe, more intensive treatment options are appropriate. Antidepressants, 
psychotherapy, or electroconvulsion therapy (ECT), combined with case 
management and self-management strategies are preferred options for severe 
and chronic cases. One key aspect of the stepped care approach is the monitoring 
of patient progress in order to recognize when it is necessary to step up to a more 
intensive treatment.5,6,11 Despite the positive recommendations in guidelines, the 
embedding of stepped depression care in normal daily primary care asks for a 
paradigm shift that has not been fully achieved. This is illustrated by previous 
research, which found that antidepressant prescription rates remained high and 
unrelated to symptom severity, and that cost-effective alternatives for patients with 
mild depression are still underused.12-14
Historically, the Netherlands has had a strongly developed primary care system, 
consisting of general medicine provided by primary care physicians (PCPs), 
paramedical and pharmaceutical care, nursing and supportive care, as well as 
non-specialized mental and social healthcare. Preventive and health educational 
activities are linked to these forms of care. The PCP is the central provider for all 
medical care, including mental healthcare, and the gatekeeper to specialist care. 
Each fulltime PCP has a caseload of around 2,400 patients and is paid on a fixed 
annual fee basis per patient subscribed to the practice. Over the last decade, 
different measures have been launched to strengthen primary mental healthcare, 
such as increasing the numbers of, and capacity of social workers, and the 
introduction of specialized mental health nurses in about 25% of the primary care 
practices.15,16 Yearly, between 11% to 13% of the adult population is registered by 
the PCP with a psychological problem or diagnosis.16 Of those presenting to the 
PCP with a psychological problem, 3% to 4% show depressive symptoms. This 
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figure has remained stable in the Netherlands between 2002 and 2008. The 
majority of patients with depression are treated by the PCP; less than 8% of cases 
are referred to a social worker, mental health nurse, primary care psychologist, or 
to a specialist. PCPs treat their patients mostly during a number of brief 
consultations of less than twenty minutes, and a large proportion of patients (up to 
70% in 2008) are treated with antidepressant medication.16
 It has been recognized, that successful implementation of complex treatment 
approaches in healthcare, such as stepped care for depression, depends on a 
complex interplay of factors and overcoming several barriers to implementation. 
There have been a wealth of theories and models developed to explain the factors
affecting implementation of innovations. The explanatory models can be 
categorized in the following manner: theories focusing on characteristics of 
individual professionals, theories on social influence or interpersonal factors, and 
theories on system characteristics such as organizational and economic 
factors.17,18 Barriers and facilitators for change can be identified on six levels: the 
innovation itself, the individual professional, the patient, the social context, the 
organizational context, and the economic and political context.18 A recently 
developed theory on implementation of innovations is the Normalization Process 
Theory (NPT), developed by May and Finch (2009), which offers a conceptual map 
for the evaluation of complex interventions.19 According to NPT, there are four 
mechanisms that drive change: coherence, cognitive participation, collective 
action, and reflexive monitoring19 (http://normalizationprocess.co.uk/whatfor.aspx).
The care system will only function seamlessly if all four constructs operate 
concurrently and are attended to.20 More recently, Gunn et al. adapted the NPT 
theory for use in depression care.20
 In this study we present the findings of a qualitative process evaluation, within a 
controlled study looking at the effectiveness of a depression Quality Improvement 
Collaborative (QIC). The findings of the controlled intervention study are presented 
in another paper submitted for publication. Previously published uncontrolled
observational data of the QIC demonstrated an improvement of stepped care 
treatment within the teams participating in the QIC.21 The qualitative process 
analysis presented here aims to add to the quantitative findings as it documents 
the way in which the intervention was received and implemented by physicians, 
and identifies the factors associated with reception and implementation. 
Furthermore, by relating the findings to the NPT constructs, we were able to 
provide another layer to the findings. The constructs provide us with sensitizing 
concepts that could lead to a better understanding of the findings of this process 
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evaluation, as well as guide additional recommendations on how to conduct 
implementation projects in depression care. 
Methods 
Study design 
Alongside the QIC, an intervention study using a controlled before-and-after 
design was performed. The overall study protocol comprised an effectiveness 
study, a process evaluation, and a cost-effectiveness evaluation. The intervention 
group consisted of PCPs participating in the QIC, the parallel control group, 
providing care as usual, consisted of a selection of PCPs from practices 
participating in the Dutch National Information Network of General Practice (LINH). 
This database holds longitudinal and nationally representative data on morbidity, 
prescribing and referrals of about 350,000 individuals. Data collection in both 
groups covered a three-year period: from the beginning of 2006 (the year prior to 
the QIC) until the end of 2008 (the year after the QICs ending). The primary 
outcome of the study was a change of antidepressant prescription rates to patients 
with a new diagnosis of depression in both groups. The qualitative process 
evaluation was directed at generating insight into the perceptions of the
participating physicians in the intervention group on the implementation of stepped 
care for depression into their daily routines. Data collection was obtained via group 
interviews, which were held between December 2006 and March 2008. 
 Ethics approval for the entire study protocol was provided by the METIGG, a 
national ethics committee in mental healthcare in the Netherlands. 
Setting and participants
Participants for the study were selected from thirteen multidisciplinary primary care 
teams participating in the depression QIC. These thirteen QIC teams had been 
recruited throughout the country by a national QIC project team on the basis of the 
following criteria: the team had a multidisciplinary structure, there was sufficient 
motivation and time for all members to participate, and a local team coordinator 
was available. Although team members sometimes had worked together in 
another context, most of them had not worked together as a depression team prior 
to the QIC. At the start of the QIC, all teams were asked to participate in the 
intervention study and the process evaluation, alongside their implementation 
work. Five teams did not wish to spend extra time on research activities and 
declined. Eight teams consented, consisting of PCPs, primary care psychologists, 
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social workers, mental health nurses, physiotherapists, consulting psychiatrists 
and psychotherapists, local managers, and team coordinators. 
Intervention
The intervention consisted of a QIC aimed at the implementation of a stepped care 
approach for depression in a multidisciplinary, primary care setting. The QIC was 
designed as a ‘Breakthrough’ QIC.22,23 Three stepped care improvement 
principles, designed by the QIC’s national expert team and derived from the 
national clinical guidelines, were intended to guide the implementation 
processes20: patient differentiation, stepped treatment, and monitoring of treatment 
outcomes (Box 1). 
Box 1. Stepped care principles of the Depression Quality Improvement Collaborative 
1. Patient differentiation. The primary care physician diagnoses the patient, using the International 
Classification of Primary Care (ICPC) diagnosis P03 or P76 (Lamberts & Wood, 1990). The physician 
classifies the depression to be either severe or non-severe, according to the criteria of the stepped care 
model.  
2. Stepped treatment. Non-severely depressed patients are offered an intervention of low intensity as a 
first line treatment, such as: watchful waiting, psycho-education, self-help, counseling, brief 
psychotherapy, physical exercise. After six to twelve weeks, when response is insufficient, physicians 
step up to a next level of intensity, antidepressant medication or cognitive behavioural psychotherapy. 
3. Outcome monitoring. The Beck Depression Inventory (BDI), a 21-item self-report inventory, for 
measuring the severity of depression, is used to monitor symptom severity. A score of 0 to 9 indicates a 
normal mood, patients with higher scores are monitored every six weeks until the score has returned to 
normal. Stepping up to higher intensity level treatments is considered in case of insufficient response. 
A local team coordinator supported the team with the aim of structuring the 
implementation process. Local team coordinators received brief training from the 
QIC national expert team about the use of Plan-Do-Study-Act (PDSA) cycles and 
about the monitoring of stepped care and depression indicators in a Microsoft 
Office Excel work sheet. Both elements, PDSA-cycles and monitoring, are crucial 
elements of QICs and help to move the implementation process forward.24 To 
assist the physicians in applying the stepped care principles into daily clinical 
practice, the QIC national expert team offered four national conference days for 
learning, seven meetings for quality improvement project managers, regular 
telephone contact, as well as working visits to all sites. The physicians 
independently set up bi-monthly local team meetings for discussions about the 
translation of the principles into their work settings, and to exchange experiences, 
progress, and steps for further improvement. In addition, all individual physicians 
had access to workshop sessions and to online materials, such as a depression 
toolkit describing evidence-based interventions. Funding for these support 
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activities primarily came from external bodies; however, the primary care teams 
also independently co-financed a small portion of the project.21
Data collection
Data collection consisted of eight semi-structured group interviews with duration of 
60 to 75 minutes with all participating multidisciplinary improvement teams. The 
interviews took place during the last half of the 15 months of the QIC. Group 
interviews with the multidisciplinary teams were appropriate, given that there is 
limited knowledge about applying stepped care principles for depression from the 
professional perspective, particularly with healthcare professionals coming from 
different backgrounds. The interviews therefore were expected to provide 
additional exploratory data that can enrich quantitative findings. The interviews
were conducted by the researchers (GF, MO), following a topic list with questions 
related to the stepped care changes made in clinical practice, the mechanisms 
and factors that influenced the change processes, and the impact of the changes 
on the care delivered as perceived by the respondents. The researchers had no 
relationship with the respondents prior to the interviews, but were familiar with the 
QIC work from holding former positions in other projects. The interviews were 
audiotaped with consent of the participants and transcribed verbatim. 
Analysis
The interview transcripts were analyzed independently by two coders 
(combinations of GF, MO, and JdL). The perspective of JdL, a qualitative research 
expert and the national project manager of the depression QIC, ensured that the 
data were interpreted and understood from different perspectives. To order the 
data, thematic coding was used with the help of MaxQda 2007, qualitative analysis 
software http://www.maxqda.com/. Samples of the coded fragments were 
compared and settled by consensus. As a result, a coding tree was built around 
the following key themes; the experiences with the QIC method, the changes 
made in the primary care practices, the factors influencing the change processes 
and the results of the change processes in terms of outcomes for patients and 
efficiency of care. Within these themes, different levels of codes were constructed. 
For example, within the theme of influencing factors, the code ‘culture’ was 
assigned, referring to the views within the teams on depression care. Within this 
code, sub-codes were drawn from the material, such as ‘pro-activity,’ ‘openness 
and trust,’ and ‘views on depression,’ the latter referring to transcripts in which 
respondents talked about how their personal concept of depression played a role 
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in introducing stepped care within the team. Finally, the material was ordered for 
reporting around the research questions about how the stepped care principles 
were applied and experienced, and which factors influenced this process. Because 
our goal was to capture groups’ experiences, the findings are reported as the 
teams’ perspectives on each of the stepped care principles. The viewpoints of 
specific professional groups were only described when relevant. 
 The interpretations were discussed within the project team. The preliminary 
results were discussed with the respondents, approximately one year after the 
QIC’s termination (member check). A researcher (MO) interviewed a member of 
each of the improvement teams by telephone. During these telephone interviews, 
team representatives were asked whether they agreed with the results from the 
qualitative interviews, if the analysis had missing information that was important for 
enriching the data, and if the results were applicable for their team. The interviews 
confirmed the results. 
 After this analysis, we used Gunn’s NPT framework on depression20 to help 
understand and further interpret the qualitative findings. Because this framework is 
a ‘conceptual framework for implementing best practice depression care that is 
informed by NPT’ we considered the additional use of the framework of interest to 
generate a more in-depth understanding of the stepped care implementation 
process.20 Gunn’s depression framework is built on the four NPT mechanisms that 
drive change: coherence, cognitive participation, collective action, reflexive 
monitoring17 (http://normalizationprocess.org). The mechanism of coherence refers 
to the way in which depression care is conceptualized by healthcare professionals, 
and implies that all actors should have a shared understanding of what constitutes 
depression and depression work. This shared understanding is necessary for 
adoption of an effective stepped care model for depression in routine care. 
Cognitive participation outlines how professionals engage in depression care, and 
implies an agreement that depression care is part of routine care and that there is 
a shared set of diagnostic and treatment techniques. The third mechanism, 
collective action, is about how depression care is organized and what factors 
constrain and structure the depression care activities. The fourth mechanism of 
reflexive monitoring is the agreement between the physicians on how depression 
care is appraised and the understanding about why the depression care happened 
as it did.20 In our study, the four NPT-based constructs served to reframe our 
findings, to describe additional relevant issues to stepped care approaches for 
depression, and to further elaborate on these issues. 
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Results
Eighty physicians and support staff working in eight primary care teams, 
expressed an intention to implement stepped depression care, introduced to them 
during the QIC. The participants consisted of PCPs (n=20), specialized mental 
health nurses (n=7), primary care psychologists (n =9), social workers (n=11), 
physiotherapists (n=5), psychiatrists and psychologists consulting in primary care 
(n=6), pharmacists (n=2), local project managers (n=10) and local supportive staff 
or managers (n=9) (Table 1).
Table 1. Distribution of participants between the QIC teams 
Team identity PCP SMHN PP SW Pht Pth/psy Pharm Pm Other 
1 1 1 1 1 1
2 2 1 2 2 1 1 1 2
3 4 1 1 1 1 1
4 1 1 1 1 1 2
5 2 1 2 1 1 2 3
6 5 1 2 2 1 1
7 1 1 1 1 1 2
8 4 1 2 2 1 2 1 1
total 20 7 9 11 5 6 2 10 8
PCP: primary care physician 
SMHN: specialized mental health nurse 
PP: primary care psychologist 
SW: social worker 
Pht: physiotherapist or psychomotor therapist 
Pth/psy: psychotherapist, psychiatrist, specialized psychologist 
Pharm: pharmacist 
Pm: local project manager 
Other: manager and supportive staff 
Patient differentiation
The first stepped care principle concerned the differentiation between two 
categories of patients: patients with severe symptoms and patients without severe
symptoms. The QIC’s national expert team provided a set of pragmatic severity 
criteria, derived from DSM-IV and diagnostic instruments, to the physicians. One 
aspect of the severity criteria was the duration of depressive symptoms. 
Discussing depression identification from the different professional perspectives 
was new to the physicians, and it took some time to create a shared 
understanding of the conceptualization of depression in daily practice: 
‘Our cultures are different and we are quite convinced of our own treatment 
approach. One can have a psychiatric view of depression and a psychological 
one. To discuss this with an open mind, it needs time, but that is what 
happened.’ (Team 7) 
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Many physicians were positive about the new criteria for differentiation between 
patient categories, which seemed to help them develop their diagnostic skills:
‘I find it remarkable that I was not used to the new terminology of severe 
depression and non-severe depression ... Especially the criterion of time as a 
factor impacting on severity was an eye-opener to me when I joined the QIC 
... and I think for others too. I find this a refinement of my diagnostics and my 
clinical approach. This is an important advantage.’ (Team 3) 
Some PCPs preferred to keep old diagnostic styles, because of fundamental 
disagreement with the medical model underlying the diagnosis of depression. 
They gave a different meaning to the concept of depression than the QIC stepped 
care model, especially to the milder forms, and rather looked at underlying 
problems instead of focusing on symptoms. For example, if a person developed 
depression following the loss of a beloved one or because of a chronic illness, the 
PCPs did not label and treat the depressive symptoms as a depression. Even 
though the QIC experts advised to include this category of patients in the project 
and offer them a selfhelp or preventive intervention, the clinicians often did not 
follow these instructions: 
‘It was difficult to include people in the depression project, because I often 
thought: if I solve the problem that causes the depression, the depression will 
disappear. Therefore, I did not interpret the problems as a depression, but 
rather as ... a mood that corresponds to what is happening to this person.’
(Team 1) 
According to these physicians, labeling and treating the symptoms as a disease 
could have the negative effect of adopting too narrow of an approach to the 
patient’s problems, offering medical solutions without considering the patient’s
story and contextual factors. Another reason for not diagnosing depression was a 
good functional state of the patient. Some physicians expressed that they would 
not discuss depression or bring the topic up when consulting with patients who still 
had high functioning. 
 The team discussions about the nature of the depression, as a part of the QIC 
method, was a learning experience for the team members, and a facilitating factor 
for further refinement of diagnostic skills:
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‘This is exactly the gain of working together, to look at depression in all its 
aspects, because one does not become depressive just like that, there is a 
whole story behind it, and if one only looks at the symptoms and treat those 
then one can make mistakes.’ (Team 6) 
Our data show that many factors influenced the implementation of the first stepped 
care principle of patient differentiation. Some can be related to the NPT constructs 
of ‘coherence,’ the process of creating a shared understanding about who is 
depressed, who is not and the severity level of the depression. This understanding 
needs to emerge in conjunction with the construct of ‘cognitive participation,’ the 
process to get physicians actively engage with the depression work.20 Both 
constructs were driving the implementation of patient differentiation. Although the 
boundaries of depression and the severity criteria were handed to the physicians 
by the QIC’s national expert team, the multidisciplinary teams went through an 
intensive process of exchange about the different perspectives on depression: the 
‘psychiatric’ and the ‘psychological’ perspective. This process was time 
consuming, but finally resulted in the ‘buy-in’ of many physicians into the stepped 
care principle of patient differentiation, except for some PCPs who had difficulties 
applying the depression criteria to patients with mild, context-related symptoms 
(see Table 2 for an overview of the NPT related factors). 
Stepped treatment of depression 
Most of the change activities of the primary care teams were spent on the second 
principle displayed in Box 1, stepped depression treatment. The implementation 
efforts were mainly directed at adding one or more low intensity treatment 
interventions to the usual routine practice, to serve as alternative treatment option 
to antidepressant medication for patients with non-severe depression. The 
stepped care model implied that, alongside the introduction of new interventions, 
the teams standardized and structured their care for the different levels of 
depression (non-severe and severe). To some, this idea of structuring and coming 
to multidisciplinary agreements was helpful, because it gave them a sense of 
control over the care process. Others were hesitant about it, because they 
believed that depression care is difficult to standardize, because all patients have 
a unique symptom profile. 
 It took some teams quite a long time to discuss the stepped care interventions, 
compare them to existing routines, study the ‘toolkit’ with descriptions of the 
interventions provided by the national expert team, define the skills and capacity 
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necessary to provide them, and reach agreement upon who should provide the 
interventions and how to implement them locally. This process was especially 
relevant in the multidisciplinary teams in which the physicians were unfamiliar with 
each other’s skills and work. Getting to know other team members was a first but 
necessary step: 
‘It is important that we now know what everybody has to offer...that process 
happened in harmony...so now I can refer even more adequately to social 
work, for instance, if I want the patient to have intensive coaching or practical 
help...that kind of care.’ (Team 4) 
The actual implementation activities consisted of different kinds of preparations for 
stepped depression care. Most teams installed a regular multidisciplinary staff 
meeting for discussions about patient care plans. Manuals, procedures, and 
patient information leaflets were developed, educational workshops were 
attended, new healthcare providers were contacted to provide specific care 
modules, and insurance companies were approached for additional funding. In 
addition, many team members participated in workshops offered by the QIC to 
train themselves in specific techniques, such as problem-solving treatment and 
psycho-education. 
Despite the hard work, it was not possible for every team to organize one (or 
more) of the new interventions within the 15-month time frame of the QIC. 
However, if they did succeed to introduce new interventions, this allowed them to 
offer new choices to patients, as alternative interventions to medication: 
‘Well, I liked noticing that I did change my routines ... When handling 
depression, I used to think: either I prescribe medication and do some 
consultations or I refer to specialty care. Now, many other options appear to 
be possible.’ (Team 7) 
Changing routines in clinical practice for depression treatment had several 
benefits. Not only were team members able to offer more alternative interventions 
to clients, but they developed the self-confidence to do so, rather than simply
prescribing antidepressants. The team members also felt that overall, changing 
routines for depression care was a positive experience: 
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‘Many people have had good experiences with antidepressants. They find it 
hard to leave them. Also the PCP is used to prescribing them...but in the 
course of the project I progressively managed to offer alternative, low 
intensity interventions, because I started to believe in them myself ...
Nowadays I tell my patients that I keep antidepressants up my sleeve.’
(Team 8)
New interventions were not always provided according to the descriptions in the 
QIC toolkit. Some physicians openly admitted to offer their patients depression 
care with ‘a bit of everything’. 
 There were several PCPs who displayed mistrust in the effectiveness of the low-
intensity treatment options. The reason for disagreement and mistrust stemmed 
from the fact that these PCPs believed that offering only low-intensity interventions 
implied insufficient treatment. This group of PCPs argued that patients with
depression are in need of more substantial treatment options, and that ‘just giving 
a self-help manual and tell them to return in six weeks, is not general medicine.’
 As a consequence of the teamwork, the contacts between the physicians within 
the improvement teams improved in terms of knowing and understanding each 
other, and facilitating more open and direct communication and a shared 
language. Physicians experienced that this improved communication positively 
impacted on day-to-day collaboration and thought this change of itself had been 
one of the most important gains of the QIC:
‘I think our collaboration improved ... getting to know each other by spending 
time together. To me, improved collaboration, independent of depression 
care, has been an enormous gain of this project.’ (Team 1) 
According to the respondents, competition between mental health nurses, social 
workers, and psychologists did lead to discussions, but did not result in real 
conflicts. The argument was that due to the vast number of depression 
interventions to be implemented, there was work to be done for all types of 
healthcare workers within primary care. Considering this, team members mostly 
preferred to be complementary instead of competitive. In relation to specialty care, 
complementary action included reaching an agreement with staff working at the 
specialist level, to refer patients to existing self help programs when necessary. 
Competitive actions included instances where several primary care teams 
established a new physical exercise group within primary care, rather than 
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referring patients to existing programs at the specialist level in psychiatric facilities. 
This reasoning for the introduction of such a program was due to the belief among 
these primary care teams that bringing exercise ‘to the patient’ was a better 
response to address the needs of the patient. 
Different factors influenced the implementation of the new interventions. Barriers 
for introducing them were poor organizational infrastructures in primary care, a 
lack of financing of some psychological or physical interventions, a shortage of 
patients with depression choosing the new interventions, and a lack of 
collaboration from specialist care organizations who were not always keen on 
sharing care. Other factors were facilitating the implementation of stepped care, for 
example national policies and regulations within the healthcare system. Some 
respondents spoke about ‘the stepped care movement’ that started about ten 
years ago, but only recently came to reality due to multiple favourable conditions 
coming together. The QIC had given this movement a ‘push,’ and although the 
implementation of the full stepped care model did not occur within the given time 
frame, change in the right direction did occur in the eyes of the teams: 
‘It is very difficult to induce change in a short period of time, I have noticed. 
On the other hand, I did sense enthusiasm for this very workable model...It 
mainly ‘structures’ the care that a PCP provides and creates possibilities for 
agreements. Yes, I do feel positive about this, it would be a waste to return to 
old routines again, and that’s what I notice amongst my colleagues as well.’
(Team 4) 
These   results  show that the  second  principle  of  the  stepped  care  model
–implementing stepped care treatment– was mainly translated by the physicians in 
trying to introduce new interventions and reduce antidepressant prescribing. This 
process demanded an intensive process of ‘cognitive participation’ and ‘collective 
action,’ engagement with a shared set of techniques and agreement on how the 
work should be organized. Collective action, according to Gunn et al. is defined as 
‘purposive action aimed at a clear goal, and is influenced by both organizational 
(external) factors and immediate (internal) factors.20’ Important positive internal 
factors in our data were related to the physicians developing trust and good 
relationships among the team members and with patients, important external 
factors were related to poor reimbursement of the new interventions, and 
stimulating stepped care policies helping the implementation process. (Table 2).
 Part II – The impact of the quality improvement collaborative on improving mental health 
114
Table 2. QIC factors influencing the achievement of the NPT constructs and depression 
propositions 
NPT constructs
(May and Finch, 2009)
Corresponding propositions 
(Gunn et al., 2010)
QIC factors 
Coherence Depression work requires 
conceptualization of bounderies 
(who is depressed, who is not 
depressed). Depression work 
requires techniques for dealing 
with diffuseness.
Facilitators:
The QIC stimulated multidisciplinary team 
discussions with open exchange of 
perspectives. The stepped care model 
offered physicians a technique for shared 
understanding on depression (who is 
severely and non severely depressed). 
The BDI offered a framework for dealing 
with diffuseness of depressive symptoms.
Barriers:
Different professional views on depression 
causing long discussions.
Disagreement of some physicians with the 
medical model underlying the stepped care 
model.
Cognitive participation Depression work requires 
engagement with a shared set of 
techniques that deal with 
depression as a health problem.
Facilitators:
The new low intensity stepped care 
treatment options fitted well into the primary 
care perspective.
The QIC meeting helped the exchange of 
the different views and come to agreements 
about the local depression care pathway 
and the task division. 
Working with the stepped care model 
improved the knowledge, skills and self 
confidence of primary care physicians.
Treatment choices could be easily shared 
with the patients, leading to better working 
relationships.
Barriers:
Unfamiliarity within the teams with each 
others skills and perspectives. 
The negative attitude of some physicians 
towards standardization of depression care.
The belief that (pro-active) monitoring is not 
a normal part of the PCP’s work, and rather 
the patient’s own responsibility.
Collective action Depression work requires 
agreement about how care is 
organized, who is required to 
deliver care, and their structural 
and human interactions.
Facilitators:
The possibility to tailor the stepped care 
model to the local setting.
Training was offered to apply the stepped 
care interventions.
Regular team meetings to discuss individual 
treatment plans helped to agree on how 
stepped care was delivered. 
Competition between the different 
disciplines was not conceived as a problem 
because of the large amount of work to be 
divided.
Government policies have stimulated ‘the 
stepped care movement’ over the last 
decade.
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NPT constructs
(May and Finch, 2009)
Corresponding propositions 
(Gunn et al., 2010)
QIC factors 
Barriers:
Poor organizational infrastructures, such as 
the absence of links with specialty care.
A lack of funding of the new low intensive 
interventions, such as physical exercise.
A lack of patients opting for specific 
interventions.
Reflexive monitoring Depression work requires the 
ongoing assessment of how 
depression care is done.
Facilitators:
Improved motivation because outcome 
measurement can structure and advance 
care for individual patients.
Positive reactions of patients and improved 
relationships, as a result of sharing the 
monitoring results.
Improved self-confidence of physicians in 
making treatment decisions based on 
objective measurement.
Barriers:
Multiple logistical problems for getting the 
questionnaires handed out and returned by 
the patients.
The absence of supportive systems (ICT, 
reminder systems) or staff.
The absence within the primary care teams 
of a culture and skills for process evaluation. 
Outcome monitoring of depression 
The third stepped care principle to be implemented consisted of structural use of 
the Beck Depression Inventory (BDI), which had to be completed every six weeks 
by the patient until a score of 10 or lower was achieved.25 This implies that in case 
of a no-show of a patient, the team needs to pro-actively contact and follow-up 
with the patient. The structural use of a depression measurement within the QIC 
context served two functions. First, it served as an outcome indicator within the 
stepped care model, to follow-up on the patient’s well-being, and step up to a next 
treatment level if the patient was unresponsive. This use of the BDI was much 
appreciated by the physicians: 
‘Such a measurement instrument in a primary care practice is very special. 
And in fact, I do feel positive and enthusiastic about it. To follow the course of 
the depression in this way and the treatment time ... three months, six months 
... and if something does not work, one can take the following step.’ (Team 4) 
The second function of the BDI was to serve as a process indicator, in an effort to 
help the improvement team reflect on the progress of the implementation process, 
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to identify barriers and adapt implementation strategies where necessary. This 
introduction of the use of the BDI instrument as a process indicator was part of the 
PDSA cycle, a formal component of the QIC method. The teams were asked to 
use process indicator patterns and trends over time to reflect on their 
implementation work, but this method of making goals and processes explicit and 
accountable did not appear to fit within the more intuitive cultures of the primary 
care teams: 
‘I did not need the Plan-Do-Study-Act method, neither did my group. Rather, it 
created confusion ... What we did, we just started and tried to profit of each 
other’s added values ... and of course we tried to improve the care for 
patients with depression. We simply worked with that in mind and that was all 
we needed.’ (Team 2) 
There were a number of barriers to the introduction of the BDI, as the structured 
use of a patient questionnaire for depression was virtually unprecedented. 
Baseline BDI measurement, at the beginning of care, was relatively easy to 
organize compared to repeated measurement. One professional-related barrier 
discussed during team meetings was the vision of some teams that depression 
measurement on a continuous basis by proactively asking patients to fill out the 
BDI, was ‘patronizing’ and therefore not in accordance with a PCP’s professional 
role but more appropriate for other roles, like social workers. Arguing that 
monitoring is the patient’s own responsibility was cited as another reason for not 
ensuring that the BDI was continuously registered over time: 
‘Sometimes I see someone with a BDI of 20, and in spite of this I still 
conclude that this is not depression ... Some weeks later the person visits me 
again and I see that things have calmed down. And after that the person does 
not turn up again ... In those cases I do not call the patient myself, that is not 
my way of working. I consider that to be somebody’s own responsibility.’
(Team 3) 
Although the physicians clearly invested time and effort to use the BDI as a 
monitoring tool and attempted to make it work, organizational barriers made the 
use of the BDI a very time consuming and difficult task. Having the BDI sent to the 
patients and returned to the practice, the lack of supportive Information and 
Communication Technology (ICT) for reminding the physicians about the BDI or 
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for registration and feedback of BDI scores, and a lack of administrative staff, were 
hindrances to BDI implementation. Despite these difficulties, some physicians did 
manage to incorporate the instrument into their work processes. The patients’ 
reactions to this were surprisingly positive, despite the prior expectations of many 
that patients would not co-operate. While using the instrument during 
consultations, the patient-doctor communication became more structured, focused, 
and therefore more meaningful for both. This was an unexpected function of the 
BDI instrument:
‘I found patients to be very enthusiastic about the BDI. You wonder how they 
will react when you give them a questionnaire like that. Well, very positively. 
And for a PCP it provides a starting point for the next consultation, something 
to talk about, a lead ....’ (Team 4) 
Additionally, another also unexpected function of the instrument was the 
physicians’ perception that the BDI legitimated treatment decisions and gave some 
objectivity to them. Like a thermometer indicating the patient’s fever, the BDI made 
the physicians feel more certain in decision-making, confirming that they were not 
‘just doing whatever came up.’ At times, the physicians noticed that this ‘objectivity’ 
also worked out positively for patients as well, particularly when their BDI score 
changed to a lower score. A declining score served as a hopeful message to the 
patient, as ‘proof’ that the depressive symptoms were going to go away even 
where the patient had not yet experienced any symptom improvement. However, 
physicians did not always trust the BDI score and sometimes valued their 
subjective assessment of the client as more important, thus relying on their own 
clinical judgment. 
 Relating back to the NPT constructs, the implementation of the BDI during the 
QIC does not correspond to the construct of ‘reflexive monitoring,’ which is the 
notion that depression work demands an ‘ongoing assessment of how depression 
care is done’.20 Reflexive monitoring, in terms of using data for understanding the 
implementation process and guide discussions that may lead to modification of the 
implementation goals and strategies, did not occur as intended by the expert team, 
mostly because it did not match with the primary care culture for introducing 
change. While teams did introduce the BDI, the function was more to appraise 
well-being and the treatment plans of the patients, rather than using it as a tool to 
measure progress and process. Different factors, related to other NPT constructs, 
influenced the actual implementation of the BDI (Table 2).
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Discussion 
The introduction of a stepped care model for depression to primary care teams 
within the context of a depression QIC was generally well received by the 
participating physicians. All three elements of the proposed stepped care model 
(patient differentiation, stepped care treatment, and outcome monitoring) were 
translated and introduced locally. The process was influenced by a complex set of 
factors. Facilitating factors for the implementation process were the stepped care 
model itself, the structured team meetings as part of the QIC method, and the 
positive reaction received from patients to stepped care. Hindrances to rapid 
implementation included the differing views of depression and depression care 
within the multidisciplinary healthcare team, lack of resources, and 
underdeveloped information systems. As a result of these hindrances, physicians 
were not able to fully adopt the stepped care model as a new treatment approach 
embedded in primary care, but did manage to take some strides towards utilizing 
this treatment approach. The stepped care changes reported by the physicians 
were: learning how to differentiate between patient groups with depressed 
symptoms and different levels of care; being able to offer a broader treatment 
package to depressed patients including low intensity interventions; changed 
antidepressant prescribing routines; and better working relationships with patients 
and with colleagues. 
Although all four NPT constructs operated concurrently in the QIC, ‘coherence’ 
and ‘cognitive participation’ appeared to be crucial drivers, especially in the 
beginning of the process. The introduction of the stepped care model by the expert 
team was not enough to get the physicians started. The teams needed time for 
discussions and information exchange to reach a shared understanding of 
depression and depression care and to come to local agreements about the 
selection of interventions and the distribution of tasks amongst the different team 
members. In teams where members did not know each other prior to the QIC, it 
was a very time consuming process to reach a shared understanding of 
depression care and get physicians engaged with the change process. The 
stepped care model itself provided clear guidance for ‘collective action’ and the 
actual implementation of new interventions for depression, but external factors 
such as poor financing hindered the change process. The NPT construct of 
‘reflexive monitoring’ did not happen as explicitly as the QIC method intended. 
Instead of following PDSA cycles, supported by monitoring results, the teams 
moved on rather intuitively, using the BDI data to follow patients outcomes and 
adapt the treatment plan accordingly. 
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Relation to other studies 
In our study, we found that a shared understanding of depression and depression 
care is a crucial step towards change. This is in line with the view of Gunn et al., 
who argue that primary care physicians ‘hold a different view of depression and 
depression work compared to the traditionally applied psychiatric viewpoint’ and 
suggest that ‘without shared agreement about what primary care means by the 
term depression, diagnosing and developing adequate treatment and 
management pathways will remain difficult’.20
 The QIC intervention relates to other national depression quality improvement 
work in primary care, such as the research by Meredith et al., a process evaluation 
of an American depression QIC, based on Wagners chronic care model, with 
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organizations.26 The evaluation comprised semi-structured interviews, conducted 
with team leaders, about the successes and the barriers that facilitators 
experienced during the QIC. Results revealed that some elements of the chronic 
care model changes were adopted by all the teams (proactive follow-up, patient 
education, patient registry systems, and care planning), while other changes were 
not (provider participation and patient activation). The only barrier that affected 
perceived success was poor leadership support. 
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organization, clearly articulated by clinical leadership and a systematic change 
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 Our results are also in line with a recently published report of a stepped care 
implementation study in the United Kingdom, concluding that implementation of 
stepped care at different sites varies greatly according to different contexts.24
Richards et al. suggest that ‘prescriptive national initiatives should incorporate 
local modeling to translate national prescriptions to specific situations’.29 Although 
the implementation intervention applied in this project did not contain local 
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time and support for primary care teams to discuss and translate the stepped care 
principles to their own contexts. 
Strengths and limitations of the study 
Strengths of this study are the depth and details generated about the introduction 
of stepped care amongst a fairly large and diverse group of primary care 
physicians, who actually experienced these change processes. The use of NPT 
helped to interpret the findings in a generalizable framework for adoption of new 
routines. A limitation of our work is that our findings are based on experiences of 
physicians who volunteered to participate in a quality improvement program and 
were supported to implement a stepped care approach. Our findings might be less 
applicable outside the context of a quality improvement project. Secondly, we only 
interviewed the improvement teams once during the course of the program. 
Additional interviews at different time points could have reduced the risk of missing 
information that would have been important to understanding the implementation 
process; however, we believed one interview was sufficient to capture experience 
with the implementation process. Furthermore, financial and pragmatic constraints 
did not allow for multiple interviews.
Interpretations of the findings and implications for practice
Our data strengthen our expectations that the introduction of stepped depression 
care within primary care teams is time consuming, and dependent on an 
interaction of complex factors. We found barriers and facilitators for this change at 
different levels: the stepped care model and the QIC itself, the individual 
professional, the patient, the social context, the organizational context, and the 
economic and political context. Despite these barriers, the QIC context helped the 
teams to move towards a more stepped care approach for depression, using the 
three principles of the QIC model. Our data underscore the unpublished 
quantitative findings of the QIC intervention study, that it seems unlikely that the 
changes reported by the physicians would have occurred by itself within the 
primary care teams. The data show that the processes of coherence and cognitive 
participation within the multidisciplinary teams were so crucial, and that without the 
QIC infrastructure of regular and structured multidisciplinary team meetings, 
coordinated by a local project manager, the stepped care model might not have 
been emphasized so much and translated to local circumstances by the 
physicians as it was during the QIC. 
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 This raises the question whether providing a care model and organizing team 
meetings are sufficient to induce change or whether physicians also need 
supportive mechanisms such as following PDSA cycles or making use of an expert 
team. According to our data, the explicit use of PDSA cycles and the expert team 
seemed to be of less value to the primary care teams. Another question that 
remains is whether QICs in mental health, instead of taking a rather one-size-fits-
all approach, should be designed in a more flexible way and show more sensitivity 
to local problems in terms of poor ‘coherence’ or ‘engagement’ of individuals. 
Additional implementation studies may be able to answer these questions and 
make suggestions for adaptations of the QIC method. 
The take-home message, based on our additional NPT analysis, is that future 
implementation projects for depression in primary care should incorporate 
sensitizing strategies for addressing local problems of participating teams. 
Facilitators who guide these processes should be particularly attentive to local 
problems related to ‘coherence’ and ‘cognitive participation.’ If implementation 
strategies are too oriented towards action and rapid implementation, clinicians 
might not engage. Also, systems for reflexive monitoring are still not implemented 
and need to be addressed if policy makers aim at processes of continuous quality 
improvement in depression care.20,30 Besides this message that the use of NPT 
has led us to, the application of the NPT constructs to our data has also been 
problematic due to the overlap and difficulty of discerning the difference between 
the constructs. Another criticism of NPT is related to the point that May and Finch 
address: that NPT ‘focuses on the work of embedding and of sustaining practices 
within interaction chains’.19 This implies that the NPT constructs are mainly based 
on perceptions of people, which present the risk of leaving some contextual factors 
beyond the scope. 
 Stepped depression care has been strongly promoted throughout the 
Netherlands in the past five years. Both the stepped care model used in our study, 
as well as several of the QIC method elements have been helpful tools to guide 
stepped care implementation in some regions. It is important to consider that users 
of the model might consider an adaptation such as the adoption of the PHQ-9
instead of the BDI. The BDI was selected by the QIC’s national expert team in 
2004, based on their own experience with this instrument in specialist care. 
However, the PHQ-9 has become more widely used by now, and has some 
advantages over the BDI, such as its ability to diagnose and monitor the severity 
of depression, in addition to its brevity and usefulness in primary care practice.31
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An adaptation of the QIC method may be to use the NPT constructs to check 
progress of change, to identify team barriers, and to develop strategies to
overcome these barriers. These adaptations of both the stepped care model as 
well as the QIC method could be topics for future research in this area. 
Conclusions
Stepped depression care can be received positively in primary care. Although 
implementation of a full stepped care approach cannot be reached within a short 
time frame, within a QIC context physicians can set steps into this direction. 
Creating a shared understanding within multidisciplinary teams of what constitutes 
depression and coming to an agreement on the content of depression care and 
the division of tasks is important to address during stepped care implementation 
processes. 
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Abstract
Objective: Internationally, guidelines for depression recommend a stepped care 
approach, implying that antidepressant medication should not be offered as a first 
step treatment to patients with sub-threshold or mild depression. In the 
Netherlands, antidepressant prescribing rates in primary care as a first treatment 
step are considered to be high. This study aimed to implement guideline 
recommendations on antidepressant prescribing within the context of a national 
Quality Improvement Collaborative (QIC) in primary care.  
Method: A quasi-experimental study with a nonequivalent control group and three 
years follow-up was performed in the primary care setting in the Netherlands. 
Primary care physicians (PCPs) participated in multidisciplinary QIC teams, which 
focused on the implementation of a guideline based model for stepped depression 
care. The model consisted of self-help and psychological treatment options for 
patients with milder symptoms as an alternative to antidepressants in primary care. 
Changes in antidepressant prescription rates of PCPs were registered for a three-
year period and compared to those in a control group of PCPs, selected from an 
ongoing national registration network. 
Results: A decrease of 23.3% (49.4%-26.1%) in antidepressant prescription rates 
for newly diagnosed patients with depressive symptoms was found within the 
intervention group, whereas no difference occurred in the intervention group 
(50.3%-52.6%). The decrease over time was significant compared to the control 
group (OR 0.44, 95% CI: 0.21-0.92). 
Conclusions: A Quality Improvement Collaborative aimed at implementing 
stepped care principles for the allocation of depression interventions, resulted in 
reduced antidepressant prescription rates in primary care. PCPs can change 
prescribing behaviour within the context of a multifaceted implementation strategy.  
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Introduction
Depression is a highly prevalent condition with a range of effective treatment 
options, many of which can be offered in primary care. Since 2004, guidelines in 
several countries recommend a ‘stepped care approach’ as a framework for 
organizing depression care, putting treatment options in a specific order and 
relating them to patient severity profiles.1-5
 Based on this framework, the national evidence-based multidisciplinary 
guideline for depression in the Netherlands, developed by a Guideline 
Development working Group (GDG) consisting of primary care physicians (PCPs),
psychiatrists, psychologists, allied health professionals and consumers and carers, 
recommended that antidepressant medication should not be offered as a first step 
treatment to patients with sub-threshold or mild depression. Instead, brief and non-
pharmaceutical interventions including watchful waiting, (guided) self-help based 
on cognitive behavioural therapy (CBT), physical exercise and problem solving 
therapy were considered appropriate choices in the beginning of a treatment 
episode. Antidepressant medication or psychotherapy were to be offered as first 
step treatment options to patients with moderate, severe or chronic symptoms.1  
Depression care according to guideline recommendations, does not seem to be 
current practice. Rates of guideline concordant care reported in the literature 
range, depending on setting, country and criteria for appropriateness. Results of 
the National Comorbidity Survey Replication showed that over twelve months, 
52% of patients with depression received treatment and only 42% of these cases 
received treatment considered adequate, which in that study referred to four 
outpatient visits for psychopharmacology, or eight or more visits with any mental 
health professional of at least thirty minutes. This resulted in 22% of all patients 
with depression being adequately treated.6 In the Netherlands, appropriate 
adherence for depression to the national guideline for PCPs was around 42% of 
patients with a confirmed 6 months recency diagnosis of depression.7 In the Dutch 
study, adherence to guidelines was defined as: receiving at least five consultations 
of the PCP in the 15 week period after the diagnosis for psychological support, or 
receiving counseling, or receiving appropriate antidepressant medication, or a 
referral to a mental health specialist. Appropriate antidepressant medication was 
defined as receiving at least one consultation within six weeks of initiating 
antidepressant drug treatment and continuation of treatment for at least five 
months or cessation after 2-6 weeks in case of no-response.7 
 Focusing on recommendations concerning antidepressant prescribing, a 
number of problems exist. Firstly, antidepressant prescription rates in primary care 
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are high in the Netherlands, 76% in 2002 and 70% in 2008.8 Although these rates 
seem to decline in recent years, they have risen strongly over the last decades, 
with rises of more than 30% being reported in different countries.9-14 One 
explanation for this rise of volume in antidepressant prescribing are the changes in 
the proportion of patients receiving long term treatment.15,16 Secondly, 
antidepressant prescription for depression during the first contact with the patient 
has also risen, from 62% of the cases in 1993 to 73% in 1998.17 Thirdly, there is a 
strong variation in prescribing between PCPs, which can be explained by 
population and PCP’s characteristics.12 And finally, prescription of antidepressants 
by PCPs seems unrelated to symptom severity.18 A stepped care approach is also 
lacking because effective and brief, low intensity alternatives are poorly known and 
yet to be implemented in primary care.19 Considering also the fact that 
antidepressant treatment does not comply with the preferences of many patients, 
many of whom give negative reports of ineffectiveness and side-effects, there 
seems to be a need to change prescribing behaviour in primary care into a more 
stepped care direction, and in accordance with the clinical guidelines.18,20-23
 In order to do so and implement key recommendations of national depression 
guidelines in the Netherlands, a Quality Improvement Collaborative (QIC) with a 
three year follow-up was run from December 2006 until March 2008, as part of the 
National Depression Initiative.24 QICs are multifaceted strategies offered to clinical 
care teams, to rapidly improve performance and outcomes.25-28 Parallel to the QIC, 
an implementation study was performed to determine the impact of the Depression 
QIC, in implementing guideline recommendations concerning antidepressants 
prescribing by PCPs.
Methods 
As adopting a stepped care model for management of depression is a major 
change and thus difficult to allocate randomly to healthcare professionals, we 
performed a quasi-experimental evaluation with a non-equivalent control group 
and three year follow-up period. The principle research question to be answered 
concerned the impact of the QIC on antidepressant prescribing of participating 
PCPs compared to prescribing behaviour of PCPs who had not participated in this 
improvement program. At the time of the study, nationally around 40%-60% of 
patients in primary care presenting with sub-threshold or mild depression received 
antidepressants.2,29 Thus, the expected overall effect of the QIC was a decrease of 
prescription rates in the participating primary care practices over the three year 
study period compared to non participating practices. Ethics approval was 
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provided by the METIGG, a national ethics committee in mental healthcare in the 
Netherlands. The study registration number was ISRCTN99634826. 
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national implementation program described in detail elsewhere.30 These persons 
had been recruited for this purpose throughout the country by directly approaching 
primary care practices, or indirectly via the healthcare insurance companies. At the 
start of the QIC, all thirty nine PCPs were invited to participate in the study, 
alongside their implementation work. The main criterion for selection in the study, 
apart from QIC participation, was the willingness to comply with data collection by 
the research team and data extraction from the EMR. Baseline performance on 
depression indicators was not a criteria for selection. Practices were paid a fee for 
the time spent on research activities. 
 The control group included PCPs from practices participating in the Dutch 
National Information Network of General Practice (LINH), holding longitudinal and 
nationally representative data on morbidity, prescribing, and referrals.31 The LINH 
database is the principle national database in the Netherlands for primary care 
research, and used as such by numerous research teams and to inform the 
Ministry of Health on the current state of primary care.7,18,29,32 Because of their 
participation in a continuous research infrastructure, the LINH participants can be 
considered a relatively well performing group of PCPs, more likely to keep 
themselves up to date with guideline recommendations as non-participating 
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research and quality improvement purposes.  
 All LINH-practices were included only if the EMR provided information about at 
least 90% of the three years duration of the study. Professional performance on 
depression indicators was not a selection criterion. Selected patients in both 
groups aged 18-65, with a newly recorded diagnosis of depression, as diagnosed 
by their PCP, were eligible for the study. Depression had to be registered by the 
PCPs in the Electronic Medical Record (EMR) with an International Classification 
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of Primary care (ICPC) diagnosis of depressive feelings (ICPC code P03) or 
depression (ICPC code P76).32-34
Intervention
A Depression QIC was executed during 15 months. QICs are multifaceted 
implementation strategies applied in many countries for various clinical problems 
and generally have five essential features: (1) a focus on a specific topic with gaps 
between best and current practice; (2), clinical experts providing ideas and support 
for improvement; (3) multidisciplinary teams from multiple sites participate; (4) 
there is a model for improvement (setting targets, collecting data and testing 
changes); and (5) a collaborative process with a series of structured activities in a 
given time frame.28,35,36 These structured activities offered to the participants 
during the Depression QIC are listed in Box 1.
Box 1. Structured activities of the depression QIC 
A network of multidisciplinary teams;
An expert team, teaching the Stepped Care Model;
SMART goal setting, a set of indicators to monitor results and an excel worksheet; 
A training for local team coordinators on breakthrough method and data collection;
Four conference days for all improvement teams for exchange and learning;
One conference day for local team coordinators for intensive exchange with the expert team;
Five meetings between local team coordinators, with the expert team present;
Team visits of experts and national project coordinators;
Telephone contact between local and national coordinators;
Written feedback on improvement reports and data charts;
A virtual network environment for exchange of best-practices, a Toolkit of instruments and treatment 
protocols, online discussions and links to relevant sites;
A two days training Problem Solving Treatment for professionals;
A workshop Workflow Improvement.
The focus of the Depression QIC was a stepped care model for depression 
treatment (see Figure 1), developed by the QIC’s clinical expert team and based 
on the multidisciplinary guideline and on previous projects.1,30,37 The model 
consisted of two pathways for patients with different severity profiles. Severity 
criteria were derived from DSM IV and based on the expert team’s opinion. 
Antidepressant medication was not an option in treatment pathway 1, but could be 
considered after a first step intervention had not resulted in sufficient treatment 
response. Antidepressants and psychotherapy were first line treatment options in 
pathway 2. The model served to guide the primary care clinicians in their 
improvement work. 
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Figure 2. Stepped care Depression Model 
Primary care physician
Check symptoms and 
register ICPC codes P03/
P76
Check symptom severity
Appoint to patient group
Patient group 1:
Symptoms not severe
Patient group 2:
Symptoms severe *
Treatment pathway level 1
First step interventions during 6-
12 weeks:
- Watchful waiting
- Psycho-education
- Self-help, group or individual
- Counseling
- Brief psychotherapy, 8 sessions
- Physical exercise
- Other
Monitoring
1 BDI per 6 weeks
Treatment pathway level 2
DSM-IV assessment
Start treatment within 1 month
Psycho-education
Depression treatment
- Antidepressants
- Psychotherapy: GT, CGT, IPT
- Other
Drop-out reduction
Monitoring
1 BDI per 6 weeks
* Severe symptoms in this model are:
Symptoms duration longer than 6 months or
Insufficient response to treatment pathway level 1 after 3 months or
Suicidal ideation, psychotic features, high level of social dysfunctioning,
inability to normal role taking (work, self care, taking care of others).
Data collection
The primary outcome was antidepressant prescribing, defined as the volume of 
antidepressant prescriptions for the depressed primary care population 
(prescription rates), issued by PCPs as a first line treatment choice, within one 
month after the diagnosis. The secondary outcome was referral by the PCPs to
clinicians providing psychological treatment. In both groups, all relevant data of 
patients with ICPC P03 or ICPC P76 registered from 2006 to 2008 were extracted 
from the EMRs of the primary care practices. Registrations by the physicians of 
co-morbid anxiety, using ICPC codes P01 (anxious, nervous, tensed feelings), P74 
(anxiety disorder, condition of anxiety) and P75 (hysteria, hypochondria) were 
extracted as well. Data extraction in the QIC group was performed by the 
physician’s assistants, who had received a detailed protocol for computerized
searching and support from the researchers. Data extraction in the control group 
was performed by the staff from the LINH database.  
 Antidepressant medication covered the subgroup N06A of the Anatomical 
Therapeutic Chemical (ATC) Classification System of the World Health 
Organization. Referrals covered a registration of a referral to a primary care or a 
specialized psychologist, a psychiatrist, a psychotherapist, an institution for 
ambulatory care or a mental health hospital. Data collection covered a three year 
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period: the year 2006 indicates the baseline measurement before the QIC, the 
year 2007 indicates the year of the intervention and the year 2008 largely indicates 
the follow-up measurement, after the QIC had ended. 
Data analysis 
Descriptive statistics were calculated within the groups. We examined the changes 
during the three year follow-up within both study groups using a t-test. To 
determine the effect of participation in the implementation program and to correct 
for the clustering effect we applied a multilevel logistical regression analysis with a 
two-level structure, with patients nested within primary care practices. Statistical 
analysis was performed in MLwiN 2.15, comparing the outcomes between the two 
conditions, with antidepressant prescription (yes or no) or referral to mental 
healthcare (yes or no) as outcomes and the following predictors: group (QIC or 
usual care), patient age and gender, co-morbid anxiety (yes or no ICPC P01, P74, 
P75), year (2006, 2007, 2008) and an interaction term with year and group to test 
the difference in changes between the two conditions. 
Results
Twenty PCPs from 17 practices participated in the intervention group, 115 PCPs 
from 41 practices were selected as controls. In the intervention group, the data of 
400 patients were extracted for analysis, in the control group this number was 
3956 (Table 1). 
Characteristics of the study population 
The mean age of patients with a ICPC registration of P03 and P76 was 39.8 years 
in the QIC group and 41.9 in the control group (table 1). In the QIC group the 
proportion of younger persons was higher (37.5% versus 32.3%), whereas the 
control group consisted of a larger proportion of older persons (23.3% versus 
29.2%). Registration of co-morbid anxiety disorder was low in both groups of 
incident cases (4% and 5.8%), compared to co-morbidity rates of 8.8% to 11.9% in 
prevalent cases reported in other studies.8
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Table 1. Characteristics of the patient population 
QIC practices (n=400) Usual care practices (n=3956)
Age 18-35 37.5 32.3
36-50 39.3 38.5
51-65 23.3 29.2
Mean 39.8 41.9
Male 30.0 35.1
Female 70.0 64.9
Co-morbid anxiety 4.0 5.8
Antidepressant prescription 
Table 2 shows the changes in professional performance within both groups. 
During the three year follow up, a decrease in prescription of antidepressant 
medication of 23.3% occurred in the QIC group (from 49.4% in 2006 to 26.1% in 
2008). The usual care group did not change prescription rates (from 50.3% in 
2006 to 52.6% in 2008). 
Table 2. Patients with new depressive symptoms receiving an antidepressant prescription or being 
referred to mental healthcare within one month (in percentages of the total of patients with 
a new depression) 
QIC practices Usual care practices
2006 2007 2008 2006 2007 2008
Antidepressant prescription 49.4 32.2* 26.1* 50.3 47.0 52.6
Referral to mental healthcare 11.5 16.4 11.2 10.1 13.0* 9.0
n 87 152 161 1261 996 1699
* sign. < 0,05 compared with baseline (2006) 
Referral rates
Overall referral rates of PCPs in the QIC practices were somewhat higher than in 
the usual care practices during the three years study interval. In 2006, 11.5% of 
the patients in QIC practices were referred within a month after diagnosis to either 
a psychologist, a primary care psychologist, a psychiatrist, a psychotherapist, an 
institution for ambulatory care or a mental health hospital. In 2008, this rate had 
remained at the same level, 11.2%. In the usual care practices the PCPs referred 
10.1% of their patients at baseline, a non-significantly decline to 9% had occurred 
in 2008 (Table 2). 
Factors associated with antidepressant prescribing and referral to mental 
healthcare 
Table 3 shows the factors associated with the changes during our study period 
between the two study groups. The usual care PCPs did not change their 
prescribing behaviour in 2007 (OR 0.92) and in 2008 (OR 0.87). In the QIC group, 
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antidepressant prescribing as a first line treatment option did not change in 2007 
(OR 0.60), but the frequency of describing decreased in 2008 in almost half of the 
cases, compared to the usual care group (OR 0.44). PCPs tended to prescribe 
more frequently to older patients, to patients having a depression (ICPC P76) and 
to those who had additional anxiety problems. Although bi-variate analysis (not
shown) showed that these characteristics were found to be associated with 
antidepressants prescription, multivariate analysis showed that these 
characteristics did not account for the effect of the intervention and that 
participation in the QIC over time influenced prescription rates. The QIC group still 
showed a significant decline in prescription (OR 0.44), compared to the usual care 
group. There was no significant change of referral behaviour in both groups. 
Table 3. Factors associated with antidepressant prescribing and referral to mental healthcare 
Antidepressant prescribing Referral to mental healthcare
OR (95% CI) OR (95% CI)
Age of patient 1.03* (1.03 - 1.04) 0.97* (0.96 - 0.98)
Sexe of patient (male = ref) 0.98 (0.86 - 1.12) 0.71* (0.58 - 0.85)
Co-morbid anxiety 1.66* (1.26 - 2.18) 0.71 (0.45 - 1.13)
Participation in Collaborative 0.98 (0.57 - 1.70) 0.93 (0.36 - 2.39)
Year (CAU) 2006 (ref)
2007 0.92 (0.69 - 1.21) 1.12 (0.68 - 1.86)
2008 0.87 (0.66 - 1.15) 1.28 (0.77 - 2.11)
Year * Collaborative 2006 (ref)
2007 0.60 (0.29 - 1.24) 1.11 (0.32 - 3.81)
2008 0.44* (0.21 - 0.92) 0.71 (0.20 - 2.52)
ICC 0.067 0.193
* p < 0,05 
n = 4356 
Discussion 
This study assessed the impact of a depression quality improvement intervention, 
based on the Dutch national multidisciplinary guideline for depression, on 
antidepressant prescribing behaviour in primary care. We found a substantial 
change in the intervention group in terms of lowered antidepressant prescription 
rates as a first step treatment choice for patients diagnosed with depression by the 
PCP. This change was also sustained in the year after the QIC’s ending. PCPs in 
the usual care group did not change their prescribing behaviour during the three 
years course of the study. In both groups there was no change in referral rates to 
mental health clinicians.  
 The results seem to support our hypothesis that, since many patients present 
with symptoms in primary care who do not meet the criteria for major depressive 
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disorder and for whom there is insufficient evidence to support the use of 
antidepressants38, a reduction of relatively high rates of antidepressant 
prescriptions can be achieved as a result of an intensive implementation strategy 
such as a QIC. This more reluctant attitude towards antidepressant prescribing is a
central indicator to a stepped care approach. Unfortunately, due to a lack of data 
about the delivery of low intensity interventions offered to patients with mild 
symptoms as alternatives to medication, our study was unable to show that the 
measured decline in antidepressant prescribing pointed at a more stepped care 
approach by the QIC PCPs. This however, was the conclusion of the qualitative 
process evaluation of the QIC, based on interviews with the PCP who reported 
that low-intensity interventions such as guided self help or brief psychotherapy, 
had been introduced in the QIC practices.39
 The second result of the study, the lack of change in referral rates in the 
intervention group, as well as in the control group, could point at the fact that the 
QIC participants did not replace the medication by a psychological intervention in 
the mental health sector but by an intervention in primary care or by ‘watchful 
waiting’, meaning psycho education and pro-active follow up. In many primary care 
practices in the Netherlands, patients can have access to mental health nurses 
who are equipped to provide brief, low intensity interventions or to do ‘ watchful 
waiting’.   
A strength of this study was the evaluation of an ambitious quality improvement 
initiative with a direct comparison between two good, naturalistic groups, which 
makes the study appropriate to be included in an evidence review of quality 
improvement interventions.40 Other strengths were the large numbers of patients, 
and the substantial effect on the primary outcome.  
 A first study limitation was the lack of a randomization procedure, not 
uncommon in implementation research, which was not an option since the 
researchers had no control over the allocation of PCPs to a particular condition. 
We dealt with this risk of selection bias, by choosing the best possible comparison 
group in the Netherlands, the ‘golden standard’ for measuring care as usual. An 
advantage of this LINH network for our study was the fact that the participating 
physicians, because of their commitment to registration and research, can be 
considered as a group of motivated and therefore relatively well performing PCPs.
The consequence of comparing two motivated groups is that we can not simply 
generalize our results to the population of PCPs who do not show a specific 
motivation to improve daily care. To this problem, one could also argue that 
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motivation is a prerequisite for any change at all, and that the message of this 
implementation study is meant to inform improvement programs targeting 
motivated physicians. Another well known challenge in observational studies, is 
the risk of bias due to confounding, which in our study could have occurred in 
terms of other factors than the QIC causing the observed changes, might not have 
been equally present in both groups. Still it is quite obvious that any one of these 
other factors could not have caused a decline in prescription in the intervention 
group of 23%, which is considered to be quite substantial in the implementation 
literature.  
 A second limitation of our study was the use of EMRs as the major source of 
data collection. Although EMRs in Dutch primary care are common research 
sources for primary care data collection, they do lack information on depression 
identification, depression severity status, treatment process and outcomes. In 
addition, technical attributes of EMRs do not adapt to innovations immediately 
which was the reason that the implementation of new low intensity treatment
interventions were not registered by the PCPs in our study period. Therefore, 
detailed information on care provision to different patient categories could not be 
identified. 
Underregistration of depression diagnosis might have been less the case in our
control group, since these PCPs had an agreement with the LINH database to 
register ICPC diagnosis and treatments provided, whereas in the intervention 
group this agreement did not exist. The lower ICPC reporting rates of the 
intervention physicians does not necessarily point at a true low incidence rate but 
could point at a more general trend observed by some authors, of a reduced entry 
of depression as a diagnosis compensated by an increased recording of 
depressive symptoms.41 This move towards recording symptoms in less specific 
terms, possibly used in patients with mild depression, may be perceived as less 
stigmatizing for patients or it may be explained by greater questioning of the 
meaning of psychiatric diagnostic categories in primary care.41  
Our study adds to the Depression QIC, organized by the Institute for Healthcare 
Improvement in the United States in 2000-2001 and based on Wagner’s Chronic 
Care Model (CCM).42 The American QIC also involved 17 primary care practices, 
who made changes in three of the six categories of the CCM: delivery system 
redesign, self-management strategies, and information systems. The changes that 
were most commonly viewed as major successes were delivery system changes 
and information system changes; these types of changes were also the most often 
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sustained over time.43 Organizational structure and leadership support were the 
most common facilitators. Staff resistance, time constraints, and information 
technology were the most common barriers.  
Our study also adds to similar European stepped care implementation studies 
for depression. The Scottish ‘Doing Well’ study incorporated the routine use of a
depression severity measure with continuous outcome monitoring, a prompt 
access to guided self-help and a “step-up” to more formal psychological therapy or 
medical care if indicated. As a result, daily doses of antidepressants increased 
less rapidly than in other areas.44 A more recent British implementation study into 
stepped care services reported a considerable variation in the design and 
implementation of the stepped care recommendations of the NICE guidelines.45 In
the UK, a large scale guideline implementation program, the Improving Access to 
Psychological Therapies (IAPT), focused on increasing the availability of evidence-
based psychological treatments, both the high intensity therapies (CBT) and the 
low intensity therapies such as guided self-help, psycho-education groups and 
behavioural activation.46 Implementation strategies mostly consisted of training 
and a National Implementation Plan specifying key principles for the operation of 
services. Three year results showed that most patients received guideline-
concordant care and that patients had a higher chance of recovery if the treatment 
sites showed higher step-up rates from low to high intensity treatment in case of 
insufficient response, and if they received an adequate number of sessions.46
There is a vast body of literature on quality improvement for depression or sub-
threshold depression in primary care, mainly performed in the United States and 
heavily building on the system components of the CCM.47 Ingredients of these 
programs are quite similar to what our QIC study offered to physicians: institutional 
commitment to quality improvement, training of local experts and nurse specialists 
to provide physician and patient education, supportive tools, identification of 
potentially depressed patients, patient access to nurses for medication follow-up or 
to trained psychotherapists48-50, collaborative care with a greater role for non-
medical specialists and supervising psychiatrist.51 Practices adopting these quality 
improvement programs improved the quality of care, mental health outcomes, 
employment status while showing lowered or equal visits to medical or mental 
health care. In one quality improvement study, collaboration between mental 
health specialists and primary care providers substantially changed prescribing 
rates of antidepressant treatment. Active follow-up by a depression nurse 
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specialist was associated with longer-term improvement in antidepressant use 
than in practices without such follow-up.48 
The key message of this study is that antidepressant prescribing by PCPs can be 
changed by a multifaceted implementation strategy which offers PCPs attractive 
alternatives to medication and the time and support to implement those in a 
multidisciplinary context. This message is relevant for PCPs, psychiatrists,
managers and policy makers both in Europe as in the USA who are motivated to 
implement guidelines for depression and to move from an overemphasis on 
psychopharmacological treatments for depression52 to stepped depression care, 
where patients with mild symptoms receive less intensive treatments such as 
medication. Policy initiatives aimed at strengthening primary care and reduce 
unnecessary antidepressant treatment in primary care can use our information, by 
addressing PCPs, psychologists, social workers and specialized mental health 
nurses to recognize, treat and monitor depression in a stepped care manner, 
offering guided self-help and brief interventions when possible and antidepressant 
medication when necessary.53
 According to Porter, process measurement, though a useful internal strategy for 
healthcare institutions, is not a substitute for measuring outcomes, whose principal 
purpose is to provide information for learning and improving, thus enabling 
innovations in care.54 Our study should be considered as one of the first studies 
focusing on the issue of overprescribing of antidepressant treatment in primary 
care. It presents data indicating that PCPs can change prescribing behaviour, 
provided that they have access to alternatives and support. Future implementation 
studies should expand on this and study actual stepped care delivery of 
depression treatments, recommended in guidelines. Fortunately, in the 
Netherlands and beyond, implementation of clinical guidelines followed by process 
and outcome monitoring for depression are gradually becoming mandatory and 
better supported by information technology. This is a hopeful message for those 
who try to improve the care for this patient group.  
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Abstract
Objective: To assess patient-level cost-effectiveness of health care delivery for 
depression by primary care clinicians, after exposure to a national guideline 
implementation program, aiming at a stepped care approach. 
Data sources/study setting: The study setting was primary care in the 
Netherlands. The intervention group consisted of primary care patients from 
practices participating in a national depression Quality Improvement Collaborative 
(QIC), the control group consisted of patients from usual care practices included in 
the Netherlands Study of Depression and Anxiety (CAU).
Study design: An economic evaluation with a comparative matched-group design. 
The QIC group received instructions and support to implement a stepped care 
approach. The central clinical end-term was remission. Costs encompassed both 
health care costs and costs stemming from productivity losses.
Data collection/extraction methods: Remission was measured with the 
Inventory for Depressive Symptomatology (IDS-SR), at baseline and at 12 months. 
Costs were measured with the Trimbos and Institute of medical Technology 
Assessment Cost Questionnaire of Psychiatry (TIC-P).
Principal findings: The remission rate in QIC was 9/35 (26%) and 10/55 (18%) in 
CAU. The mean per-patient societal costs were lower in the QIC group (€5,012) 
than in the CAU group (€5,871).
Conclusion: From a societal perspective, the QIC approach is likely to offer more 
value for money than CAU, but a larger and randomized study is needed to verify 
our findings. 
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Background
Depression is the single leading cause of non-fatal disease burden, accounting for 
almost 12% of all years lived with disabilities worldwide and posing a substantial 
economic burden to societies.1,2 In the Netherlands, annual excess cost of 
depression are 2,278 euro per depressed case aged 18-65 years, summing to a 
total of 132 million euro per one million population.3 Evidence-based clinical 
management of patients with depression is crucial to protect and promote quality 
of life and to reduce the economic costs stemming from productivity losses.
Prevailing clinical guidelines provide a range of specific recommendations on 
diagnosis and treatment of patients with depression. The first national 
multidisciplinary guideline for depression in the Netherlands, developed for 
physicians in the primary and secondary care setting, was published in 2005.4 This 
guideline contained recommendations for treating patients with mild, moderate and 
severe depression. The recommendations ranged from watchful waiting and brief 
treatments of low intensity for mild cases of depression to psychotherapy and/or 
antidepressant medication for patients with moderate and severe depression. Brief 
treatments included psycho-education, guided self-help, Problem Solving Therapy 
and follow-up visits. The guideline implicitly recommended a stepped care 
approach for the delivery of these interventions, starting with a low-intensity 
intervention likely to induce a significant health gain, and only to step up to a more 
intensive intervention in case of non-response, which should be monitored.4,5 
Although progress has been achieved in the access and quality of care for 
depressed patients in recent decades, depression guideline recommendations 
have not been well implemented in daily practice.6-10 In Europe, the overall 
proportion of treatment adequacy for depression is 45.8% (95% CI 38.47–53.05).11
In Dutch primary care, only 18% of patients with a diagnosis of depressive 
disorder, confirmed with the Composite International Diagnostic Interview12 have a
registration in the primary care Electronic Medical Record of an appropriate or 
partial diagnosis of depression. And of all CIDI positive patients, 42% is treated in 
accordance with guidelines.9 Despite the growing evidence of the value of 
depression care, awareness about the substantial economic costs generated 
through absenteeism, presenteeism, and disability remains limited.13
 Guidelines do not implement themselves, but require (sometimes complex) 
changes in clinical practice, with often comprehensive approaches at different 
levels (physician, team, practice, hospital, and wider environment), tailored to 
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specific settings and target groups.14,15 In the Netherlands, a national quality 
improvement program using the Quality Improvement Collaborative (QIC) method 
was used as such a strategy to implement a stepped care model for depression, 
based on the multidisciplinary guideline and previous projects.16,17 The QIC 
method, which is popular in many western countries18, has five key features: (1) a 
focus on gaps between best and current practice; (2), clinical experts providing 
ideas and support for improvement; (3) participation of multidisciplinary teams from 
multiple sites; (4) systematic process for achieving improvement (setting targets, 
monitoring and evaluating changes); as well as (5) a collaborative process with a 
series of structured activities in a given time frame.19,20 
Parallel to the Depression QIC, an implementation study was performed as part 
of a large research program21 to assess professional performance and the cost-
effectiveness of healthcare delivery according to QIC standards compared to care 
as usual. Professional performance outcomes were presented in a different paper 
and showed that the QIC effectively reduced the number of patients on anti-
depressive medication.22 The present paper focuses on the cost-effectiveness of 
primary care for patients with depression after the QIC was implemented, thus 
focusing on a guideline-based and stepped care approach while using remission 
as the clinical endpoint of interest. The aim of this paper therefore, is not to test 
hypotheses about the effectiveness of the QIC, but to evaluate the tradeoffs 
between health benefits and costs and to make probabilistic statements to support 
medical decision making under the conditions of uncertainty. In addition, we 
address the implementation costs related to the QIC. 
Methods 
Design
We conducted an economic evaluation with a comparative matched group study, 
with a 12 months follow-up period to assess the differential impact of the primary 
care after exposure to QIC versus care as usual (CAU) on clinical outcomes and 
economic costs. The rationale for this design, rather than a randomized design, 
was that it was not feasible to randomize primary care physicians (PCPs) 
volunteering to participate to QIC or usual care. 
 The economic evaluation was a cost-effectiveness analysis (CEA) using a 
societal perspective, as recommended for the evaluation of healthcare programs, 
meaning that costs were calculated independently of those who incur these costs 
(or benefits) and encompass costs related to the intervention, healthcare uptake, 
patients’ out-of-pocket costs and costs stemming from productivity losses.23 Data 
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specific settings and target groups.14,15 In the Netherlands, a national quality 
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for the study were collected in the Netherlands from December 2006 until 
December 2009. Ethics approval was provided by the METIGG, a national 
medical-ethics committee in mental healthcare. The study registration number was 
ISRCTN99634826. 
Sample of patients 
The study population comprised of patients in the age of 18-65 years, newly 
diagnosed with depression, and receiving treatment in the primary care setting. In
the QIC group, patients were consecutively included by the 20 PCPs who 
participated in the Depression QIC. After having consented to participate in the 
study, patients received a telephone interview using the depression section of the 
Composite International Diagnostic Interview-SF (CIDI). Telephone interviews 
should not affect the results in any meaningful way.24 Patients with a CIDI 
diagnosis of current minor depressive disorder (one month recency), a major 
depressive disorder, or co-morbid dysthymia were included.  
 The CAU group consisted of a matched sample of patients, who had been 
included in the primary care cohort of the Netherlands Study of Depression and 
Anxiety (NESDA), an ongoing longitudinal study to investigate the course of 
depression and anxiety disorders in five regions in the Netherlands.25 This cohort 
(n=423) had been recruited from 72 primary care practices, following a three-stage 
screening procedure. First, a random sample of patients who consulted their PCP
over a period of 4 months, irrespective of the reason for consultation, filled out a 
screening questionnaire. Those who consented with the study and screened 
positive were offered a face-to-face interview, using the CIDI. Patients were 
included in the NESDA primary care cohort if they fulfilled the CIDI criteria for 
current minor or major depression, dysthymia, depression and co-morbid anxiety 
disorder or co-morbid dysthymia, and who were not treated for psychiatric 
conditions in a mental healthcare setting.  
 To generate a control group with a similar recruitment path as the QIC group, a 
subsample from the NESDA primary care cohort was selected with patients who 
were recruited in 2006 and 2007, being the period after the publication of the 
depression guidelines and the period in which the Depression QIC was organized. 
In addition, patients were selected only if they had indicated during the NESDA 
baseline interview that they had had a consultation with their PCP for mental 
problems. This was considered as an indication of PCP’s recognition of depressive 
symptoms, in line with the QIC group.  
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 To assure comparability between study groups at baseline we matched the 
study groups, by relevant patient characteristics that were regarded predictive of 
treatment response, where treatment response (remission) was defined as an IDS 
lower than 13. To identify predictors of remission we performed a multivariate 
regression analysis in both groups with age, gender, diagnosis (current 
depression, co-morbid dysthymia) and anxiety at baseline, measured with the 
Beck Anxiety Inventory (BAI) as independent variables. Only age appeared to be a 
factor that impacted on recovery (p= 0.059). After testing for differences in the 
mean age between the groups, a significant difference occurred with a mean age 
in the QIC group of 38.9 years and a mean age in the usual care group of 45.9 
years. Also the percentage of patients with co-morbid dysthymia differed, with 
8.6% of patients in the QIC group and 21.1% in the usual care group. To assure 
that differences in age and dysthymia did not bias our results, both the QIC and 
CAU groups were further matched for age and dysthymia, by first stratifying both 
groups into three age categories (18-34, 35-49, 50-64) and then removing 
1 patient from the QIC group and 16 patients from the CAU group who could not 
be matched. Finally, we looked at comparability of costs at baseline (covering 
costs prior to inclusion) and removed 13 outliers with extremely high costs (over 
35,000 euro, see Figure 1  
 Because there was a relatively large pool of patients receiving usual care, and 
because sample size in the experimental group was small, we conducted a 1:2 
matching – when and where feasible. In the end we had matched 34 QIC 
participants with 55 usual care participants (in a 1:1.6 ratio), because there were 
not two similar CAU participants for every QIC participant. In the context of an
economic evaluation however, small sample data can be used to evaluate the 
tradeoffs between health benefits and costs and to make probabilistic statements to 
support medical decision making under situations of uncertainty. 
Intervention
In order to implement a stepped care approach, the QIC offered a range of 
implementation strategies to the participating multidisciplinary teams, including 
training sessions, conference days, and site visits of national experts and written 
feedback on performance from a national project team.17 These strategies aimed 
to encourage physicians in the QIC group to follow a guideline based stepped care 
model for depression consisting of two pathways for patients with two different 
depression severity levels: mild and moderate versus severe.17
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Figure 1. Patient flow chart 
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In the first pathway, patients diagnosed by the PCP with an International 
Classification of Primary Care (ICPC) diagnosis P03 or P7626, and considered to 
have a non-severe depression, were offered treatment of low intensity as a first 
line intervention such as watchful waiting, self-help, physical exercise and brief 
psychological interventions or a combination of these. In the second pathway, 
patients with ICPC P03 or P76 and considered to manifest with a severe 
depression were offered antidepressant medication or psychotherapy, or a 
combination of both, as first choice options after confirmation of their diagnostic 
status, using the DSM-IV classification.  
 In the CAU condition, no specific interventions were applied to change clinical 
practice and patients received routine medical care. In the Netherlands, routine 
primary care for depression consists of a number of brief consultations with the 
PCP of less than twenty minutes. A little more than 50% of patients receive 
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antidepressant medication or benzodiazepines during the first contact with the 
PCP.27 Low-intensity psychological interventions are rarely offered.28 Less than 
8% of cases are referred to a social worker, mental health nurse, primary care 
psychologist or to specialized mental healthcare although referral to specialty care 
has increased between 2002 and 2008.29,30 
Measures 
The primary clinical outcome used was treatment response, defined as recovery 
(yes-no), measured with the Inventory for Depressive Symptomatology (IDS-SR), 
a 30 item self-report questionnaire.31 Recovery was defined as IDS score of 13 or 
lower. Costs were measured with the Trimbos and Institute of medical Technology 
Assessment Cost Questionnaire of Psychiatry (TIC-P), a self-report questionnaire 
with two parts: medical consumption and indirect costs, due to productivity losses.32
Direct medical costs included medication, visits to healthcare providers, inpatient 
or outpatient stays, and self-help groups. Direct non-medical costs are also known 
as ‘out of pocket costs’ of patients when traveling to and from health services. We 
also included the patients’ time costs (technically known as opportunity costs). 
Finally costs stemming from productivity losses were included and these 
encompass absence from paid work and work cut-back days, productivity losses in 
volunteer work, and days too ill to perform domestic tasks. Productivity losses in 
paid work were valued with the average gender and age specific friction costs as per 
the relevant guideline; while patients’ time costs and productivity costs in the domestic 
area are based on the current price of domestic help. Here we follow the pertinent 
guideline for computing costs in healthcare.33 All costs were expressed in euros on a 
per patient basis and indexed for the year in which they were spent. IDS and costs 
were measured at baseline and at one year follow-up, and were, therefore, not 
discounted.  
To estimate the investments needed to run the QIC we calculated the initial 
program costs including the time costs of participating PCPs, the national project 
management team, the national expert team and the costs of conferences, meetings, 
travel and supportive materials. 
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Analysis
The analysis of clinical outcomes and costs was conducted in accordance with the 
intention to treat principle. Imputation of missing clinical outcome data and of costs 
at follow-up was performed with STATA 11, applying multiple regression 
imputation34,35 on the variables: age, gender, paid work, diagnosis, study group 
(intervention), costs at baseline.  
 Descriptive statistics were used to describe the two study groups at baseline on 
relevant variables and to calculate the remission rates at follow-up. The costs 
analysis was performed by calculating the incremental cost-effectiveness ratio 
(ICER) of treatment in the QIC condition versus treatment in the usual care 
condition, as the difference in costs between QIC and CAU divided by the 
difference of effects in both conditions (C1-C0)/ (E1-E0). In this formula C is the 
average annual per-patient cost and E is the percentage of patients who 
recovered from a depression in the experimental and control conditions 
(subscripted 1 and 0 respectively). The amount of stochastic uncertainty in the 
ICER was assessed using 5000 non-parametric bootstraps (thus simulating 5000 
costs/effect ratios). 
Sensitivity analysis
To test the robustness of our findings and more specifically to check whether the 
procedures for imputation had any appreciable impact on the conclusion of the 
analysis, a second bootstrap analysis was performed using the data imputed with 
the Hotdeck technique.36
Results
Sample characteristics 
The analyses were based on 89 patients: 34 in the QIC group and 55 in the usual 
care group (Figure 1). The mean age was 39.5 years in the QIC group and 42.8 
years in the usual care group (Table 1). The participants were predominantly 
female (QIC 73.5%, usual care 72.7%) and employed (QIC 61.8%, usual care 
63.6%). At baseline the mean IDS score was 35.3 in the QIC group and 31.6 in the 
usual care group. The CIDI diagnosis for current Major Depressive Disorder was 
found in 88.2% of the QIC patients and in 94.5% of the patients in the usual care 
group. Minor Depression occurred respectively in 11.8% and 5.5% and co-morbid 
dysthymia occurred in 8.8% in the QIC group and 16.4% in the usual care group. 
 Part II – The impact of the quality improvement collaborative on improving mental health 
152
Table 1. Sample characteristics 
QIC
N=31-34
Usual care
N=45-55
p*
Sociodemograhic variables
Age, mean ± SD 39.5 ± 11.9 42.8 ± 11.1 .19
Women, % 73.5 72.7 .93
Employed, % 61.8 63.6 .86
Clinical characteristics
Major Depressive Disorder, % 88.2 94.5 .42
Minor Depressive Disorder, % 11.8 5.5 .42
Comorbid Dysthymia, % 8.8 16.4 .36
IDS, mean score ± SD 35.3 ± 10.2 31.6 ± 11.2 .13
BAI, mean score ± SD 20.5 ± 10.6 18.9 ± 11.0 .51
Costs
Direct costs, mean ± SD 1675 ± 2842 2001 ± 3127 .62
Indirect costs, mean ± SD 6888 ± 8338 7049 ± 7791 .93
* P-values based on independent sample t-test (continues variables) and chi-square (dichotomous 
variables) 
Outcomes 
In the QIC group 9/34 (26.5%) patients recovered, in the usual care group 10/55 
patients (18.2%) recovered, which suggests a likelihood ratio of 26/18=1.4 of a 
better outcome in the QIC group relative to the usual care group. 
Costs
Mean total per-patient costs were €5,012 in the QIC group and €5,871 in the usual 
care group. Mean direct medical costs for the QIC group were €1,541, compared 
to €1,208 euro in the usual care group (Table 2). In terms of healthcare uptake, 
the QIC patients generated higher costs related to visits to their PCPs and the 
occupational physician, on ambulatory specialized mental care and on 
hospitalization. The usual care group generated higher costs stemming from visits 
to psychologists, psychiatrists, physiotherapists and on self-help, home care and 
alternative medicine. Mean indirect medical costs, due to production losses, were 
€2,828 in the QIC group and €10,638 euro for the usual care group, whereas work 
status at baseline was equal for both groups. 
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Table 2. Annual per capita costs categorized by condition (in euro, corrected for the year in which 
costs were made) 
 
 QIC Usual Care Difference (QIC–UC) 
 Mean (SD) Mean (SD) Diff 
Direct medical costs 1541 (2121) 1208 (1236) 333 
Primary care physician 131 (123) 103 (67) 28 
Psychological therapist 443 (671) 479 (798) -36 
Medical specialist 87 (171) 127 (217) -40 
Occupational physician 25 (51) 23 (48) 2 
Physiotherapist 81 (171) 208 (611) -127 
Self help 59 (891) 79 (423) -20 
Alternative medicine 50 (121) 65 (167) -15 
Ambulatory mental health 401 (1358) 133 (396) 268 
Pharmacotherapy 27 (28) 22 (27) 5 
Hospitalization  273 (891) 31 (112) 242 
Indirect non-medical costs 5130 (5841) 7599 (13484) -2469 
Work loss 2828 (4669) 10638 (13709) -7810 
Work cut-back 3966 (5086) 2705 (4102) 1261 
Domestic 2854 (2149) 73 (19) 2781 
Total costs 5012 (5953) 5871 (11117) -859 
* Psychological therapist means either: social work, specialized nurse, psychologist, psychiatrist, and 
psychotherapist 
 
Cost effectiveness 
The incremental cost-effectiveness ratio was calculated as (C1-C0/E1-E0). 
Substitution yielded (€5,138-€5,993/0.26-0.18)=- €10,311 per additional remission. 
Hence, for each case of recovery that can be achieved by offering a QIC treatment 
rather than CAU, a saving is made of €10,311. 
 
Figure 2. Cost-effectiveness plane 
 
Each dot (n=5000) represents a bootstrapped cost-effectiveness ratio. 
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The incremental cost-effectiveness ratio (ICER) is surrounded by a certain amount 
of uncertainty. Figure 2 presents the cost-effectiveness plane for the intervention 
versus care as usual. The incremental costs are plotted on the y axis and the 
incremental effects on the x axis. Each dot (n=5000) represents a bootstrapped 
replication of the ICER. 24% of the simulated ICERs are in the upper right-hand 
quadrant, indicating that a health gain is produced by QIC but at additional costs. 
60% of the dots are in the lower right-hand quadrant, indicating a 60% probability 
that QIC is superior to CAU because it generates better effects against lower 
costs. There is a 3% probability that QIC is inferior to CAU, and a 13% probability 
that it is both less costly and less effective.
Figure 3. Cost-effectiveness acceptability curve 
Figure 3 shows a cost-effectiveness acceptability curve, indicating the probability 
that the incremental cost-effectiveness ratio is acceptable (y-axis) given varying 
thresholds for willingness to pay (x-axis) for gaining one recovery, based on 5000 
bootstrap replications. The acceptability curve intersects the y-axis at 73%, 
indicating that when the willingness to pay (WTP) for a recovered depressive 
patient is absent (equal to € 0), then there is a 73% probability that QIC care is 
more cost-effective than usual care. When the willingness to pay is raised to 
€10,000 per recovered depression, then the intervention has a probability of 86% 
of being cost-effective compared to CAU. At €20,000 the probability of an 
acceptable cost-effectiveness has risen to 89%.  
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The sensitivity analysis with the Hotdeck imputation confirmed the results of our 
main analysis. Substitution based on the Hotdeck imputed dataset yielded 
(€4,811– €5,830/0.26-0.24) = - €35,928. Hence, for each recovery that can be 
achieved by offering a QIC treatment approach instead of usual care, a saving is 
made of €35,928. Of all simulated ICERs 18% is in the upper-right quadrant (more 
costs; better effects), and 44% in the lower-right quadrant (less costs; better 
effects). 7% falls into the upper left quadrant, indicating that the intervention is 
inferior; 32% falls into the lower left quadrant, indicating less effect at lower costs. 
When the WTP equals €0, then the QIC approach has a probability of 76% of 
being acceptable. At a WTP of €20,000 this probability is at 79%.
Implementation costs 
In order to implement a stepped care approach, a total of 80 clinicians with 
different professional backgrounds and local staff participated in the QIC, for a
duration of 60 weeks. On average, 144 hours per person were spent locally on 
implementation activities of the professionals, such as team discussions and national 
learning sessions, for a total amount of €724,000, which is around €36,000 per PCP 
(724,000:20). Apart from this, €340,500 was spent to pay for the national project 
management, the national expert team and for conferences, meetings, travel and 
supportive materials. Adding these components up, we estimated that, to organize 
the QIC in eight different regions in the country, a total budget of about 1 million 
euro (€1,064,798) was invested (Table 3). 
Table 3. Depression QIC implementation costs 
Time costs per discipline participating in the QIC Costs
Primary care physicians* (n=20) 177,154
Primary care psychologists* (n=9) 46,667
Specialty care psychologists/ psychotherapists* (n=1) 12,733
Social workers* (n=12) 34,988
Specialised mental health nurses (n=8) 34,214
Physiotherapist* (n = 5) 6,929
Psychiatrists* (n = 5) 72,495
Doctor, trainee** (n=1) 7,381
Pharmacists** (n=2) 20,712
Local staff QIC teams** (n=9) 138,240
Staff, managers supporting local QIC teams** (n=8) 172,800
Total time costs (n=80) 724,313
National project management team, 234 days*** 178,510
National expert team, fixed fees*** 95,000
Conferences, meetings, travel, materials*** 66,975
Total costs 1,064,798
* Based on: Oostenbrink. 2004. Handleiding voor kostenonderzoek [Guidance for costing research] 
** estimation, *** based on QIC administration. 
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Discussion 
Patients in the QIC condition showed similar or (potentially slightly better) 
outcomes than patients in the CAU condition, while societal costs appeared lower. 
The economic evaluation indicated that, when choosing the QIC approach over 
CAU, there is a 73%-89% probability that QIC is more cost-effective, even cost-
saving, as compared to CAU, even when the willingness to pay for an additional 
recovery from depressive disorder is zero (€0). 
 From a societal perspective, this cost-effectiveness analysis showed that for 
each recovery that can be achieved under the QIC treatment approach a cost 
reduction is made of €10,311 relative to CAU. However, the costs of implementing 
QIC were substantial and this is an issue in its own right.37
There are several limitations to our study. First, randomization of patients was not 
an option, since the QIC program was designed as an implementation intervention 
for Dutch clinicians who wanted to adopt the Depression Stepped Care Model. 
Randomization is rarely used in studies of systemic change.38 Second, we were 
charged with evaluating an improvement process, in which participation of PCPs
was voluntary. We do not know whether, if the QIC program would be imposed on 
a larger group of clinicians, the results would be the same. Third, recruitment 
pathways of patients were not exactly the same in the QIC group and in the 
matched CAU group. In the CAU group, patients were recruited from primary care 
practices through screening of all patients, following a three-stepped screening 
procedure. In the intervention group, PCPs themselves recruited patients after 
having recognized mental problems. We tried to reduce the risks of these and 
similar biases by using a matching procedure to make both study groups 
comparable, but the limitations inherent in matching place this study on a less 
robust footing, and leave our results open to confounding. A last limitation is that 
both groups contained small numbers of patients, causing a possible lack of power 
to detect differences by statistically testing hypotheses. In the QIC group, the low 
numbers were mainly due to perceived barriers amongst the PCPs to make a 
research contribution in terms of approaching their patients for informed consent to 
participate in the study. The low numbers made have made the study 
underpowered and unfit to test hypotheses and draw conclusions based on 
statistical analyses. Because of this, we considered the study’s outcomes tentative 
rather than final. 
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While recognizing these limitations, our study suggests that depressed patients 
receiving care from clinicians participating in a QIC program based on guidelines, 
pose a lesser economic burden to society, due to fewer productivity losses. This is 
in agreement with the as yet limited body of QIC literature in the general medical 
setting, which shows that the QIC strategy can be cost-effective.39
 However, our overall positive results are not in line with an economic evaluation 
performed alongside a pragmatic randomized trial of a depression disease 
management program for elderly patients, based on the guideline of the Dutch 
College of General Practitioners.40 Bosmans et al40 observed no differences in 
depressive symptoms, quality of life and costs at 12 months. Perhaps, our non-
randomized design may have led to portray an overly rosy picture, but there is also 
the fact that production losses are less relevant in the elderly population, which 
may have accounted for the different findings.  
 Increased medical costs to patients who receive guideline-concordant care, is 
what has been found by Prins et al41, who studied the delivery of care within the 
larger naturalistic cohort of patients with depression and anxiety from the NESDA 
study, a small selection of which we matched with our intervention group. Delivery 
of care data were extracted from the Electronic Medical Records (EMRs) of the 
primary care practices and assessed with a set of quality indicators, derived from 
the guidelines of the Dutch College of General Practitioners (NHG), a different 
guideline than the one used during the QIC. Guideline concordant care, defined as 
patients having received psychological support or counseling or antidepressant 
medication or referral to a mental health specialist, was found to incur higher costs 
than non-guideline concordant care. The patients receiving guideline-concordant 
care received more primary care services, except for medication prescriptions and 
physiotherapist visits, and more consultations with a specialty care clinician.40
 Our study adds to the growing body of knowledge, mostly modeling studies 
based on assumptions, on implementing evidence-based interventions in mental 
health42-44, because it is one of the rare studies based on empirical data about 
implementation of guideline based interventions, although it did not employ a 
randomized design.  
This pilot study carries a promising message for those who are driven by 
improving the quality of depression care. Internationally, a large majority of 
patients receives antidepressant medication by their PCP before psychological 
interventions are undertaken.30,45 In the Netherlands, a decline in prescribing has 
been measured from 76% in 2002 to 70% in 2008. This is considered a positive 
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trend, since it is believed that this high proportion of patients with antidepressant 
medication is not in accordance with the most recent multidisciplinary depression 
guidelines that recommend low-intensity treatments for patients with mild 
symptoms.30 However, the effectiveness of stepped care for depression, including 
the delivery of low-intensity treatments, still needs to be fully confirmed.46 In the 
mean time, to help PCPs seek alternative interventions in a cost-effective way for 
depressive patients who do not need medication, strategies such as the 
depression QIC might be of help but randomized replication studies are needed to 
confirm this.  
Our study showed that, in line with the message of Mason et al37, having to invest 
resources to change physicians behaviour imposes an additional, or loading 
factor, upon treatment cost-effectiveness. Larger health gains per patient, higher 
prevalence of disease, larger practice size or longer duration of behavioural
change, all reduce the loading.37 One could wonder who might have an incentive 
to invest in quality improvement programs for depression, if implementation costs 
are high and direct medical costs are only to rise as a result of better quality of 
care. As long as direct healthcare costs and indirect costs of sickness absence are 
treated separately by government budgets, it will be difficult to drive action.44 In
health systems were stakeholders, such as policy makers, healthcare insurance 
companies and employers, do have to make decisions on whether to invest in 
better depression care, estimated cost-effectiveness of a quality improvement 
program, as performed in this study, provides crucial information.47 Before taking 
this policy cost-effectiveness decision, one should be aware that an initial 
investment to set up a QIC will only be attractive if a fairly large number of
clinicians and patients are engaged and if cost-effective interventions leading to 
reduced production losses are being implemented. Moreover, both the clinicians’ 
readiness to change as well as good data registration should be addressed before 
making the decision to invest in depression QIC. 
Conclusion
From a societal perspective, depression QICs carry the promise to offer good 
value for money, but a sufficiently powered randomized clinical trial is needed to 
confirm this. Furthermore, the high costs of implementation need to be considered. 
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Abstract 
Objective: Many patients with schizophrenia are not treated in line with evidence-
based guidelines. This study examined the large scale implementation of the 
national multidisciplinary guideline for schizophrenia in the Netherlands. 
Design: Observational, prospective study with repeated measurement. 
Setting: 30 Mental healthcare teams in different regions in the Netherlands.  
Participants: 359 Clinicians with different professional backgrounds and 
1489 patients suffering from schizophrenia. 
Intervention(s): Six evidence-based interventions for schizophrenia were 
implemented, in the context of a Quality Improvement Collaborative (QIC). 
Assertive Community Treatment (ACT) or its adapted version Functional Assertive 
Community Treatment (FACT), Cognitive Behavioural Therapy (CBT), Psycho-
Education (PE), Family Interventions (FI), Individual Placement Support (IPS), 
Pharmacotherapy (PHth). 
Main outcome measure(s): Professional performance, symptom severity, social 
functioning and relapse rates.
Results: Improved professional performance, in line with guidelines. Availability of 
(Functional) Assertive Community Treatment improved from 23% to 60%, and of 
Individual Placement Support from 20% to 53%. Complete care plans were 
composed for 38% of the patients and routine outcome monitoring was introduced 
in most teams. Social functioning improved slightly (HoNOS mean: from 6.2 to 5.6) 
as well as symptom severity (CGI-S mean: from 4.1 to 3.9). Relapse rates did not 
improve during the course of the study.  
Conclusions: An intensive implementation program can result in improved 
delivery of evidence-based care and continuity of care, and improved outcomes for 
individuals with schizophrenia. More rigorous research designs have to confirm 
these findings.
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Introduction
The first Dutch evidence-based multidisciplinary guideline for Schizophrenia was 
published in 2005.1 This guideline was developed by the organizations of patients, 
families and physicians. It incorporated recommendations concerning diagnosis 
and pharmacological, psychosocial and family interventions as well as effective 
community treatment approaches. An analysis of the gap between actual care and 
guideline recommendations, performed at the release of the guideline, reported a 
considerable 'science-to-service gap’.2 Although best-practices were available in 
Dutch mental healthcare, patients generally did not receive the effective 
interventions, or not in a sufficient number of sessions and within an appropriate 
timeframe. Moreover, coordination of care appeared hard to come about.3 This 
finding was repeated in the first Quality Assessment of Regional Treatment 
Systems for Schizophrenia (QUARTS), a structured interview with stakeholders, 
showing that in 2005 an estimated 25%-50% of patients was offered care 
according to the guideline.4
 There is a lack of knowledge about effective guideline implementation strategies 
in schizophrenia care.5,6 Quality Improvement Collaboratives (QICs) have induced 
better quality and outcomes of care in other settings.7 Over the last decade, this 
method for improving practice has been nationally promoted and funded by the 
Dutch government to bridge the gap between evidence-based and routine mental 
healthcare. In schizophrenia care this has led to the launch of two waves of a QIC, 
between February 2006 and April 2008.  
 The Schizophrenia QIC was designed by a team of experts, including experts by 
experience. It aimed at the achievement of two goals: a reduction of relapses and 
improved social functioning.8 Both goals strongly reflected the perspective of 
consumers and carers. Social functioning, in terms of having a job, a partner or 
friends, suitable housing and being able to participate in society, is of key 
importance in the lives of persons with schizophrenia. Although for many of them 
symptom reduction is not a goal as such, a reduction of relapses is essential 
because relapses make patients feel more isolated, and interfere negatively with 
functioning.9,10 In order to achieve these goals, a number of evidence-based 
interventions and best practices, derived from the guideline, were recommended 
by the expert team. In this paper the methods and results of the Schizophrenia 
QIC are described and suggestions for further implementation efforts in this field 
will be given. 
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Methods 
Design
The design of the study was a cohort study, with repeated measures. Comparison 
to a reference group was not an option, since all schizophrenia teams in the 
Netherlands were invited to participate in the QIC and routine monitoring data from 
non-participating teams were not available.  
Study population 
The study population consisted of clinicians and the patients they treated. 
Clinicians were selected after a general call to all mental healthcare organizations. 
Criteria for selection were: being part of a multidisciplinary specialized team, 
motivation to improve care, active leadership support, a local team coordinator and 
payment of a participation fee. All patients were selected by the clinicians from 
their own caseload. Criteria for selection of patients were: having a chart diagnosis 
of schizophrenia and a need of continuous care.
Implementation strategy 
The two consecutive waves of the quality improvement project followed the 
‘Breakthrough’ Quality Improvement Collaborative method.11,12 This method has 
been applied in many countries for various clinical problems and generally has five 
essential features: (1) there is a focus on a specific aim, with gaps between best 
and current practice; (2) clinical experts provide recommendations and support for 
improvement; (3) multidisciplinary teams from multiple sites participate; (4) there is 
a model for improvement (setting targets, collecting data and testing changes); 
and (5) a quality improvement process is organized with a series of structured 
activities in a given time frame.7,11,13 The structured activities offered to the 
participants during the Schizophrenia QIC are listed in Table 1. 
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Table 1. Implementation strategies used during the Schizophrenia QICs 
Professionals National expert team on Schizophrenia care and quality improvement 
National network of multidisciplinary teams for exchange and learning
SMART goal setting and indicators to monitor results in excel (PDSA cycles)
Training on Breakthrough method and data collection
Four conference days for exchange and learning
Eight meetings between local team coordinators and expert team 
Team visits and telephone contact by experts
Written feedback on three improvement reports and data charts 
A virtual network environment for exchange of best-pratices and online discussion
A Toolkit of protocols on evidence based interventions leading to fidelity
Patients Involvement of patient representatives in improvement teams, care teams
Quality of life measurement and feedback (optional)
A patient participation training 
Two meetings for local patient representatives for exchange and learning
Organization Active management involvement
Include care plan into electronic patient record where possible
Conference day for local management 
Workshops Reducing waiting lists and Spreading and sustaining QI-results
Uptake of new interventions in organizational policy and planning
Local newsletters and folders
Financial Structural funding of new interventions
The aims of the Schizophrenia QIC were implementation of one or more of the 
evidence-based interventions recommended in the guideline1 and optimal 
continuity of care. The evidence-based interventions included: Assertive 
Community Treatment (ACT) or its adapted version Functional Assertive 
Community Treatment (FACT)14, Cognitive Behavioural Therapy (CBT), Psycho-
Education (PE), Family Interventions (FI), Individual Placement Support (IPS), 
Pharmacotherapy (PHth). Optimal continuity of care was to be achieved by the 
introduction of comprehensive and up-to-date patient care plans, covering 
treatment, early warning signs and rehabilitation. This was based on the 
assumption that having a recent comprehensive care plan implies regular patient 
contact, and a proper assessment of patient’s needs and goals.
Measures 
To assess the impact of the QIC, outcome and process indicators were developed. 
Outcome indicators concerned relapse rates and level of social functioning. 
Process indicators concerned the degree of implementation of the evidence-based 
interventions, and the existence of a recent comprehensive care plan.  
 Data collection to calculate the degree of implementation of the evidence-based 
interventions consisted of repeated self-assessment surveys amongst the team 
coordinators (n=30). In the surveys, three levels of implementation were 
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distinguished: level 1, interventions are available; level 2, local protocols 
describing the proper procedures for the intervention have been developed; level 
3, 70% or more of the patients receive care according to the protocol. The survey 
also contained questions to gather qualitative information on influencing factors 
and further results of the QIC.  
 To measure improvements in continuity of care, dates of completion of a recent 
comprehensive care plan were registered for each patient. A recent complete care 
plan should not be older than one year, and consist of: a treatment plan, a crisis 
plan and a rehabilitation plan.  
 Relapse data were collected with the Dutch version15 of the Clinical Global 
Impression (CGI) scale.16 This instrument was considered to be more informative 
than other measures used in literature, such as re-hospitalisation, because of its 
ability to capture serious deterioration experienced by the patient, without being 
(re)hospitalized. Since there is no general rule for cut-off points of the CGI for 
relapse, these cut-off points were selected at face-value by the expert team. 
Relapse was defined as a score of ≥ 5 on the 7-point Severity subscale of the CGI 
(CGI-S), combined with a score of ≥ 6 on the 7-point Improvement subscale of the 
CGI (CGI-I). Data for social functioning were collected with the corresponding 
subscale of the Dutch version of the Health of the Nation Outcome Scales 
(HoNOS).17 Both the CGI and the HoNOS are validated instruments and feasible 
to be implemented in daily practice.18-20 Data were collected on a monthly basis by 
the clinicians and registered in a database, during 12-14 months. This difference in 
duration was caused by the context of the second QIC wave, which took part 
within a large improvement program, the National Action Plan Quality Mental 
Health and Addiction care. 
Statistical analysis
All data were aggregated on a quarterly basis in a SPSS database for statistic 
analysis. Because these data involved repeated measures over time within 
patients, and as a consequence were likely to be correlated, the Generalized 
Estimation Equation (GEE) method18,20 was used to test for significance in the rate 
of change. The GEE method is a type of regression analysis of longitudinal data, 
specifically useful in multi-site cohort studies as it can handle many types of 
unmeasured dependence between outcomes. 
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Results
Eighty organizations were invited to participate in the QIC, 30 healthcare teams 
from 24 mental health organizations agreed to participate. Three organizations 
participated in both QIC waves. Participating teams came from all regions of the 
Netherlands. Most teams already functioned as a regular care team prior to the
QIC, a few teams were composed for the occasion of the project. In total 359 
clinicians participated in both projects: 40 psychiatrists/doctors, 21 psychologists, 
167 case managers, 19 vocational therapists, 41 supported housing professionals, 
48 managers, 9 experts by experience and 14 other clinicians.  
 A total of 1489 patients were included by the clinicians, with a range of 26 to 
102 patients in each participating team. Of these patients, 367 were classified by 
the clinicians as chronic, unstable patients and 1122 as chronic patients with 
stable symptomatology. The mean age of the patient population was 41.3 years 
(with a range of 18-83 years). Outcome data from one improvement team were 
excluded from analysis, due to a short (crisis) treatment period of three months 
maximum. 
Evidence-based interventions 
The teams selected one to three evidence-based interventions to be implemented, 
according to their own priorities. (F)ACT was selected as a priority to be 
implemented by fifteen teams, PE by fourteen teams, IPS and FI both by eight 
teams, CBT and PHth both by five teams.
Table 2 shows the degree of implementation of the interventions, in the beginning 
and at the end of the QIC. Only half of the evidence-based interventions (CBT, PE, 
PHth) was available in most of the teams at the start of the QIC, and less than half 
of the teams could offer their patients (F)ACT, FI or IPS. At the end of the QIC, 
most teams had implemented all interventions (implementation level 1), and a 
majority of the teams had developed protocols for all interventions (implementation 
level 2), except for FI and IPS. Adherence to the protocols for at least 70% of the 
patients (implementation level 3) was reported by a minority of teams, except for 
pharmacotherapy (53% of the teams), although for all interventions the number of 
teams who routinely provided the care according to protocol improved over time.  
 The degree of level 1 implementation of (F)ACT and IPS improved most 
(respectively from 23% to 60% and from 20% to 53%), although both being 
marginally implemented at the start of the QIC and both remaining at a relative low 
implementation rate at the end. The largest level 2 improvement, having a protocol 
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for the specific intervention, was seen in PE (from 23% to 70%), although only 
33% of the teams reached level 3 for this intervention. The intervention with the 
highest baseline scores on all three implementation levels but with the least 
increase at the end of the QIC was pharmacotherapy. 
 
Table 2. Self-reports of teams on implementation of interventions (% of total) 
 
 Level 1 
EB Intervention 
available in team 
Level 2 
Protocol present for 
EB intervention in team 
Level 3 
Adherence to protocol  
with >70% of patients 
Evidence-based (EB) 
Intervention 
Start  
QIC 
End 
QIC 
Start  
QIC 
End 
QIC 
Start  
QIC 
End 
QIC 
(F)ACT 23% 60% 17% 53% 7% 40% 
CBT 70% 83% 33% 60% 3% 10% 
PE 70% 90% 23% 70% 7% 33% 
FI 43% 60% 10% 27% 0% 10% 
IPS 20% 53% 13% 40% 3% 10% 
PHth 90% 93% 60% 70% 43% 53% 
Bold > 50% of the teams reported a positive score on this item 
 
Continuity of care 
Complete and up-to-date care plans, including a treatment plan, crisis plan and 
rehabilitation plan, were hardly present at the start of the QIC. All teams worked on 
this aim. At the end of the QIC the overall percentage of patients having a 
complete and up-to-date care plan, had increased to more than 30% (See 
Figure 1). 
 
Figure 1. Percentage of patients with a complete care plan not older than 1 year 
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Social functioning and relapse
During the QIC, teams learned to measure patient outcomes routinely, which was 
new for most of them. At the start of the QIC, CGI- and HoNOS scores were 
obtained from a quarter of the included patients (respectively 27.2% and 23.7% in 
the first month). 
During the last month, when some teams were not able to update their excel file 
before final deadline, CGI- and HoNOS scores were obtained from half of the 
patients (45.3% and 51.5%). Over the course of the QIC, teams managed to 
obtain a monthly score on both the CGI and the HoNOS from 64.5% to 85.1% of 
the included patients.
Time series analysis (using the GEE method) pointed out that the HoNOS mean 
scores showed a decrease on the 7-point subscale 'Social functioning' from a 
mean of 6.2 in the  first  quarter of the  QIC to a mean of 5.6  in the  last  quarter 
(β=-0.20; p=0.000), reflecting an improvement in social functioning. The 
percentage of patients with at least two points improvement on social functioning, 
increased from 8.5% to 54% of the patients (β=0.65; p=0.000).
Table 3. Functional health status and improvement in functional status in schizophrenia patients 
with outcome measuring, at different stages of the Schizophrenia QIC 
Social functioning Relapse
Mean Score 
Honos
% ptn with 
2 point 
decrease 
(improvement)
Mean score 
CGI-S / 
% ≥ 5 CGI-S
Mean score 
CGI-I /
% ≥ 6 CGI-I
% ptn with a 
relapse:
≥ 5 CGI-S and
≥ 6 CGI-I
Quarter 1 6.2 (SD 3.3)
(N=535)
8.5%
(N=505)
4.1 (SD 1.3)
45.3% 
(N=949)
4.0 (SD 0.7)
4.8%
(N=439)
4.3% 
(N= 439 )
Quarter 2 6.0 (SD 3.3)
(N=824)
31.3%
(N=710)
4.0 (SD 1.3)
45.2% 
(N=1248)
4.0 (SD 0.7)
5.3% 
(N=788)
5.0% 
(N=788)
Quarter 3 5.7 (SD 3.3)
(N=803)
47.0%
(N=534)
3.9 (SD 1.3)
42.8% 
(N=1193)
4.0 (SD 0.6) 
7.5% 
(N=723)
7.1%
(N=723) 
Quarter 4 5.6 (SD 3.3)
(N=747)
54.0%
(N=457)
3.9 (SD 1.3)
38.2%
(N=1106)
4.0 (SD 0.7)
7.6% 
(N=656)
6.9% 
(N=656)
β (p) -0.20* (0.000) 0.65* (0.000)
-0.09* (0.000)
-0.12* (0.000)
-0.01 (0.242)
0.18* (0.014) 0.18* (0.018)
CGI-S Severity Subscale of the CGI 
CGI-I Improvement Subscale of the CGI 
β Regression coefficient: size and direction of change (using the GEE method)
* Sign. p < 0.05
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Concerning relapse, mean scores of the Severity-subscale (CGI-S) showed a 
decrease from 4.1 to 3.9 (β=-0.09; p=0.000). Also, the proportion of patients with 
scores of 5 or higher on the  Severity-subscale reduced from  45.3% to 38.2%  
(β=-0.12; p=0.000), reflecting a small reduction in symptom severity. 
Unfortunately, the Improvement-subscale (CGI-I) showed an increase in the 
percentage of patients with scores of 6 or higher from 4.8% to 7.6% (β=0.18; 
p=0.014), reflecting a deterioration of clinical status during that period. Relapse 
rates, defined as the proportion of patients with a score of 5 or higher on the CGI 
Severity-subscale combined with a score of 6 or higher on the CGI Improvement-
subscale, showed an increase in the percentage of patients with a relapse from 
4.3% to 6.9% (β=0.18; p=0.018) (See table 3).
Influencing factors and qualitative results
Factors facilitating the QIC, reported by the team coordinators (n=30) in the self-
assessment survey, were support and interest of the institutional management, a 
capable local team coordinator, and a motivated and skilled multidisciplinary team 
of clinicians. Qualitative impacts of the QIC were: increased capacity to work 
systematically according to protocols while monitoring outcomes, improved 
knowledge of evidence-based practices and a sense of urgency to bring 
schizophrenia care to a higher quality standard. The QIC also improved team 
cohesion and collaboration within the organizations, due to better communication 
and to using the guideline as a common language for implementing evidence-
based care.  
 Reported factors hindering the project were: a lack of dedicated time for 
participating clinicians and team coordinators to restructure care- and monitoring 
processes, and ongoing organizational changes at institutional level. Resistance to 
innovations amongst clinicians and patients were also mentioned as barriers for 
change. In relation to this, team coordinators reported that the timeframe of the 
QIC, 12-14 months, was too short for real changes. 
Discussion 
During the Schizophrenia QIC the standard of care provided by the 30 
participating teams improved in terms of professional performance and patient 
outcomes. Most teams made all evidence-based interventions available for 
patients and developed protocols, except for FI and IPS. Self-reported adherence 
to the protocols increased, with some of the more frequently indicated 
interventions (FACT, PE, PHth) being offered routinely after the QIC. The degree 
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of implementation of (F)ACT and IPS improved the most. The overall percentage 
of patients having a complete and up-to-date care plan changed from almost 0% 
to more than 30%. Small clinical improvements were made in terms of social 
functioning and symptom severity. However, teams did not succeed in reducing 
relapse rates. 
 The improvements in quality of care, introduced by the QIC teams, are relevant 
for patients with schizophrenia, since effectiveness research into the implemented 
evidence-based interventions has shown positive results in terms of 
hospitalization, employment participation, relapse, adherence to therapy, social 
functioning, quality of life, coping with positive symptoms and somatic problems.19
In addition, progress in availability of up-to-date comprehensive care plans is
essential within this setting of long-term care, and systematic monitoring of 
outcomes is believed to improve quality of care. Finally, the authors estimate the 
small improvements of the mean CGI and HoNOS scores as clinically relevant, 
considering the robustness of these variables. The deterioration on the 
improvement scale of the CGI is not easy to understand, but might be due to: a) 
registration difficulties with the CGI-I; b) a lack of training in proper use of the CGI; 
c) the choice of cut-off points; or d) a deterioration due to relapse. 
There are several strengths and limitations to our study. A strength is that this 
study is one of the first documented, structured large scale implementation 
projects, with a participation rate of more than 20% of Dutch mental health 
organizations. Furthermore, we were able to analyze process as well as outcome 
data from a large number of patients in a naturalistic context. A first limitation is 
that data collection was performed by participating clinicians and partly based on 
self-reports. Secondly, no educational program was arranged for applying the 
evidence-based interventions. This might have caused practice variation and a 
delay in the improvement of professional performance. Finally, the duration of the 
QIC was about one year; teams might need more time to adapt to new methods 
and this duration might have been too short to measure a consistent change on 
robust indicators such as relapse rates. 
The results of our study are in line with the literature on Quality Improvement 
Collaboratives, showing modest effects on clinical outcomes.7,21,22 Results are also 
partly consistent with results of the National Implementing Evidence-Based 
Practice Project, in which 53 American community health centres implemented 1 
out of 5 evidence-based programs for severe mental illnesses. Preliminary results 
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after two years showed a high degree of fidelity in implementing the selected 
programs in 55% of participating sites.23 The American project had a longer 
duration and offered slightly more extensive support to the sites.24 Results on 
clinical improvements were not measured within this project. 
The present study shows that, despite the positive changes in process and 
outcome measures, improving care for a substantial part of patients with 
schizophrenia is a long and complex process. Even though teams focused on the 
implementation process for 12-14 months and received a lot of support, they were 
not able to offer evidence-based care according to protocol to the majority of their 
patients within this timeframe. On the other hand, this study shows that a quality 
improvement program like the Schizophrenia QIC is feasible in the chronic mental 
healthcare setting and can lead to changes in the quality of care. An improvement 
model, based on the schizophrenia guideline, offering clinicians specific goals, 
instruments and support to engage in an improvement process, can help clinicians 
and healthcare organizations to foster evidence-based routines in schizophrenia 
care.  
 The results presented in this study can be helpful to inform others in improving 
care for patients with schizophrenia. Still, a lot of questions about implementing 
evidence-base care in this setting remain unanswered, and more rigorous 
research is needed to confirm our findings and understand factors hindering the 
uptake of the interventions, effective elements of the QIC method, and the cost-
effectiveness of these large and intensive implementation programs, in order to 
inform policy and practice.
Conclusions
Implementing evidence-based care with positive outcomes is possible in the care 
for patients with schizophrenia, although it needs intensive and continuous support 
during an extensive time. Although the Schizophrenia QIC changed healthcare 
practices, controlled follow up research is necessary to evaluate which method 
generates long-term improved healthcare practices compared with control 
conditions and at what costs and benefits. 
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General discussion 
In this final chapter we summarize and discuss the main findings of this thesis in 
relation to our overall theme: improving mental healthcare by transferring 
knowledge into practice. We present some overall methodological considerations 
and discuss our findings in the context of the existing literature. Finally, we 
conclude with a number of implications for research and practice. 
Key findings Part I: strategies for quality improvement in mental healthcare 
Two types of implementation strategies, believed to have the potential to transfer 
knowledge into practice, were discussed in part one of this thesis: clinical 
guidelines and organizational strategies. 
Guidelines have become evidence-based and accepted but bottlenecks remain 
Between 1999 and 2009, a large national guideline program in mental health 
resulted in 13 multidisciplinary guidelines and in a set of related deliverables, such 
as consumer versions, checklists and implementation materials. Bottlenecks in
guideline development concerned: 1. the method of evidence-based guideline 
development; 2. the participation of users and carers and 3. the dissemination of 
the multidisciplinary guidelines.
 During the last decade the internationally accepted method of evidence-based 
guideline development was introduced among almost 30 professional 
organizations and a range of service user organizations in Dutch mental health. 
Lessons learned included that guideline development needs to be a transparent 
and evidence-based process, with nationally organized topic selection, a clear 
division of tasks between participating professionals and a supportive ‘technical 
team’ and a rigorous process management in order to prevent delays and 
mismatches of expectations. 
 Although different methods of consumer participation were used, full integration 
of the service users’ perspective into the guidelines often remained unsatisfying 
and final versions of guidelines were unfit to be of use to individual patients. 
Bottlenecks were the dominant medical perspective and the lack of a structured 
process and systematic approach to participation.  
 Actual use of the multidisciplinary guidelines has been limited so far, although 
psychiatrists have become more familiar with their content than other disciplines.
The disorder based guideline recommendations did not seem to fit easily in the 
professional paradigms and working methods of allied health professionals. Apart 
from this other barriers to implementation were the narrow medical focus of 
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guidelines, the limited evidence base (the randomized controlled trial being the 
golen standard design used by guideline working groups), the lack of 
recommendations for problems encountered in daily practice, the poor integration 
of the different multidisciplinary perspectives (including those of patients) and last 
but not least the volume and format of the published guidelines, both unattractive 
for daily use.
Some organizational strategies are evidence-based, but good implementation 
research is still scarce 
In severe mental illness care, organizational strategies and models to improve the 
quality of care, such as assertive community treatment, supported employment 
and community mental health teams, have been found to improve patient 
outcomes. Intermediate measures of professional and organizational performance 
are much less studied. From an implementation perspective this lack of 
information on performance measures limits the lessons to be learned from these 
studies. 
High-level studies and systematic reviews into the impact of other popular 
improvement strategies, such as the revision of professional roles or the use of 
information technology or performance measurement, are lacking although in 
practice much is expected of their ability to improve the quality of severe mental 
illness care.
Key findings Part II: the impact of the quality improvement collaborative on 
improving mental health 
QICs can support the transfer of knowledge into mental health practice 
Quality improvement in mental healthcare, in terms of professional and 
organizational performance in accordance with guidelines, can be enhanced in 
both primary and secondary care with the aid of QICs. Our QIC studies showed 
improved delivery of evidence-based care both in primary care as in specialty 
care. Some outcome indicators improved as well in both QICs, but their 
interpretation is unclear.
Antidepressant prescribing behaviour can be changed within a QIC context 
The quasi-experimental evaluation study showed that the depression QIC was 
effective in terms of changing the antidepressant prescribing behaviour of PCPs 
over the course of three years, compared to controls that did not change overtime. 
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Care delivered by practices participating in the depression QIC might be more 
cost-effective than usual care 
The cost-effectiveness analysis, although underpowered and suffering from 
selection bias, suggested that care according to the depression QIC did not 
generate better rates of recovery compared to usual care but was more cost-
effective from a societal perspective. Although direct medical costs were higher in 
the practices that implemented guideline recommendations, productivity losses 
were lower than the usual care patients. 
Stepped care for depression can be introduced amongst PCPs and change 
existing routines
In our qualitative study clinicians reported practice changes in terms of better 
differentiation between patient groups, reduced antidepressant prescribing as a 
consequence of having a broader treatment package to offer, and better working 
relationships with patients and colleagues. Successful elements of the depression 
QIC were the pragmatic stepped care model itself, their motivation to implement 
low intensity interventions, the structured team meetings and clear goal setting 
(part of the QIC method), and the positive reaction from patients to stepped care 
including outcome monitoring. Routine monitoring of depression symptoms was 
difficult to organize due to a lack of clinician pro-activeness, administrative support, 
information technology and compliance of the patient.
In implementation projects, attention needs to be paid to the concept of depression 
and depression care 
An important driver for change in the multidisciplinary primary care setting, 
although time consuming, was the process of creating a shared understanding of 
what constitutes depression and reaching consensus about the content of 
depression care and the division of tasks. 
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Methodological considerations 
The overall finding of this thesis, that QICs can enhance the quality of care in 
mental healthcare by enhancing the implementation of guideline 
recommendations, has to be submitted to some methodological considerations, 
since the different designs all had their limitations, which have influenced the 
robustness of our findings.  
The most fundamental limitation overall was the lack of a randomization procedure 
in any of our studies, as it is frequently seen in studies of systemic change.1 Both 
our effectiveness study and the cost-effectiveness study consisted of a before–
after comparison between two non-equivalent groups of clinicians and patients. In 
the evaluation of both the depression and the schizophrenia QIC, the gold 
standard of the randomized clinical trial was not applicable in the naturalistic 
context of clinicians volunteering to make an implementation effort and not to be 
part of a control condition. This fact, that clinicians were highly motivated to 
participate in the QIC, but to a much lesser extent to make an additional research 
contribution, has also impacted on the inclusion of patients and the data gathering 
during the study. These limitations might have introduced different types of bias, 
such as confounding bias, in terms of other factors than the QIC causing the 
observed changes, not having been equally present in both groups. Selection bias, 
caused by the fact that the QICs worked with highly motivated clinicians who had 
volunteered to participate in a quality improvement program, limits the 
generalizability of the positive findings to all mental healthcare workers in the 
country or beyond. Outside the QIC context, implementing guidelines might be a 
different process.  
Despite these limitations, our studies generated valuable information to the 
emerging science of quality and safety in mental healthcare. First, the QIC studies 
confirmed what is known in general health, that the QIC method can enhance 
change in professional and organizational performance. Moreover, we showed 
that QICs can serve as vehicles to implement mental health guidelines in different 
settings. Second, our results have provided answers to research questions 
considered crucial in this field,2 such as how to present new evidence to 
professionals and how to guide and support them towards scientifically correct 
practice. Third, our studies also generated insight into important determinants for 
successful implementation in mental healthcare that need to be addressed in 
future programs. An example of these determinants is a shared understanding and 
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shared language amongst professionals with different backgrounds about the 
nature of disorders such as depression. Finally, this thesis generated new 
research questions, to be addressed in the last paragraph. 
Discussion of key findings of Part I: strategies for improving mental 
healthcare 
Towards high standard guideline development methods 
Guidelines have become key strategies to many stakeholders to improve the 
quality of care for patients with mental health conditions. At the start, guidelines 
were considered instruments for clinicians and their patients to support clinical 
decision making. Over the last years other stakeholders have become interested in 
using guidelines for purposes of policy making, commissioning, accountability and 
jurisdiction. With this growing influence of guidelines, the need for good and 
transparent guideline development methods becomes crucial. If guidelines contain 
systematic bias, the effects will be widespread.3
Internationally, high quality standards of guideline developments have been 
developed and shared. The Guideline International Network (GIN), a network of 
guideline developers from 46 countries, defined a set of key components for 
guideline development in order to ensure that all guidelines meet basic criteria.4
These components address working group composition, decision-making process, 
conflicts of interest, guideline objective, development methods, evidence review, 
basis of recommendations, ratings of evidence and recommendations, guideline 
review, updating processes and funding. Another relatively new innovation in this 
respect is the widespread introduction of the Grading of Recommendations 
Assessment, Development and Evaluation (GRADE) methodology, an approach 
which ‘enables more consistent judgments, and communication of such judgments 
can support better informed choices in health care’.5,p.1 The GRADE working group 
has presented a systematic and explicit approach to making judgments about the 
quality of evidence and the strength of a guideline recommendation. 
Despite these developments, the National Collaborating Centre for Mental 
Health (NCCMH) for the National Institute for Health and Clinical Excellence 
(NICE), probably the most comprehensive and methodologically advanced mental 
health guideline program in the world, has recognized imperfections and patterns 
of bias in the way that evidence is generated and included in guidelines. According 
to some, the pharmaceutical industry remains a major source of bias through 
selective reporting and publishing, and represents a threat to ensuring the 
evidence underpinning guidelines and clinical decision-making is as complete and 
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reliable as possible.3 Another concern is that guidelines, although developed in a 
rigorous way, still may not have the desired impact if they are not integrated with 
other quality improvement initiatives such as performance measurement and 
quality improvement programs.6
Service user involvement is expected to enhance the implementation of guidelines
One of the innovations in guideline development, believed to enhance the uptake 
of guidelines, is the creation of a bigger role for service users and carers in the 
development process. The assumption is that, if guidelines provide 
recommendations that reflect the users perspective, clinicians will be more 
motivated to use guidelines. For example, in the depression QIC showed BDI 
measurement was hard to implement and it was only after positive reactions of 
patients that clinicians managed to do so.
 According to Sackett et al.7 evidence-based medicine is not restricted to 
randomized trials and meta-analyses but it involves tracking down the best 
external evidence with which to answer our clinical questions. Patients may have 
very different perspectives on healthcare processes, priorities and outcomes from 
those of health professionals. Empowered patients want to take control of their 
conditions and therapy, and thus are crucial to the development of treatment 
guidelines.8 Some argue that good user involvement in guidelines, in terms of the 
integration of the clinical expertise with the best available research evidence and 
patient values, is so hard to achieve that it should be reconsidered.9 Still, we 
believe that it is possible to give health care users more influence on the guideline 
topics, on the selection of relevant outcomes of care and on the actual draft of the 
recommendations. This might lead to different questions to be answered by the 
guideline and different types of research being assessed. An example of such a 
guideline is the recently published guideline on service users’ experience of adult 
mental health services, for which a development group was chaired by a service 
user jointly with a healthcare professional.10
The inclusion of service users in mental health guidelines will in the near future be 
an important focus for high-quality guidelines which are becoming increasingly 
person-centred. Unfortunately there is a paucity of research into the conditions 
under which patient and public involvement is most likely to be effective.11
According to Harding et al.12 progress in three main areas of guideline 
development and service user involvement should be aimed for during the coming 
years: (1) translating evidence into recommendation; (2) optimizing the 
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acceptability of recommendations; and (3) reconciling different types of 
knowledge. As Kendall et al.3 say: 
 The future role of service users in monitoring their own experience of care 
and ensuring that trusts are accountable to them is now a real possibility and 
is likely to have an impact upon the traditional power relations in mental 
health and the stigma usually associated with psychiatric problems. 
Removing barriers for guideline implementation in mental health 
Implementation of guidelines for mental health, high on the policy agendas to 
speed up improvement, remains a challenge across the world. In mental health, 
one could argue, the challenge is even bigger than in general health. One of the 
more fundamental reasons is that underlying concepts of illness and illness 
management are not clearly presented, defined, studied and shared amongst 
professionals and patients. Due to this, the mental health guidelines themselves 
may not contain unambiguous recommendations, which hampers their 
implementability.  
 Recently a guideline implementability framework was developed and tested, 
including 22 elements in the domains of adaptability, usability, validity, 
applicability, communicability, accommodation, implementation, and evaluation.13
It appeared that current guidelines hardly contain features that could improve 
guideline use, such as alternate versions for different users and purposes, 
summaries of evidence and recommendations, information to facilitate interaction 
with and involvement of patients, details of resource implications, and instructions 
on how to locally promote and monitor guideline use. Using this framework, future 
guideline products in mental health might become more appealing to users. 
Another barrier for the implementation of guidelines to practice is the fact that 
especially in depression care, different guidelines for the same topic exist and 
contrasting sets of quality criteria or quality indicators have been derived from 
them, possibly leading to confusing messages to policy and practice. In the 
Netherlands, this was illustrated by a publication of Piek et al.14 entitled ‘most 
antidepressant medication in primary care is justified’, referring to good quality of 
care for depression in the Netherlands. This publication has received a lot of 
attention from the media and from clinicians since its message was in contradiction 
with recent policies and the opinion of many leading psychiatrists, scientists and 
policy makers who believed that inappropriate overuse of antidepressant 
Chapter 9: Discussion 
184
acceptability of recommendations; and (3) reconciling different types of 
knowledge. As Kendall et al.3 say: 
 The future role of service users in monitoring their own experience of care 
and ensuring that trusts are accountable to them is now a real possibility and 
is likely to have an impact upon the traditional power relations in mental 
health and the stigma usually associated with psychiatric problems. 
Removing barriers for guideline implementation in mental health 
Implementation of guidelines for mental health, high on the policy agendas to 
speed up improvement, remains a challenge across the world. In mental health, 
one could argue, the challenge is even bigger than in general health. One of the 
more fundamental reasons is that underlying concepts of illness and illness 
management are not clearly presented, defined, studied and shared amongst 
professionals and patients. Due to this, the mental health guidelines themselves 
may not contain unambiguous recommendations, which hampers their 
implementability.  
 Recently a guideline implementability framework was developed and tested, 
including 22 elements in the domains of adaptability, usability, validity, 
applicability, communicability, accommodation, implementation, and evaluation.13
It appeared that current guidelines hardly contain features that could improve 
guideline use, such as alternate versions for different users and purposes, 
summaries of evidence and recommendations, information to facilitate interaction 
with and involvement of patients, details of resource implications, and instructions 
on how to locally promote and monitor guideline use. Using this framework, future 
guideline products in mental health might become more appealing to users. 
Another barrier for the implementation of guidelines to practice is the fact that 
especially in depression care, different guidelines for the same topic exist and 
contrasting sets of quality criteria or quality indicators have been derived from 
them, possibly leading to confusing messages to policy and practice. In the 
Netherlands, this was illustrated by a publication of Piek et al.14 entitled ‘most 
antidepressant medication in primary care is justified’, referring to good quality of 
care for depression in the Netherlands. This publication has received a lot of 
attention from the media and from clinicians since its message was in contradiction 
with recent policies and the opinion of many leading psychiatrists, scientists and 
policy makers who believed that inappropriate overuse of antidepressant 
Chapter 9: Discussion 
185
medication in primary care should be reduced15. In their discussion the authors 
admit that their positive conclusion is based on relatively loose indications for
prescribing derived from the monodisciplinary depression guideline of the Dutch 
College of General Practitioners (NHG). If they would have applied criteria based 
on the more conservative and overarching multidisciplinary guideline developed by 
a range of professional organizations in primary and secondary care, they would 
probably have drawn a different conclusion. It seems to us that this variety of 
guidelines, leading to contrasting criteria for quality assessment, does not improve 
the uptake of evidence by clinicians.  
A next barrier to guideline implementation is related to the current perspective on 
implementation, and the top down approaches of implementation programs. 
Some people, like Hutschemaekers,16 argue that the impact of implementing 
guidelines so far is disappointing. Even with thoroughly designed implementation 
programs, an absolute change of about 10% on aspects of professional 
performance on average can be expected.17 In Hutschemaekers’16 point of view, 
the gap between research and practice can only be bridged when both sides are 
considered mutually complementary. He claims that it is not appropriate to 
consider science superior to practice and to suggest that clinicians should 
passively apply the lists of interventions coming from research and guideline 
development groups. Simple translation for a range of interventions recommended 
in guidelines will not result in the expected outcomes shown in the original studies 
due to complex influencing factors. According to Hutschemaekers16 clinicians need 
to adapt guideline recommendations to individual patients using their clinical 
experience and involving patients’ preferences.18 Hutschemaekers18 proposes the 
model of the scientist-physician as a solution to bridging the two different worlds of 
science and practice, being a clinician who acknowledges the value of both clinical 
experience and scientific knowledge. It would indeed be interesting to study the 
impact of this approach on clinical processes and outcomes of mental healthcare.
In a more recent Dutch guideline implementation program using tailor-made and 
multifaceted implementation strategies, significantly improved adherence rates to 
the Dutch multidisciplinary guidelines for anxiety disorders in the community 
mental healthcare  centre were measured, with greater symptom reduction, higher 
satisfaction rates and no differences with respect to changes in impairment of 
functioning and quality of life compared to patients who were not treated according 
to guidelines.19 These types of guideline implementation programs are promising, 
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worth spreading to other organizations and might need additional research into 
effective program components and longterm success. 
Applying effective organizational strategies to improve mental healthcare 
We found that, in severe mental illness, there is a fairly large body of evidence 
based on systematic reviews on the impact of multidisciplinary teams and 
integrated care on patient outcomes such as symptom severity, functioning, 
employment, and housing. Other strategies, such as changes in professional 
roles, quality or knowledge management, have either not been the subject of 
systematic reviews or have not been evaluated in randomized controlled trials 
(RCTs).  
The Cochrane’s Effective Practice and Organization of Care group (EPOC) has 
so far published 38 systematic reviews on organizational interventions, most of 
which are structural interventions such as changes in settings of service delivery or 
provider directed interventions, such as skill mix changes.20 The only EPOC 
review concerning skill mix changes in mental health provides some modest 
evidence that mental health workers working in primary care to deliver 
psychological therapy and psychosocial interventions can change the PCP’s 
behaviour in terms of reduced consultations, prescribing, and referrals to specialist 
care.21 This is in line with the review of Gilbody et al.22 who concluded that, in 
primary care for depression, effective improvement strategies will require 
substantial organizational change in terms of enhancement of the role of nurses 
and greater integration with secondary care.  
 This change of skill mix is what currently happens in primary care in the 
Netherlands and other countries, where care management models such as 
stepped care and collaborative care are about to be introduced on a large scale for 
patients with common mental disorders. Care managers, specialized nurses and 
primary care psychologists are gradually playing an important role in managing 
depression. Also, many interventions have been developed and researched to 
train patient self-management skills, with the aim to empower patients in 
enhancing their own health. In organizing effective mental health programs in 
which doctors, nurses and patients collaborate effectively, a major system barrier 
seems to be that Dutch primary care is not yet seen and organized to manage 
chronic mental conditions. This is unlike the American perspective which stresses 
that disease management strategies for depression require a longitudinal 
perspective with systematic monitoring, application of evidence-based models, and 
active patient engagement23–25 In the Netherlands, depression management is still 
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predominantly organized in line with the principles for treating acute conditions, in 
contrast to the care for diabetes, where PCPs do follow the principles of the 
chronic care model. This could change in the future, with the introduction of new 
care models based on disease management principles, such as the stepped care 
model and the collaborative care model but also when quality improvement 
instruments such as routine outcome monitoring and patient self management are 
being implemented. 
Discussion of key findings of Part II: the QIC as a strategy for improving 
mental healthcare
QIC effectiveness in mental health is in line with other settings 
Our QIC studies were based on the assumption that guidelines, summarizing the 
best available evidence, can be translated to goals and instructions relevant to 
daily practice and, with intensive guidance and support for over a year, could help 
improve professional performance of clinicians treating patients with mental health 
problems. Our overall finding, that QICs can serve to implement guidelines and 
enhance the quality of care in mental healthcare, supports this assumption. This is 
in line with the emerging evidence underlying QICs in different settings, which 
suggest that, overall, the impact of QICs are moderately positive on a selection of 
the parameters, whereas the only randomized controlled trial published on QICs 
did not show a significant result.26
Opening the black-box of the QICs 
Our qualitative work provided insight into the ‘black box’ of the depression QIC and 
the determinants of success. According to Schouten26 who performed most 
studies in the general medical setting, collaboratives might be most successful in 
improvement settings where a team approach is required and in order to enhance 
change incentives will have to be build into team and organizational processes. 
Other determinants of success, apart from team functioning, were organizational 
preparation and alignment, senior management support and interaction with 
peers.26
 These factors may have been present in the mental health QICs as well. In the 
depression QIC primary care physicians were encouraged to change their 
prescribing behaviour by making more use of psychological interventions as 
alternatives to medication. Multidisciplinary teams, non-existent before the start of 
the QIC, implemented these new, low intensity interventions. From the qualitative 
data of the depression QIC we know that, for some clinicians the positive 
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experience with these less intensive, more ‘empowering’ interventions, delivered in 
collaboration with the nurses or psychologists from the QIC team, was an incentive 
for change. In the schizophrenia QIC, these team processes were already existent 
prior to the start of the QIC.  
 Smolders et al.27 reported that adherence to depression guidelines is related to 
a stronger confidence of PCPs in depression identification, which was enhanced 
during the depression QIC according to the clinicians. In addition, perceived time 
limitations, known to be associated with a decrease of delivering appropriate non-
pharmacological care27 might have been removed during the QIC, due to the 
support that the PCPs received from the mental health workers. 
 In addition to these factors our studies identified other barriers to 
implementation processes in primary depression care. A first crucial factor was the 
creation of a shared understanding of the concept of depression and depression 
care and a consensus amongst different PCPs on a shared set of tasks, from the 
start of the process. A second, almost decisive factor for successful 
implementation of change, was the uptake of depression process and outcome 
indicators in the EMRs of PCPs. Without feedback information depression care 
can not be properly improved. Here, there is still a lot to gain in the Netherlands. 
The last factor that needs attention in stepped care implementation programs is 
the risk of undertreatment of patients with severe or long term depression, when 
everybody’s focus is on implementing low intensity interventions for mild cases.  
Investing in QICs .. making the business case first 
Little is known about the costs of interventions to improve the quality of care. 
Further, the costs and effectiveness of these interventions are likely to be context-
specific and depending on the culture of the setting and other variables.28 QICs 
are time consuming interventions and do not come for free. Our cost-effectiveness 
study of the depression QIC estimated the overall initial time costs of the clinicians 
plus the organization of the QIC on a national level, to be over €1 million. 
Economies of scale can be obtained if nationally or regionally organized QIC reach 
a large number of primary care practices and mental health organizations and if 
the clinicians involved in QICs offer the new approaches to a large number of their 
patients. Since patient identification of depression in primary care is not optimal in 
the Netherlands,15 project managers and funding bodies should make their 
business cases before investing in QICs, and assess costs, returns on 
investments and the stakeholders who will actually cash the profits. If important 
funding bodies such as health insurance companies in the Netherlands invest in 
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direct healthcare costs and improvement strategies without profiting or increased 
productivity gains, it will be difficult to drive action.29
Patient differentiation and non-pharmacological treatments in mild cases more 
explicitly recommended in depression guidelines in primary care
In four studies we looked at the impact of the QIC method in primary care for 
depression. The most solid result was generated by the controlled before-after 
study, showing a substantial reduction in antidepressant prescribing by PCPs as a 
first treatment step to patients with a new or first episode of depression compared 
to the control group, who did not change overtime. Clinical outcomes could not be 
measured.  
 Whether the reduced prescription rates pointed to a more stepped care 
approach and better clinical outcomes is not clear, since those data could not be 
extracted from the Electronic Medical Records (EMRs). Still, we are inclined to 
consider the changed prescribing behaviour of the QIC clinicians to be more in line 
with guideline recommendations to PCPs to refrain from antidepressant 
prescribing in patients with mild or moderate depression.30
 This reluctant attitude towards antidepressant medication has been made more 
explicit in the latest version of the monodisciplinary guideline for PCPs, published 
in 2012 and recommending antidepressants as initial treatment only to patients 
with a severe depression.31 This new guidance for primary care also seems to 
have adopted the stepped care principles, which can be concluded from the 
comment that: 
Depressive symptoms are included (in the guideline, GF) in addition to 
depression because primary care physicians see more patients with 
depressive symptoms than patients with depression, and doctors need 
diagnostic and therapeutic advice about these patients. Moreover, there is 
increasing evidence that the non-pharmacological treatment of depressive 
symptoms by PCPs is effective.31
Stepped care for depression: easy to recommend, hard to implement 
Stepped care for depression was the central focus of the depression QIC and the 
majority of our studies. Although the model is recommended in the most recent
guidelines in the Netherlands, the existing evidence for its effectiveness is still 
limited and diffuse, partly due to the methodological problems related to studying 
this approach. Also, current guidelines lack clarity on the exact content of a 
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stepped care model for different depressed populations. As a consequence, 
different interpretations of stepped care models for depression exist, some 
focusing on patients with mild symptoms,32 some on stepped-collaborative care for 
patients with moderate depression33 and some on stepped care models for 
patients with depression and anxiety.34
 In the United Kingdom (UK) stepped care was one of the fundamental principles 
underpinning a nationwide stepped care implementation program to introduce 
evidence-based psychological treatments for common mental health disorders.35
The difficulties encountered underway this Improving Access to Psychological 
Therapies program (IATP) led Richards to conclude that ‘stepped care is 
considerably simpler in conception than application’.35,p.212 Evaluation data showed 
high levels of implementation diversity and low rates of less than 10% of stepping 
up from low-intensity treatment to more intensive treatment.36 The program has 
generated several lessons for implementation to be addressed when stepped care 
is spread on a large scale.35 Some of these lessons overlap with the key findings 
in this thesis, such as the conclusion that case managers can play an important 
role in the delivery of the lower level evidence-based psychological treatments 
provided that they receive competency-based skills training to implement 
guideline-approved psychological treatments and to replicate the protocolized 
treatments. Another lesson learned in the UK is the critical role of ‘smart’ 
information technology as a facilitator for managing high volumes of patients and 
to collect routine outcome measures.35 Despite this, the IATP is considered to be 
very successful, although a range of implementation issues such as the large 
attrition levels or the influence of professional background on patient flow, urge for 
more in-depth implementation research into stepped care.36
Implications for practice and research
Towards ‘living guidelines’
Representatives of the Dutch Ministry of Health, Welfare and Sport and patient 
and professional organizations, health insurance companies and healthcare 
providers organizations have recently come to an agreement to work together in 
making mental healthcare efficient and of high quality. Crucial elements of the 
agreement are ‘having one language for the quality of care and making outcomes 
of care in terms of price and quality, comparable’.37 In order to reach these quality 
goals, multidisciplinary guidelines will become the backbone of an ambitious 
quality improvement program for 2013–2014. The context of this agreement, and 
the promise of the government to facilitate the quality program, creates a 
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momentum to integrate guidelines with other quality improvement initiatives in 
mental health such as routine outcome measurement (ROM), care pathways and 
care standards. This can be done by revising the existing guidelines in such a way 
that they are of high methodological quality, acceptable and implementable for 
patients and a range of professional groups, linked to multi-level quality and 
performance indicators, translated to local care pathways and to solid data 
registration systems. The purpose should be to develop a new generation of 
guidelines that is based on thoroughly assessed scientific evidence and to which 
knowledge is added generated through practice data collection. In the coming 
decade, hopefully good practice data on processes and outcomes of care, 
including patient experience, will become available in specialty and primary care. 
The challenge will be to use these data for purposes of local quality improvement 
and to aggregate them nationally in a reliable way for guideline development 
purposes. Guidelines can then contain, in addition to scientific recommendations, 
additional information about the organization of effective treatments that is directly 
linked to daily practice. This new generation of guidelines can than be truly called 
‘living guidelines.’
Towards continuous quality improvement 
Integrated guidelines can only become ‘living’ and make an impact if clinicians use 
them for quality improvement purposes. This means that quality improvement work 
has to be initiated on a continuous basis. A prerequisite for this seems to be that 
clinicians and their professional bodies will take the lead in the quality 
improvement movement. Apart from developing guidelines and implementing 
evidence-based interventions, clinicians should take the challenge of monitoring 
their processes of care and the generated outcomes, reflect on them and learn. 
Just as Batalden et al.38,p.2 promoted that ‘healthcare will not realize its full 
potential unless change making becomes an intrinsic part of everyone’s job, every 
day, in all parts of the system’. Creating such a positive culture and climate of 
change in mental healthcare requires strategic, well-planned and evidence-based 
implementation strategies. Elements of the QIC method, that could be of use in 
local change projects are target setting, creating a shared understanding and 
engagement amongst clinicians, continuous monitoring, supportive materials and 
feedback and guidance of experts and management. In addition, financing and 
accountability systems, information technology and monitoring systems, education, 
the appropriate work force and capacity and effective organizational models of 
care are all needed to drive quality improvement.36
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Fortunately, many current practice initiatives in the Netherlands are pointing in this 
direction. In primary care, health insurance companies are starting to work with 
local primary care groups to implement integrated stepped (collaborative) care 
depression programs. These include the stepped care organization of effective 
interventions for prevention, self-help and management of depressed feelings and 
diagnosed depression. The new discipline of ‘practice assistant in mental health 
(POH GGZ)’ is introduced on a large scale, being responsible for large parts of the 
care and the monitoring of outcomes. Effective e-mental health interventions are 
slowly finding their way to these practices, holding the promise to contributing to 
increased capacity building in primary care and to the desired shift of patient flow 
from expensive secondary care to primary care.  
Eventually, in a few years time, effective management of mental health problems 
needs to be regionally organized, with the healthcare insurance companies and 
the municipalities in the lead, in line with the recommendations of Unützer and 
Park,25 directed at depression care. These include the adoption of a: 
 systematic, population-based approach, which entails systematic case finding 
and diagnosis, patient engagement and education, use of evidence-based 
treatments, close follow-up to ensure patients are improving, and a 
commitment to adjust treatments or consult with other disciplines until 
patients are significantly improved.25,p.415
As for depression care programs will be needed in which primary care providers 
and mental health specialists collaborate effectively, applying the stepped care 
principles in order to substantially improve patients’ health and functioning while
reducing overall healthcare costs.25
Towards a shared research agenda for quality improvement in mental health 
A national research agenda into stepped care models for depression will be 
important in the coming years in order to align scientific efforts and allocation of 
research funding. Many different and local stepped care or stepped collaborative 
care models are implemented and studied in the Netherlands, but their 
contribution to the overall body of evidence body is unclear. Rigorous and large 
trials appear difficult to perform because of the numerous methodological issues 
involved, the difficulties with the inclusion of patients and an increasing lack of 
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good control groups. It is important that leading researchers engage in a national 
research agenda in order to collectively generate the answers to the research 
questions in relation to stepped care. These answers could then be fed back to 
new revisions of the depression guidelines. 
According to Grol et al.2 the research field on quality and safety in healthcare, 
including guideline implementation studies, is not yet fully developed. Evidence is 
lacking to support decisions about which guideline dissemination and 
implementation strategies are likely to be efficient under different circumstances, 
but getting this evidence is essential to inform policy and practice and to know if 
expensive quality improvement programs yield value for money.2,39
 The policy developments described above might generate an unprecedented 
opportunity to create a high-performance mental health system in the Netherlands. 
As for the implementation research agenda in Dutch mental health, it should 
generate information on the process and impact of the quality program initiated in 
the context of the stakeholders’ agreement. Research questions could refer to the 
implementability of the revised guidelines, or the impact of linking guidelines to 
performance-based quality improvement, or to the methods of incorporation of 
practice data into evidence-based guidelines. This research agenda will need a 
strong, multidisciplinary research program and team in which the limited resources 
for implementation research are spent in the best possible way. 
 Guiding policy makers in decisions about the allocation of research funds is also 
a responsibility of the research community. It is crucial to convince policy makers 
of the fact that investing in mental health is good value for money, since it 
contributes to economic prosperity and to the sustainability of the healthcare 
system. A recent and powerful report of the London School of Economics in the 
United Kingdom40 can serve as a strong example of what the research community 
can do to lobby for quality improvement. The report has alerted commissioners to 
think again about planned cuts on mental health by stating that ‘there is a massive 
inequality within the National Health Service (NHS): the way it treats mental illness 
as compared with physical illness’40,p.1 and that investing in mental health by 
promoting effective early interventions and psychological treatments, training of 
PCPs and the uptake of specific quality targets in the NHS outcomes framework 
will result in savings that outweigh the costs.40 
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Chapter 1: Introduction
This thesis is about improving the quality of healthcare for patients with mental 
health problems, in particular depression and schizophrenia, by implementing 
knowledge in clinical practice. Implementation is important because one of the 
most critical issues in mental health services today is the gap between what is 
known about effective treatment and what is provided to and experienced by 
consumers in routine care. In primary care, about 21% of the patients suffer from 
depressive symptoms and only 42% of them are treated in accordance with 
guidelines. In schizophrenia care an estimated 25–50% of patients receive 
guideline-concordant care. 
 In the last decades different strategies have been developed in healthcare to 
implement knowledge in daily practice and improve the quality of care. In this 
thesis we examined to what extend some of these ‘implementation strategies’ 
used in general medical healthcare, can improve the quality of care for patients in 
the mental healthcare setting. Implementation strategies are ‘targeted activities to 
realize the introduction of a specific method or product or to enhance a specific 
change’. In the healthcare sector, these activities can target clinicians (for example 
education, audits), organizations (for example skill-mix changes), patients (for 
example co-payments, information leaflets) or regulations (for example health 
insurance policies, legislation).  
 The studies presented here concentrate on three different but related strategies 
targeting clinicians and organizations:  
1) Clinical practice guidelines as strategies to inform clinicians and make 
recommendations about effective treatments; 
2) Organizational strategies to organize these treatments in daily practice; 
3) The Quality Improvement Collaborative (QIC), a ‘multifaceted’ strategy, 
combining both organizational and professional directed strategies.  
The first two strategies are the subject of part I of the thesis, whereas part II
entirely focuses on the QIC strategy. 
Part I
Strategies for quality improvement in mental healthcare 
Two types of implementation strategies were presented in part one: clinical 
practice guidelines (guidelines) and organizational strategies. Guidelines make 
recommendations to clinicians and patients, based on scientific evidence, clinical 
expertise and the expertise of healthcare users. The rationale for developing 
guidelines is their expected contribution to ‘evidence-based’ practice, in which 
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decisions are supported by scientific information, and thus lead to better quality of 
care, and healthier patients and societies. Organizational implementation 
strategies are interventions that involve a change in the service delivery of health 
care. This change can involve who delivers health care (a doctor or a nurse), how 
care is organized (in multidisciplinary teams or by a single clinician, face-to-face or 
online) or where care is delivered (in the hospital or at home). 
In chapter 2 we gave an overview of the activities in the last decade concerning 
the development of the multidisciplinary mental health guidelines in the 
Netherlands, developed to be used by multiple disciplines working in mental 
health. We based our information on the Dutch literature and documents. 
 Between 1999 and 2009, thirteen multidisciplinary guidelines and a set of 
related deliverables, such as consumer versions, checklists and implementation 
materials were published in the Netherlands. The method of evidence-based 
guideline development, according to Offringa a method that ‘makes conscientious, 
explicit and judicious use of the existing proof’, was introduced among almost 
30 professional organizations and a range of service user organizations. Although 
different methods of consumer participation were used, full integration of the 
service users’ perspective into the guidelines remained unsatisfying.  
Dissemination of the national multidisciplinary guidelines in terms of clinicians 
being aware of them has occurred, but actual use of the multidisciplinary 
guidelines has been limited so far, although psychiatrists have become familiar 
with the content and use of the guidelines.  
 Although guidelines did become a key quality instrument of professional and 
service user organizations, different criticisms have been expressed. One of them 
was related to the disorder based focus of guidelines, which did not seem to fit 
easily in the professional paradigms and working methods of non-medical 
professionals. Other criticisms were related to the limited evidence base of 
guidelines (the randomized controlled trial being the most dominant research 
design), the lack of recommendations for problems encountered in daily practice, 
the poor integration of the different perspectives (including those of patients) and 
their volume and format, both unattractive for daily use. 
 Based on this overview we recommended a stronger focus on the adaptation of 
coming guidelines to the information needs of all user groups, and on their 
implementation in terms of making professionals, service users and managers 
more sensitive and skilled to using evidence in daily decision making. 
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Chapter 3 contains an overview of the scientific literature concerning another 
implementation strategy, organizational strategies and models to improve the 
quality of care. For this study a search of systematic literature reviews was 
performed in PubMed, PsycINFO, CINAHL, EMBASE and the Cochrane Central 
Register of Systematic Reviews. Three reviewers independently selected and 
assessed the studies’ quality. We categorized the studies using an existing 
taxonomy of six broad categories of strategies for organizational change. A total of 
21 reviews were included. Among these seventeen had reasonably good 
methodological quality. Almost all reviews included or intended to include 
randomized controlled trials (RCTs), six reviews did not identify studies that met 
eligibility criteria. 
 Studies into the effectiveness of multidisciplinary teams and integrated care 
models had been reviewed most frequently (a total of fifteen reviews). Other types 
of organizational changes, such as changing professional roles and the use of 
electronic decision support, were much less the topic of systematic reviews. This is 
surprising since these strategies have been encouraged strongly by policy makers. 
 In most studies, the organizational changes led to better outcomes in terms of 
symptom severity, functioning, employment and housing, compared with 
conventional services. Unfortunately, very few reviews looked at effects of 
organizational changes on intermediate measures of professional performance (for
instance the number of times a certain treatment was given). We argued that from 
an implementation perspective this lack of information on performance measures 
limits the lessons to be learned from these studies and to provide guidance on 
how to implement a specific organizational model in daily care. 
Part II  
The impact of the Quality Improvement Collaborative on the quality of mental 
healthcare 
In part two we presented several studies on the impact of two QIC programs, 
organized in Dutch mental healthcare from 2006-2008 on the quality of care for 
patients with depression and schizophrenia. The quality of care was defined in 
terms of key recommendations of the first multidisciplinary guidelines for these 
conditions, both published in 2005. QICs had become very popular in the 
Netherlands over the last decade and from the 1990’s the Ministry of Health, 
Welfare and Sports invested heavily to initiate them in many settings, both cure 
and care. QIC projects bring together multidisciplinary groups of professionals
from different healthcare organizations to improve aspects of the quality of their 
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service, in a structured way of setting targets, collecting data and testing changes 
(Plan-Do-Study-Act Cycles). National learning sessions, conference calls and 
feedback on progress reports are organized. Clinical experts and experts in quality 
improvement provide ideas and support.  
 The next four studies (chapters 4-7) all focus on the impact of the Depression 
QIC, organized in the primary care setting to implement a stepped care approach 
and change antidepressants prescribing behaviour of primary care physicians. 
Chapter 8 presents a study into the Schizophrenia QIC organized in specialty care 
to implement a series of evidence-based interventions and improve continuity of
care. 
In chapter 4 we described the content, activities and quality improvement data of 
the thirteen multidisciplinary primary care teams participating in the Depression 
QIC. The aim of this QIC was to implement a guideline-based stepped care 
depression model, which had been developed by an expert team and printed on a 
smart card. The stepped care model consisted of two care pathways with different 
levels of treatment intensity: a first low intensity treatment pathway for patients with 
non-severe depression and a second treatment pathway offering antidepressants 
or psychotherapy to patients with severe depression or with insufficient response 
to the first step. In both pathways monitoring of depression symptoms with a 
questionnaire was required. The criteria to differentiate between severely and non-
severely depressed patients were defined by the national expert team. 
 In total 101 mostly primary care health professionals were involved, and 536 
patients were diagnosed. Overall 356 patients (66%) were considered non-
severely depressed by the clinicians and 180 (34%) patients showed severe 
symptoms. The mean percentage of non-severe patients treated according to the 
stepped care model was 78%, and 57% for the severely depressed patient group. 
The proportion of non-severely depressed patients receiving a first step treatment 
according to the stepped care model improved during the project, this was not the 
case for the severely depressed patients. The teams were able to monitor 
depression symptoms to a moderate to reasonable extent during a period of six 
months. Within three months, 28% of monitored patients had recovered, meaning 
a Beck Depression Inventory (BDI) score of 10 and lower, and another 27% 
recovered between three and six months. 
 We concluded that a stepped care approach seems acceptable and feasible in 
primary care, introducing different levels of care for different patient groups, 
Summary 
202
although special attention should be paid to the quality of care for severely 
depressed patients. 
Chapter 5 presented the qualitative results of semi-structured group interviews 
with the eight multidisciplinary teams (out of thirteen) from the Depression QIC 
who consented to participate in additional implementation research activities. The 
aim of this study was to provide insight into the perceptions of the primary care 
physicians, mental health nurses, social workers, physiotherapists, psychiatrists, 
psychologists and others on the implementation of stepped care for depression 
into their daily routines. The interviews took place during the last half of the fifteen 
months of the QIC and were audio taped, transcribed verbatim and independently 
coded by two researchers, applying thematic coding with the help of qualitative 
analysis software. To help understand and further interpret the qualitative findings, 
the analysis was supported by an existing conceptual framework for implementing 
best practices for depression, based on the Normalisation Process Theory (NPT).  
 The interviews showed that all three stepped care principles (patient 
differentiation, stepped care treatment, and outcome monitoring), were locally 
partially translated and introduced. Clinicians reported changes in terms of 
learning how to differentiate between patient groups and different levels of care, 
changing antidepressant prescribing routines as a consequence of having a 
broader treatment package to offer to their patients, and better working 
relationships with patients and colleagues. Factors facilitating the process were 
the simple and pragmatic stepped care model itself, the structured team meetings 
(part of the QIC method), and the positive reaction from patients to stepped care. 
The differing views of depression and depression care within multidisciplinary 
health teams, lack of resources, and poor information systems hindered the rapid 
introduction of the stepped care model.  
The two NPT constructs ‘coherence’ and ‘cognitive participation’ appeared to be 
crucial drivers in the initial stage of the implementation process. Coherence refers 
to the way in which depression care is conceptualized by healthcare professionals, 
and implies that all actors should have a shared understanding of what constitutes 
depression and depression work. This shared understanding is necessary for 
adoption of an effective stepped care model for depression in routine care. 
Cognitive participation outlines how professionals engage in depression care, and 
implies an agreement that depression care is part of routine care and that there is 
a shared set of diagnostic and treatment techniques.  
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 We concluded that while it is difficult for the implementation of a full stepped-
care approach to occur within a short time frame, clinicians can make progress 
towards achieving this within the context of a QIC. Creating a shared 
understanding within multidisciplinary teams of what constitutes depression and 
reaching a consensus about the content of depression care and the division of 
tasks are important factors to address when implementing new models for 
depression care. 
In chapter 6 we presented a quasi-experimental implementation study into the 
impact of the Depression QIC on antidepressants prescribed by primary care 
physicians. The stepped care model for depression implied that antidepressant 
medication should not be offered as a first step treatment to patients with sub-
threshold or mild depression. Instead, low intensity interventions were being 
implemented. At the time of the study around 40%-60% of Dutch patients in 
primary care presenting with sub-threshold or mild depression received 
antidepressants, which was considered to be high by many. Therefore, the 
expectation was that during the QIC a reduction of antidepressant prescribing by 
primary care physicians would occur. 
 To test this hypothesis a quasi-experimental study was performed, with a non-
equivalent control group and three years follow-up. The percentage of 
antidepressant prescriptions provided by the QIC primary care physicians, as a 
first treatment step for adult patients diagnosed with depressed feelings (ICPC 
P03) or a depression (P076) was compared before, during and after the QIC to the 
prescribing behaviour of physicians participating in the Dutch National Information 
Network of General Practice (LINH). This is a national database holding 
longitudinal and nationally representative data on morbidity, prescribing, and 
referrals in primary care. In both groups prescribing data were gathered from the 
Electronic Medical Records of the participating practices. In addition we gathered 
information on referrals to mental health specialists. 
 The QIC group consisted of 20 primary care physicians from 17 practices, the 
control group included 115 primary care physicians from 41 practices. Data 
regarding 400 patients in the QIC group and 3956 patients in the control group 
were included in the analyses. A decrease of 23.3% (49.4%-26.1%) in 
antidepressant prescription rates for newly diagnosed patients with depressive 
symptoms was found within the intervention group, whereas no difference 
occurred in the control group (50.3%-52.6%). Multilevel regression analysis 
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showed that a decrease over time due to participation in the QIC was significant 
compared to the control group (OR 0.44, 95% CI: 0.21-0.92).   
 We concluded that QICs can lead to a substantial reduction of antidepressant 
prescriptions as a first treatment step for depression in primary care. Future 
research has to determine if this reduction is part of an adequately implemented 
stepped care approach, in which patients with mild symptoms have access to low 
intensity interventions and severely depressed patients to medication and 
psychotherapy. 
In chapter 7 patient-level cost-effectiveness was assessed of health care delivery 
for depression by primary care clinicians after exposure to the QIC. We performed 
an economic evaluation using a societal perspective which means that costs 
encompass both health care costs and costs stemming from productivity losses. 
The intervention group consisted of primary care patients from practices 
participating in a national depression Quality Improvement Collaborative (QIC), the 
control group consisted of patients from usual care practices included in the 
Netherlands Study of Depression and Anxiety (NESDA). To assure comparability 
at baseline we matched the study groups by relevant patient characteristics that 
were regarded predictive of treatment response. The central clinical end-term of 
the study was remission, measured with the Inventory for Depressive 
Symptomatology (IDS-SR) at baseline and at twelve months. Costs were 
measured with the Trimbos and Institute of medical Technology Assessment Cost 
Questionnaire of Psychiatry (TIC-P).
 The costs analysis was performed by calculating the incremental cost-
effectiveness ratio (ICER) of treatment in the QIC condition versus treatment in the 
usual care condition, as the difference in costs between QIC and the control group 
divided by the difference of effects in both conditions (C1-C0)/ (E1-E0), where C is 
the average annual per-patient cost and E is the percentage of patients who 
recovered from a depression in the experimental and control conditions 
(subscripted 1 and 0 respectively).  
 The analyses were based on 89 patients: 34 in the QIC group and 55 in the 
control group. These small numbers of patients made the study underpowered and 
unfit to test hypotheses and draw conclusions based on statistical analyses. In the 
context of an economic evaluation however, small sample data can be used to 
evaluate the tradeoffs between health benefits and costs and to make probabilistic 
statements to support medical decision making under situations of uncertainty.  
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Symptomatology (IDS-SR) at baseline and at twelve months. Costs were 
measured with the Trimbos and Institute of medical Technology Assessment Cost 
Questionnaire of Psychiatry (TIC-P).
 The costs analysis was performed by calculating the incremental cost-
effectiveness ratio (ICER) of treatment in the QIC condition versus treatment in the 
usual care condition, as the difference in costs between QIC and the control group 
divided by the difference of effects in both conditions (C1-C0)/ (E1-E0), where C is 
the average annual per-patient cost and E is the percentage of patients who 
recovered from a depression in the experimental and control conditions 
(subscripted 1 and 0 respectively).  
 The analyses were based on 89 patients: 34 in the QIC group and 55 in the 
control group. These small numbers of patients made the study underpowered and 
unfit to test hypotheses and draw conclusions based on statistical analyses. In the 
context of an economic evaluation however, small sample data can be used to 
evaluate the tradeoffs between health benefits and costs and to make probabilistic 
statements to support medical decision making under situations of uncertainty.  
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 In the QIC group 26% recovered and 18% in the control group. The mean per-
patient societal costs were lower in the QIC group (€5,012) than in the control 
group (€5,871). There was a 73%-89% probability that QIC care was more cost-
effective than usual care and for each case of recovery that could be achieved by 
offering a QIC treatment a saving was made of €10,311. However, the investments 
for implementing the QIC approach were estimated at over one million euro.
 We concluded that from a societal perspective the QIC approach is likely to offer 
more value for money than care as usual after being implemented, but a larger 
and randomized study is needed to verify our findings.  
In our last study in chapter 8 we presented the Schizophrenia QIC. The context 
and design of the study were similar to the study in chapter four on the Depression 
QIC. The study was based on the quality improvement data collected by 30 QIC 
teams from the Netherlands in which 359 clinicians with different professional 
backgrounds participated. This QIC aimed at implementing six guideline-based 
interventions for schizophrenia: Assertive Community Treatment (ACT) or its 
adapted version Functional Assertive Community Treatment (FACT), Cognitive 
Behavioural Therapy (CBT), Psycho-Education (PE), Family Interventions (FI), 
Individual Placement Support (IPS), Pharmacotherapy (PHth). In addition, teams 
worked on better continuity of care by developing an individual care plan for each 
patient covering treatment, early warning signs and rehabilitation.  
 The degree of implementation of the interventions was measured at the end of 
the QIC in a survey amongst participants. Care plans were collected and counted 
and clinical outcomes were measured at different instances with the Health of the 
Nation Outcome Scales (HoNOS) en de Clinical Global Impression scale (CGI).  
 Analyses were based on 1489 patients suffering from schizophrenia. Before the 
QIC only half of the evidence-based interventions (CBT, PE, PHth) had been 
available in most of the teams, and less than half of the teams could offer their 
patients (F)ACT, FI or IPS. At the end of the QIC, most teams had made all 
interventions available and a majority of the teams had developed protocols for 
most of them. Still, only a minority of teams was able to adhere to the protocols for 
at least 70% of their patients, except for pharmacotherapy (53% of the teams), 
although for all interventions the number of teams who routinely provided the care 
according to protocol improved over time. Complete care plans were composed for 
38% of the patients, as opposed to 3% previous to the QIC. Social functioning 
improved slightly (HoNOS mean: from 6.2 to 5.6) as well as symptom severity 
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(CGI-S mean: from 4.1 to 3.9). Relapse rates did not improve during the course of 
the QIC. 
 Our conclusion was that a QIC can result in improved delivery of evidence-
based care and continuity of care in the specialized mental health care setting, 
and in improved outcomes for individuals with schizophrenia. More rigorous 
research designs have to confirm these findings. 
In the general discussion we reflected on the main findings of this thesis. Our 
results, although not based on randomized designs, pointed in the same direction, 
that QICs can improve implementation of guideline recommendations, and lead to 
better quality of care and possibly to better clinical outcomes. These effects 
occurred both in primary care for patients with depression as well as in specialized 
mental healthcare for patients with schizophrenia.  
 Most studies focused on the implementation of a stepped care model for 
depression in primary care. The most solid result of the depression QIC was the 
changed antidepressant prescribing behaviour of the participating primary care 
physicians. Although we could not determine which patient groups exactly profited 
of this change, these reduced prescribing rates are quite remarkable because they 
interrupt a solid trend of consistent, higer prescription rates in primary care. 
 The implementation of a full stepped care model was hard to organize during 
the course of the QIC and most teams concentrated on the implementation of the 
low intensity treatments for patients with mild depression and continuous 
monitoring. Possibly care delivered according to the QIC depression model might 
also be more cost-effective than usual care, because of lower productivity losses. 
Still, large investments are needed to initiate QICs which requires funding bodies 
to make the business case before doing so. 
 A range of factors impacting on stepped care implementation have been 
identified in our work. Most of them, like sufficient time, motivation and resources 
are not specific to depression care and have already been described in the 
general implementation literature. A few factors actually do seem unique to mental 
healthcare and important to mention for future implementation programs. A first 
crucial factor is the creation of a shared understanding of the concept of 
depression and depression care and a consensus amongst different primary care 
clinicians on a shared set of tasks, from the start of the process. A second, almost 
decisive factor for successful implementation of change, is the uptake of 
depression process and outcome indicators in the EMRs of primary care 
physicians. Without feedback information depression care can not be properly 
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improved. Here, there is still a lot to gain in the Netherlands. The last factor that 
needs attention in stepped care implementation programs is the risk of 
undertreatment of patients with severe or long term depression, when everybody’s 
focus is on implementing low intensity interventions for mild cases.  
 It is expected that multidisciplinary guidelines will become the backbone of 
future quality improvement programs in mental health initiated by the government 
and the professional and patient organizations. This thesis can provide relevant 
input for the design of these programs. We suggested that future guidelines will be 
developed in such a way that they are of high methodological quality and at the 
same time acceptable and implementable for patients and professionals. This can 
only be done by linking them, more than currently happens, to other quality 
improvement instruments such as performance indicators, local care pathways 
and routine outcome monitoring systems. If professionals and patients can directly 
link to guideline recommendations and receive personalized decision support, 
chances are high that the science-to-practice gap will be reduced. If guidelines 
then become the common source for developing local and national indicators to 
monitor the quality and outcomes of care, improvement activities can be set up 
more easily and performances of organizations can be better compared. In that 
situation nationally organized QICs might become superfluous and managers can 
take the lead in initiating local or regional QIC-like networks for quality 
improvement.  
The conditions for this ‘culture of change’ in mental healthcare seem to come in 
sight. The professional organizations are gradually taking responsibility for the 
national quality improvement agenda and a more effective and efficient healthcare 
system. Consumer organizations are better involved and heard, and health 
insurance companies are looking for more collaboration with professionals. And 
perhaps most of all, the possibilities of information technology systems to provide 
feedback information has improved tremendously. The only thing yet to happen 
seems to be that all who are involved in mental healthcare start to fully profit of 
these circumstances without negative external pressure, for instance by studying 
data on local care processes and outcomes, reflect on them, learn and act to 
improve daily care. For the well-being of patients and the sound allocation of 
available budgets, the development of these improvement processes will be 
crucial for the years to come, because as Paul Batalden from the Institute for 
Healthcare Improvement (the institute who invented the QIC) and his colleagues 
stated: ‘healthcare will not realize its full potential unless change making becomes 
an intrinsic part of everyone’s job, every day, in all parts of the system’.
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Hoofdstuk 1: Introductie
Dit proefschrift gaat over het verbeteren van de kwaliteit van zorg voor mensen 
met psychische problemen, met name depressie of schizofrenie, door de 
implementatie van onderzoekskennis in de alledaagse praktijk. Implementatie is 
belangrijk omdat er in de geestelijke gezondheidszorg (GGZ) een grote kloof is 
tussen de beschikbare kennis (wat men weet) over effectieve behandelingen en 
de dagelijkse praktijk en ervaringen van mensen (wat men krijgt). Zo lijdt ongeveer 
21 procent van alle patiënten in de huisartspraktijk aan depressieve klachten en 
krijgt slechts 42 procent van deze groep een behandeling die in overeenstemming 
is met richtlijnen. Van alle mensen die voor schizofrenie behandeld worden 
ontvangt 25 tot 50 procent een behandeling in overeenstemming met de richtlijn. 
In de afgelopen decennia zijn er in de zorgsector vele strategieën ontwikkeld om 
het gebruik van kennis in de praktijk te bevorderen en daarmee de kwaliteit van de 
zorg te verbeteren. In dit proefschrift werd onderzocht in hoeverre enkele van deze 
‘implementatiestrategieën’ uit de algemene gezondheidszorg geschikt zijn voor het 
verbeteren van de kwaliteit van zorg in de GGZ. Implementatiestrategieën zijn 
‘gerichte activiteiten om de introductie van een specifieke methode of product te 
realiseren of om een specifieke verandering te bevorderen’. In de zorg kunnen 
deze activiteiten gericht zijn op hulpverleners (bijvoorbeeld bij- en nascholing, 
visitaties), op organisaties (bijvoorbeeld veranderingen in taakomschrijvingen), op 
patiënten (bijvoorbeeld eigen bijdragen, informatiefolders) of op regelgeving 
(bijvoorbeeld nieuw verzekeringsbeleid of wetgeving).  
De hier gepresenteerde studies concentreerden zich op drie verschillende maar 
aan elkaar gerelateerde implementatiestrategieën, namelijk:  
1) Klinische richtlijnen, gericht op hulpverleners om hen te informeren en 
aanbevelingen te doen over effectieve of werkzame zorg; 
2) Organisatorische strategieën om effectieve zorg in de dagelijkse praktijk te 
organiseren; 
3) De “Quality Improvement Collaborative (QIC)”, een samengestelde strategie 
waarmee men zowel hulpverleners als organisaties poogt te veranderen. 
De eerste twee implementatiestrategieën zijn het onderwerp van deel 1 van het 
proefschrift, deel 2 gaat geheel over QICs. 
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Deel 1
Implementatiestrategieën in de GGZ
In deel 1 werden twee verschillende implementatiestrategieën gepresenteerd: 
klinische richtlijnen (kortweg richtlijnen) en organisatorische strategieën. 
Richtlijnen bevatten vakinhoudelijke aanbevelingen aan hulpverleners en 
patiënten voor optimale zorg, en zijn gebaseerd op wetenschappelijk bewijs, 
klinische expertise van hulpverleners en ervaringskennis van patiënten. De 
gedachte achter het ontwikkelen van richtlijnen is dat zij kunnen bijdragen aan 
‘evidence-based’ geneeskunde, waarin wetenschappelijke kennis wordt 
meegewogen bij het nemen van behandelbeslissingen. Richtlijnen zouden zo 
kunnen leiden tot betere zorg, betere gezondheid van patiënten en tot een 
welvarender maatschappij.  
 Organisatorische implementatiestrategieën zijn veranderingen in de manier 
waarop zorg in de praktijk geleverd wordt, met als doel de kwaliteit van zorg te 
verbeteren en daardoor gezondheidswinst voor patiënten te bereiken. 
Organisatorische strategieën kunnen bestaan uit veranderingen in het type 
hulpverlener dat een behandeling geeft (de verpleegkundige in plaats van de 
dokter), de manier waarop de hulp is georganiseerd (in teams in plaats van in een 
solopraktijk, zorg geleverd door een computer of een hulpverlener) en de plaats 
waar de behandeling wordt gegeven (thuis in plaats van het ziekenhuis). 
In hoofdstuk 2 werd een overzicht gegeven van de activiteiten in Nederland op 
het gebied van multidisciplinaire richtlijnen in de GGZ, bedoeld voor de 
verschillende beroepsgroepen in de eerste- en tweedelijns GGZ. Dit overzicht 
werd gebaseerd op Nederlandse literatuur en documenten.  
 Tussen 1999 en 2009 werden in de GGZ dertien multidisciplinaire richtlijnen 
ontwikkeld en kwamen vele van deze richtlijnen afgeleide documenten uit, zoals 
patiëntenversies, checklists en implementatiemateriaal. Bijna dertig 
beroepsverenigingen en tal van patiëntenorganisaties waren bij de 
richtlijnontwikkeling betrokken. Deze volgde de methode van ‘evidence-based’ 
richtlijnontwikkeling, een methode waarbij volgens Offringa gestreefd wordt naar 
het ‘gewetensvol, expliciet en oordeelkundig gebruik van het bewijsmateriaal’. 
Hoewel patiënten op verschillende manier bij de richtlijnontwikkeling 
participeerden, bleef het perspectief van hen in de richtlijnen vaak onderbelicht. 
 Hulpverleners in de GGZ werden zich in de afgelopen jaren bewust van het 
bestaan van de landelijke richtlijnen, maar men gebruikte ze slechts in beperkte 
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mate, met uitzondering van psychiaters die de inhoud van de richtlijnen vaak 
kenden en toepasten in dagelijks praktijk.  
Hoewel richtlijnen een belangrijk instrument zijn geworden voor beroepsgroepen 
en cliëntenorganisaties, was er ook veel kritiek. Eén van de kritiekpunten was dat 
de richtlijnen sterk diagnose georiënteerd waren, wat niet goed paste in de 
professionele paradigma’s en werkwijzen van diverse niet-medische 
beroepsgroepen. Andere kritiekpunten hielden verband met de beperkte 
onderbouwing van richtlijnen (de randomized controlled trial als het dominante 
onderzoeksdesign), het gebrek aan aanbevelingen voor concrete problemen uit de 
praktijk, de moeilijkheid om in een tekst de perspectieven van diverse 
beroepsgroepen en cliënten te verenigen en de omvang en vormgeving van de 
richtlijnen, beiden onaantrekkelijk voor dagelijks gebruik. 
 Gebaseerd op dit overzicht kwamen we tot de conclusie dat toekomstige 
richtlijnen in de GGZ beter moeten aansluiten op de informatiebehoeften van 
hulpverleners, hulpvragers en managers. Daarnaast zullen deze gebruikers de 
komende jaren beter moeten leren om de richtlijnen te gebruiken bij beslissingen 
in de dagelijkse praktijk. 
Hoofdstuk 3 bevat een overzicht van de wetenschappelijke literatuur over 
organisatorische implementatiestrategieёn voor het verbeteren van de zorg. We 
concentreerden ons op gepubliceerde overzichtstudies oftewel systematic reviews 
en voerden een systematische literatuursearch uit in de databases PubMed, 
PsycINFO, CINAHL, EMBASE en in het Cochrane Register van Systematische 
Reviews. Drie onderzoekers selecteerden en beoordeelden de kwaliteit van de 
studies onafhankelijk van elkaar. De geselecteerde studies werden vervolgens 
geordend aan de hand van een bestaande indeling van zes categorieёn van 
organisatorische implementatiestrategieёn.
 In totaal werden 21 systematische reviews geselecteerd, waarvan zeventien 
van een redelijke methodologische kwaliteit. Bijna alle reviews hadden 
gerandomiseerde, gecontrolleerde trials geїncludeerd of beoogden dat. In zes 
reviews werden er geen studies gevonden die aan de gestelde inclusie criteria 
voldeden. Vijftien reviews gingen over multidisciplinaire teams en geїntegreerde 
zorgmodellen. Over andere organisatorische veranderingen in de zorg, zoals een 
verandering in professionele rollen en het gebruik van informatietechnologie bij het 
nemen van behandelbeslissingen, waren veel minder reviews gepubliceerd. Dit is 
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opvallend omdat deze innovaties de laatste jaren door beleidsmakers sterk 
worden gestimuleerd.  
 In de meeste van de beoordeelde reviews leidden de organisatorische 
veranderingen tot minder psychiatrische symptomen, beter functioneren en betere 
uitkomsten met betrekking tot werk en wonen. Helaas bevatten de studies weinig 
informatie over het effect van organisatorische veranderingen op intermediaire 
maten zoals het handelen van hulpverleners (bijvoorbeeld het aantal keer dat een 
bepaalde behandeling werd gegeven), omdat dergelijke uitkomsten vaak niet in de 
studies werden gemeten. Vanuit implementatie oogpunt is het dan moeilijker om 
uit dit type onderzoek af te leiden hoe een specifiek organisatorisch model in de 
dagelijkse praktijk werkt en kan worden geїmplementeerd.
Deel 2 
De impact van de Quality Improvement Collaborative op de kwaliteit van zorg 
in de GGZ 
Deel 2 van het proefschrift presenteerde verschillende studies over twee QICs die 
van 2006 tot 2008 in Nederland werden uitgevoerd. Het doel van deze 
programma’s was om de kwaliteit van zorg voor mensen met depressie of 
schizofrenie te verbeteren door het implementeren van centrale aanbevelingen uit 
de in 2005 gepubliceerde, eerste landelijke multidisciplinaire richtlijnen voor deze 
onderwerpen. QICs zijn de laatste tien jaar erg populair geworden in de 
Nederlandse zorgsector. Het Ministerie van Volksgezondheid, Welzijn en Sport 
investeerde vanaf 1990 veel overheidsgeld in deze programma’s, zowel in de 
kortdurende zorg als in de langdurende zorg. In QICs vormen multidisciplinaire 
teams van hulpverleners uit verschillende organisaties een landelijk netwerk om 
een jaar lang te werken aan het verbeteren van de zorg in hun eigen instelling. Dit 
gebeurt op een gestructureerde manier door het stellen van duidelijke doelen, het 
verzamelen van zorggegevens en het testen van veranderingen in de zorg (de 
Plan-Do-Study-Act cyclus). Door een landelijk expertteam worden conferenties, 
begeleiding, training en feedback op tussenrapportages georganiseerd. De rol van 
de experts is te adviseren over inhoudelijke en verandervraagstukken.  
De vier studies uit hoofdstuk 4 tot 7 gaan over de impact van de Depressie QIC in 
de eerstelijn. Deze QIC beoogde een zogeheten stepped care model voor 
depressie in te voeren en daarmee het voorschrijfgedrag van huisartsen met 
betrekking tot antidepressiva te veranderen. Hoofdstuk 8 gaat over een QIC in de 
tweedelijns GGZ met als doel effectieve behandelingen uit de multidisciplinaire 
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richtlijn schizofrenie te implementeren en de continuїteit van zorg voor deze 
doelgroep te verbeteren. 
In hoofdstuk 4 werden de inhoud, activiteiten en de verbetergegevens 
beschreven van dertien multidisciplinaire teams in de eerstelijn die deelnamen aan 
de Depressie QIC om een stepped care model oftewel getrapte zorg voor 
depressie in hun praktijken in te voeren. Dit model was ontworpen door een 
landelijk QIC expert team en gedrukt op een geplastificeerd kaartje. Het stepped 
care model bestond uit twee ‘zorgpaden’ of behandelstappen van verschillende 
intensiteit. Voor patiёnten met niet-ernstige depressieve klachten bestond het 
zorgpad uit kortdurende, niet intensieve behandelingen gedurende zes tot twaalf 
weken en uit een instrument om de klachten te monitoren. Een tweede zorgpad 
was bedoeld voor mensen met ernstige depressieve klachten. Dit bestond uit 
antidepressiva en/of psychotherapie als eerste behandelstap en uit het monitoren 
van de klachten. Deze tweede stap was ook aangewezen voor de lichte groep bij 
onvoldoende effect van de eerste stap. De ernstcriteria voor het differentiëren 
tussen ernstige en niet-ernstige patiënten waren door de experts gedefinieerd. 
 In totaal deden 101 hulpverleners uit voornamelijk de eerstelijn mee aan de 
QIC. Zij implementeerden het model voor 536 patiёnten bij wie zij depressieve 
klachten of een depressie hadden geconstateerd. Van deze groep werden 356 
mensen (66%) als niet-ernstig depressief beschouwd, 180 patiёnten (34%) waren 
ernstig-depressief volgens de hulpverleners. Gemiddeld werd 78% van de niet-
ernstige groep volgens het stepped care model behandeld en 57% van de ernstige 
groep. Het percentage niet-ernstig depressieve patiёnten dat behandeld werd 
volgens het model verbeterde tijdens het project, voor de ernstige groep was dat 
niet het geval. Tijdens de QIC waren de teams matig tot redelijk in staat om de 
depressieve klachten zes maanden lang te monitoren. Binnen drie maanden bleek 
28% van de gemeten patiёnten te zijn hersteld, met een score op de Beck 
Depression Inventory van 10 of lager. Nog eens 27% knapte drie tot zes maanden 
na de start van de behandeling op.
 We concludeerden dat een stepped care aanpak voor depressie, waarbij 
verschillende niveaus van zorg voor verschillende patiёntengroepen worden 
georganiseerd, in de eerstelijn haalbaar en acceptabel is hoewel speciale 
aandacht uit moet gaan naar adequate zorg voor mensen met ernstige depressies 
en het herhaaldelijk meten van depressieve klachten. 
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In hoofdstuk 5 werden de resultaten gepresenteerd van semi-gestructureerde 
interviews met acht van de dertien multidisciplinaire teams uit de Depressie QIC, 
die hadden toegezegd om mee te doen aan aanvullend implementatieonderzoek. 
Het doel van dit kwalitatieve deelonderzoek was het verkrijgen van inzicht in het 
perspectief van huisartsen, sociaal psychiatrisch verpleegkundigen, 
maatschappelijk werkers, fysiotherapeuten, psychiaters, psychologen en anderen 
op het implementeren van het stepped care model voor depressie in hun 
dagelijkse routines. De interviews werden in de laatste helft van de vijftien 
maanden durende QIC gehouden, op de band opgenomen, woordelijk 
uitgeschreven en door twee onderzoekers onafhankelijk van elkaar thematisch 
gecodeerd met behulp van een software programma. Als laatste stap in de 
analyse werden de resultaten bekeken vanuit een bestaand conceptueel model 
voor het implementeren van veranderingen in de depressiezorg, gebaseerd op de 
Normalisation Process Theory (NPT).
 De uitkomsten van deze studie lieten zien dat de drie principes van het stepped 
care model (differentiatie tussen patiёntengroepen, stepped care of getrapte 
behandeling en het monitoren van uitkomsten), lokaal vertaal werden naar de 
praktijken en op onderdelen werden ingevoerd. De hulpverleners gaven aan dat 
ze tijdens de QIC beter onderscheid leerden te maken tussen lichte en ernstige 
depressies en de bijbehorende verschillende niveaus van behandeling, dat zij in 
sommige gevallen anders omgingen met antidepressiva omdat zij een breder 
pakket aan behandelingen tot hun beschikking hadden. Ook noemden zij de 
verbeterde relaties met patiёnten en collega’s door de invoering van het stepped 
care model. Factoren die deze veranderingen bevorderden waren het eenvoudige 
kaartje met het stepped care model, de lokale teambijeenkomsten en de positieve 
reacties van patiёnten op stepped care zorg, met name op het gebruik van 
vragenlijsten. Andere zaken zaten de invoering van het stepped care model in de 
weg, zoals de verschillende visies op depressie onder de diverse disciplines en 
het gebrek aan tijd en geld en aan goede informatietechnologie om 
depressiesymptomen te kunnen monitoren.  
 De uit de NPT afkomstige concepten ‘coherentie’ en ‘cognitieve participatie’
bleken cruciale fenomenen voor het op gang komen van het implementatieproces. 
Coherentie impliceerde dat de visie op depressie en depressiezorg eerst door alle 
betrokkenen moest worden uitgewisseld en gedeeld om effectieve invoering van 
het nieuwe depressiemodel in de praktijk mogelijk te maken. Cognitieve 
participatie verwees naar het belang van overeenstemming tussen de 
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hulpverleners over het feit dat depressiezorg onderdeel was van ieders werk en 
dat er een gedeelde set van diagnostische en behandeltechnieken nodig was.  
 De conclusie van deze studie was dat hoewel het moeilijk is om in korte tijd een 
heel stepped care model voor depressie in de eerstelijn te implementeren, de QIC 
hulpverleners voortgang boekten op de drie onderdelen. Het ontwikkelen van een 
gedeelde visie op depressie binnen multidisciplinaire teams en het bereiken van 
overeenstemming over de inhoud van depressiezorg en de onderlinge 
taakverdeling hebben expliciete aandacht nodig bij de implementatie van nieuwe 
zorgmodellen voor depressie.  
Hoofdstuk 6 besloeg een quasi-experimentele implementatiestudie naar de 
impact van de Depressie QIC op het voorschrijven van antidepressiva door 
huisartsen. Het stepped care model voor depressie impliceerde dat antidepressiva 
niet als eerste stap in de behandeling van mensen met lichte klachten zouden 
worden gegeven. In plaats daarvan werden laag intensieve behandelingen in de 
huisartspraktijk geïmplementeerd. In Nederland werd ten tijde van de studie, aan 
40 tot 60 procent van de patiёnten met depressieve klachten in de eerstelijn 
antidepressiva voorgeschreven, hetgeen door velen als een hoog percentage 
werd beschouwd. De verwachting was dan ook dat door de introductie van het 
stepped care model, het aantal voorschriften van een antidepressivum door 
huisartsen in de loop van de QIC zou dalen.  
 Om deze hypothese te testen werd een quasi-experimentele studie opgezet met 
een ongelijke controlegroep en drie jaar follow-up. We vergeleken voor, tijdens en 
na de QIC het percentage voorschriften voor antidepressiva van de QIC 
huisartsen, als eerste stap in de behandeling van volwassen patiënten met een 
eerste of nieuwe episode van depressieve klachten (ICPC P03) of een depressie 
(ICPC P076) met het voorschrijfgedrag van huisartsen uit het Landelijk Informatie 
Netwerk Huisartsenzorg (LINH). Dit is een database met representatieve, 
longitudinale gegevens over ziekte, voorschrijven en verwijzing in de 
huisartspraktijk. In beide groepen werd in het Huisartsen Informatie Systeem (HIS) 
van de deelnemende huisartsen gezocht naar gegevens over voorschrijven. Ook 
werd gekeken naar verwijzingen door de huisarts naar GGZ hulpverleners in de 
eerste- of tweedelijn. 
 De QIC groep bestond uit 20 huisartsen uit 17 praktijken, de controlegroep 
bestond uit 115 huisartsen uit 41 praktijken. De gegevens van 400 QIC patiёnten 
en van 3956 patiёnten uit de controlegroep werden in de analyses meegenomen. 
In de QIC groep verminderde het percentage antidepressiva voorschriften als 
Samenvatting 
216
hulpverleners over het feit dat depressiezorg onderdeel was van ieders werk en 
dat er een gedeelde set van diagnostische en behandeltechnieken nodig was.  
 De conclusie van deze studie was dat hoewel het moeilijk is om in korte tijd een 
heel stepped care model voor depressie in de eerstelijn te implementeren, de QIC 
hulpverleners voortgang boekten op de drie onderdelen. Het ontwikkelen van een 
gedeelde visie op depressie binnen multidisciplinaire teams en het bereiken van 
overeenstemming over de inhoud van depressiezorg en de onderlinge 
taakverdeling hebben expliciete aandacht nodig bij de implementatie van nieuwe 
zorgmodellen voor depressie.  
Hoofdstuk 6 besloeg een quasi-experimentele implementatiestudie naar de 
impact van de Depressie QIC op het voorschrijven van antidepressiva door 
huisartsen. Het stepped care model voor depressie impliceerde dat antidepressiva 
niet als eerste stap in de behandeling van mensen met lichte klachten zouden 
worden gegeven. In plaats daarvan werden laag intensieve behandelingen in de 
huisartspraktijk geïmplementeerd. In Nederland werd ten tijde van de studie, aan 
40 tot 60 procent van de patiёnten met depressieve klachten in de eerstelijn 
antidepressiva voorgeschreven, hetgeen door velen als een hoog percentage 
werd beschouwd. De verwachting was dan ook dat door de introductie van het 
stepped care model, het aantal voorschriften van een antidepressivum door 
huisartsen in de loop van de QIC zou dalen.  
 Om deze hypothese te testen werd een quasi-experimentele studie opgezet met 
een ongelijke controlegroep en drie jaar follow-up. We vergeleken voor, tijdens en 
na de QIC het percentage voorschriften voor antidepressiva van de QIC 
huisartsen, als eerste stap in de behandeling van volwassen patiënten met een 
eerste of nieuwe episode van depressieve klachten (ICPC P03) of een depressie 
(ICPC P076) met het voorschrijfgedrag van huisartsen uit het Landelijk Informatie 
Netwerk Huisartsenzorg (LINH). Dit is een database met representatieve, 
longitudinale gegevens over ziekte, voorschrijven en verwijzing in de 
huisartspraktijk. In beide groepen werd in het Huisartsen Informatie Systeem (HIS) 
van de deelnemende huisartsen gezocht naar gegevens over voorschrijven. Ook 
werd gekeken naar verwijzingen door de huisarts naar GGZ hulpverleners in de 
eerste- of tweedelijn. 
 De QIC groep bestond uit 20 huisartsen uit 17 praktijken, de controlegroep 
bestond uit 115 huisartsen uit 41 praktijken. De gegevens van 400 QIC patiёnten 
en van 3956 patiёnten uit de controlegroep werden in de analyses meegenomen. 
In de QIC groep verminderde het percentage antidepressiva voorschriften als 
Samenvatting 
217
eerste behandelstap van 2006 tot 2008 met 23% (van 49.4% naar 26.1%). In de 
controlegroep trad geen verandering op (van 50.3% naar 52.6%). De multilevel 
regressie analyse liet zien dat participatie in de QIC invloed had op verandering in 
het voorschrijfgedrag (OR 0.44, 95% CI: 0.21-0.92). Het percentage verwijzingen 
veranderde niet in beide groepen.  
 De conclusie van deze studie was dat QICs kunnen leiden tot een aanzienlijke 
daling in het aantal voorschriften voor antidepressiva als eerste behandelstap in 
de huisartspraktijk. Nader onderzoek moet aantonen of deze daling onderdeel 
uitmaakt van een adequate stepped care benadering, waarbij mensen met lichte 
klachten in eerste instantie lichte interventies krijgen aangeboden en mensen met 
een ernstige depressie antidepressiva of psychotherapie.  
In hoofdstuk 7 werd de individuele kosteneffectiviteit van de zorg volgens het QIC 
model vergeleken met gebruikelijke zorg. We voerden een economische evaluatie 
uit vanuit maatschappelijk perspectief, hetgeen betekent dat de berekende kosten 
zowel zorgkosten omvatten als kosten veroorzaakt door productiviteitsverliezen. 
De interventiegroep bestond uit patiёnten van huisartsen die deelnamen aan de 
Depressie QIC. De controlegroep bestond uit patiёnten van huisartsen die 
gebruikelijke zorg gaven en deelnamen aan de Netherlands Study of Depression 
and Anxiety (NESDA). Om deze twee groepen vergelijkbaar te maken werden ze 
gematched op een aantal factoren. De centrale uitkomstmaat van de studie was 
herstel, gemeten met de Inventory for Depression Symptomatology (IDS-SR), op 
baseline en na twaalf maanden follow-up. Kosten werden gemeten met de 
Trimbos and Institute of medical Technology Assessment Cost Questionnaire of 
Psychiatry (TIC-P).
 Voor de economische analyse werd de incrementele kosteneffectiviteits ratio 
(ICER) berekend van behandeling in de QIC groep versus behandeling in de 
controlegroep. Dit gebeurde door het berekenen van het verschil in kosten tussen 
de groepen gedeeld door het verschil in effecten tussen de beide groepen (C1–C0)
/ (E1–E0), waarbij C staat voor de gemiddelde kosten per patiёnt per jaar en E voor 
het percentage patiёnten dat herstelde van een depressie in de QIC en de 
controlegroep (respectievelijk subscript 1 en 0). 
Er werden gegevens van 89 patiёnten geanalyseerd: 34 in de QIC groep en 55 
in de controlegroep. Dit kleine aantal maakte de studie ongeschikt voor het 
statistisch toetsen van hypothesen, maar voor een economische analyse kunnen 
kleine aantallen wel gebruikt worden voor het doen van probabilistische uitspraken 
om beslissingen in situaties van onzekerheid te onderbouwen.  
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In de QIC groep herstelde 26% van de patiёnten, in de controlegroep 18%. De 
gemiddelde kosten per patiёnt per jaar waren lager in de QIC groep (€5,012) dan 
in de controlegroep (€5,871). De economische evaluatie liet zien dat wanneer de 
QIC benadering werd gekozen in plaats van gebruikelijk zorg, er 73%-89% kans 
was dat de QIC kosteneffectiever was en dat er voor elke herstelde patiënt 
€10,311 kon worden bespaard ten opzichte van de gebruikelijke zorg. Wel werden 
er, om de QIC benadering in acht regio’s te implementeren, investeringen van 
ongeveer 1 miljoen euro gedaan.  
 De conclusie van deze studie was dat de geïmplementeerde depressie QIC 
benadering vanuit maatschappelijk perspectief waarschijnlijk meer value for 
money geeft maar dat een grotere en gerandomiseerde studie nodig is om dit te 
bevestigen. 
Hoofdstuk 8 beschrijft de QIC in de schizofreniezorg, zoals hoofdstuk 4 de 
Depressie QIC beschreef. De gegevens voor deze studie waren afkomstig van 30 
QIC teams, waarin 359 GGZ hulpverleners met verschillende achtergrond 
deelnamen. Het doel van de teams was het implementeren van zes interventies 
die in de multidisciplinaire richtlijn werden aanbevolen: Assertive Community 
Treatment (ACT) of de aangepaste variant Functionele Assertive Community 
Treatment (FACT), Cognitieve Gedrags Therapie (CGT), psycho-educatie (PE), 
Familie Interventies (FI), Individual Placement and Support (IPS) en 
farmacotherapie (FT). Een tweede doel was het verbeteren van de continuїteit van 
zorg door het invoeren van zorgplannen. 
 De implementatie van deze interventies werd aan het eind van de QIC met een 
vragenlijst onder hulpverleners gemeten. Daarnaast werden van alle patiёnten de 
zorgplannen geteld en werd op verschillende momenten het sociaal functioneren 
en ernst van de symptomen bij patiënten gemeten met respectievelijk de Health of 
the Nation Outcome Scales (HoNOS) en de Clinical Global Impression scale 
(CGI).
In totaal werden 1489 patiёnten met schizofrenie in de QIC betrokken. 
Voorafgaand aan de QIC waren in de meeste teams alleen CGT, PE en FT 
beschikbaar en kon minder dan de helft van de teams (F)ACT, FI of IPS 
aanbieden. Aan het eind van de QIC waren in de meeste teams alle interventies 
aanwezig en had een meerderheid voor de meeste interventies ook protocollen 
ontwikkeld. Toch was maar een minderheid van de teams in staat om zich bij meer 
dan 70% van de patiënten aan de protocollen te houden, behalve bij 
farmacotherapie. De invoering van zorgplannen nam fors toe. Aan het eind van de 
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QIC had 38% van de patiёnten een zorgplan, terwijl dat percentage voor de QIC 
slechts 3% was. Het sociaal functioneren van patiёnten verbeterde licht 
(gemiddelde HoNOS score van 6.2 naar 5.6), evenals de ernst van de symptomen 
(gemiddelde CGI-S van 4.1 naar 3.9). Terugvalpercentages verbeterden niet.  
 De conclusie van deze studie was dat een QIC in de tweedelijns GGZ kan 
leiden tot meer evidence-based zorg en een betere continuïteit van zorg voor 
mensen met schizofrenie en tot verbeterde uitkomsten. Vergelijkend onderzoek 
moet dit resultaat bevestigen.  
In de discussie werden de belangrijkste resultaten van het proefschrift besproken. 
Hoewel deze niet gebaseerd waren op gerandomiseerde studies, wezen ze allen 
in dezelfde richting namelijk dat QICs kunnen helpen bij het implementeren van 
richtlijnaanbevelingen in de praktijk, en daarmee kunnen leiden tot betere kwaliteit 
van zorg en mogelijk tot betere uitkomsten voor patiënten. Deze effecten traden 
zowel op in de eerstelijns depressiezorg als in de gespecialiseerde zorg voor 
mensen met schizofrenie. Deze effecten lijken in onze ogen generaliseerbaar naar 
de zorg voor sterk vergelijkbare patiëntencategorieën, zoals angststoornissen in 
de eerstelijn en bipolaire stoornissen in de tweedelijn.
 De kern van het proefschrift betrof de implementatie van een stepped care 
aanpak in de eerstelijns depressiezorg, het doel van de depressie QIC. Het meest 
robuuste resultaat van deze QIC was het veranderde voorschrijfgedrag van 
huisartsen met betrekking tot antidepressiva. Hoewel niet kon worden onderzocht 
welke patiёnten er precies van deze verandering profiteerden, is deze daling in 
voorschriften op zichzelf een bijzonder resultaat omdat het een jarenlange 
landelijke trend van constante, hogere voorschrijfpercentages doorbreekt. De 
implementatie van het gehele stepped care model voor depressie bleek te 
complex om in een jaar tijd te realiseren, maar het lukte de hulpverleners om 
enkele nieuwe interventies in te voeren voor mensen met lichtere problematiek, 
naast het monitoren van depressiesymptomen. Mogelijk dat zorg volgens het 
depressie QIC model ook kan leiden tot minder productieverliezen en dus 
kostenbesparingen, hoewel de initiële investeringen voor het organiseren van een 
QIC fors zijn. Dit vraagt om een goede kosten-baten afweging van financiers 
voordat zij aan QICs beginnen. 
 Uit onze studies kunnen we een aantal factoren destilleren die de implementatie 
van stepped care bij depressie hebben beïnvloed. De meeste hiervan, zoals 
voldoende tijd, motivatie en middelen, zijn niet uniek en al ruimschoots in de 
literatuur beschreven. Een paar factoren lijken echter wel specifiek voor 
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veranderprocessen in de eerstelijns GGZ en belangrijk voor toekomstige 
veranderprogramma’s. Zo bleken het ontwikkelen van een gedeelde visie op 
depressie en depressiezorg en consensusvorming onder de verschillende 
eerstelijns hulpverleners over onderlinge taakverdeling cruciaal voor het op gang 
komen van veranderingen. Een tweede bijna doorslaggevende factor voor 
succesvol veranderen bleek de registratie van proces- en uitkomstindicatoren voor 
depressie in het HIS van de huisarts. Zonder feedbackinformatie over de 
verleende zorg en zorguitkomsten valt depressiezorg niet goed te verbeteren. Hier 
valt op dit moment nog veel aan te verbeteren in ons land. De laatste factor die bij 
implementatie van stepped care programma’s zeker aandacht behoeft is het risico 
op onderbehandeling van mensen met ernstige of langdurende depressies 
wanneer lichte interventies te veel naar voren geschoven worden. 
 Het lijkt er op dat multidisciplinaire richtlijnen in de GGZ de komende jaren nog 
een grote rol gaan spelen in de kwaliteitsprogramma’s van de overheid en de 
landelijke beroeps- en patiëntenverenigingen. Dit proefschrift bevat 
aanknopingspunten voor de inrichting van dergelijke programma’s. Zo 
suggereerden wij dat toekomstige richtlijnen of herzieningen van de bestaande 
richtlijnen zo worden ontwikkeld dat ze én van hoge methodologische kwaliteit zijn 
én acceptabel en implementeerbaar in de praktijk. Dit kan alleen gerealiseerd 
worden als richtlijnen, veel meer dan nu het geval is, geïntegreerd worden in 
andere kwaliteitsinstrumenten zoals proces en uitkomstindicatoren, zorgpaden en 
het elektronisch patiënten dossier (EPD). Als hulpverleners en patiënten vanuit het 
EPD kunnen doorklikken naar richtlijnen en op maat adviezen kunnen ontvangen 
bij behandelbeslissingen, neemt de kans toe dat de science-to-practice gap wordt 
verkleind. Als richtlijnen daarnaast de bron worden voor het ontwikkelen van lokale 
en landelijke prestatieindicatoren die in het EPD worden bijgehouden, kunnen 
verbeteractiviteiten makkelijker worden georganiseerd en organisaties beter 
onderling worden vergeleken. Dan zijn landelijke QICs wellicht niet meer nodig, 
maar kunnen managers in hun instelling of regio QIC-achtige netwerken opzetten 
voor het implementeren van richtlijnen of innovaties.  
De voorwaarden voor een dergelijke ‘verbetercultuur’ in de GGZ komen steeds 
meer in zicht. Beroepsgroepen nemen de laatste jaren meer verantwoordelijkheid 
voor de landelijke kwaliteitsagenda en het tot stand brengen van een betere en 
doelmatige GGZ. Patiëntenorganisaties raken beter betrokken en gehoord, 
zorgverzekeraars zoeken naar samenwerking met de veldpartijen en, misschien 
wel de meest belangrijke voorwaarde, de mogelijkheden van ICT systemen om 
feedbackinformatie te leveren zijn enorm verbeterd. Het enige wat resteert lijkt nog 
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 Het lijkt er op dat multidisciplinaire richtlijnen in de GGZ de komende jaren nog 
een grote rol gaan spelen in de kwaliteitsprogramma’s van de overheid en de 
landelijke beroeps- en patiëntenverenigingen. Dit proefschrift bevat 
aanknopingspunten voor de inrichting van dergelijke programma’s. Zo 
suggereerden wij dat toekomstige richtlijnen of herzieningen van de bestaande 
richtlijnen zo worden ontwikkeld dat ze én van hoge methodologische kwaliteit zijn 
én acceptabel en implementeerbaar in de praktijk. Dit kan alleen gerealiseerd 
worden als richtlijnen, veel meer dan nu het geval is, geïntegreerd worden in 
andere kwaliteitsinstrumenten zoals proces en uitkomstindicatoren, zorgpaden en 
het elektronisch patiënten dossier (EPD). Als hulpverleners en patiënten vanuit het 
EPD kunnen doorklikken naar richtlijnen en op maat adviezen kunnen ontvangen 
bij behandelbeslissingen, neemt de kans toe dat de science-to-practice gap wordt 
verkleind. Als richtlijnen daarnaast de bron worden voor het ontwikkelen van lokale 
en landelijke prestatieindicatoren die in het EPD worden bijgehouden, kunnen 
verbeteractiviteiten makkelijker worden georganiseerd en organisaties beter 
onderling worden vergeleken. Dan zijn landelijke QICs wellicht niet meer nodig, 
maar kunnen managers in hun instelling of regio QIC-achtige netwerken opzetten 
voor het implementeren van richtlijnen of innovaties.  
De voorwaarden voor een dergelijke ‘verbetercultuur’ in de GGZ komen steeds 
meer in zicht. Beroepsgroepen nemen de laatste jaren meer verantwoordelijkheid 
voor de landelijke kwaliteitsagenda en het tot stand brengen van een betere en 
doelmatige GGZ. Patiëntenorganisaties raken beter betrokken en gehoord, 
zorgverzekeraars zoeken naar samenwerking met de veldpartijen en, misschien 
wel de meest belangrijke voorwaarde, de mogelijkheden van ICT systemen om 
feedbackinformatie te leveren zijn enorm verbeterd. Het enige wat resteert lijkt nog 
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te zijn dat alle betrokkenen de mogelijkheden volop gaan benutten, bijvoorbeeld 
door zonder negatieve externe druk beschikbare gegevens over geleverde zorg te 
analyseren, ervan te leren en actie te ondernemen om geconstateerde problemen 
in het dagelijks werk op te lossen. Voor het welzijn van patiënten en de juiste 
besteding van zorgbudgetten is het cruciaal dat deze verbeterprocessen de 
komende jaren overal worden ontwikkeld, omdat zoals Paul Batalden van het 
Institute for Healthcare Improvement (het instituut waar QIC is ontworpen) aangaf: 
‘de zorgsector nooit optimaal zal functioneren tenzij ‘veranderen’ een integraal 
onderdeel wordt van ieders werk, elke dag, in alle onderdelen van het systeem’.  
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Het is precies zeven jaar geleden dat ik in het Brabantse Veldhoven de bus naar 
station Eindhoven nam, na afloop van het implementatiecongres Kennis Beter 
Delen, waar volgens de website ‘mensen van elkaar leren hoe ze met 
zorgvernieuwing om kunnen gaan’. In die bus stond toevallig ook Richard Grol. Ik 
waagde het er op en vertelde hem dat ik net had gehoord dat het Trimbos-instituut 
subsidie zou krijgen om Doorbraakprojecten in de GGZ uit te voeren en dat ik dan 
graag rond dit onderwerp bij hem zou willen promoveren. ‘Maak een afspraak’ zei 
Richard ‘en vraag daar meteen Michel Wensing bij’. 
 Zo geschiedde en vervolgens volgde ruim een jaar waarin het 
onderzoeksvoorstel langs ZonMw commissies ging en de Doorbraakteams werden 
geworven. De kartrekker van het Doorbraak Depressie verbetertraject, Jochanan 
Huyser, had inmiddels als co-promotor het wetenschappelijke team versterkt.  
 In de zeven jaar dat ik over dit proefschrift heb gedaan heb ik veel hulp 
gekregen. Die had ik nodig omdat het proefschrift min of meer ‘naast het werk’ is 
geschreven, zoals veel van de ‘promovendi-op-leeftijd’ overkomt. Het leuke 
hiervan is wel het proefschrift hierdoor mijn vijftien jaar werk in het Trimbos-
instituut globaal is gaan weerspiegelen. In die tijd heb ik met velen samengewerkt 
en nog meer mensen hebben mij geïnspireerd. Het is onmogelijk hen hier nu 
allemaal te noemen, ik moet me beperken tot degenen die bij het proefschrift 
waren betrokken. 
Richard Grol wil ik bedanken voor het gestelde vertrouwen in mij, toen in die bus 
en in de afgelopen zeven jaar in Nijmegen. Vanaf het eerste overleg ging hij heel 
voortvarend af op het resultaat: de artikelen. Terwijl ik nog geen idee had waar ik 
aan begon, moest ik van Richard meteen een inhoudsopgave van het proefschrift 
maken. Richard, ik denk dat jij door had dat dit pragmatisme voor iemand als ik 
van groot belang is om te voorkomen dat het gehele traject op niets uitdraait. Dat 
is mede dankzij jou niet gebeurd. Naast het proefschrift was je de afgelopen tien 
jaar ook betrokken bij sollicitaties voor twee banen in het buitenland: in 2002 in 
Australië en nu in de VS. Ook daar bedank ik je voor.
 Met Michel Wensing heb ik het meest gewerkt en van hem heb ik zeer veel 
geleerd. Hij werd vanaf de dag dat Richard Grol met emeritaat ging dan ook mijn 
eerste promotor. Ik heb enorme bewondering voor zijn intelligentie en kennis op 
het gebied van implementatie onderzoek en voor zijn bescheidenheid daarover. 
Ook waardeerde ik zijn manier van begeleiden: kritisch, nooit over-enthousiast 
maar optimistisch. Gewoon doorgaan en benoemen wat je wel hebt kunnen 
aantonen. Michel, ik dank je zeer voor de tijd en aandacht die je in mij investeerde 
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en ben er trots op dat ik bij jou promoveer. Omdat ik al vroeg in het traject vond 
dat de Nederlandse GGZ meer van jou als hoogleraar implementatiewetenschap 
zou moeten profiteren, tekenden onze instituten een convenant en werk jij nu ook 
met diverse collega’s van mij. Ik hoop dat dit nog een lange toekomst heeft. 
Mochten alle literatuur databases het ooit begeven, dan heeft de 
wetenschappelijke wereld hem nog, denk ik wel eens. Je hebt veel van je kennis 
met me gedeeld, ik hoop dat we samen blijven werken in dit veld. 
 Jochanan Huyser was Mister Doorbraak Depressie en degene met wie ik zeer 
intensief heb opgetrokken vanaf het eerste pilot project (2004-2006). Jochanan 
was toen werkzaam als psychiater op een derdelijns depressieafdeling en toonde
zich enorm enthousiast over de Doorbraakmethode, waar hij vijf jaar lang vele 
overuren in heeft geïnvesteerd. Hij vertelde me later dat deze ervaring een rol 
heeft gespeeld in de overstap van psychiater naar manager in Arkin, waar hij 
verantwoordelijk is voor grote verandertrajecten. Over die veranderingen in de 
GGZ hebben we de afgelopen jaren vaak gediscussieerd, als ik op zijn werkkamer 
in Amsterdam mijn artikelen kwam bespreken. Jochanan, je bent een zeer 
vertrouwde en belangrijke link naar de praktijk voor me geworden en als ik de 
afgelopen tijd zelf twijfelde over het nut van mijn richtlijn- en implementatiewerk 
dan hoefde ik maar aan jouw overtuiging te denken om te weten dat deze 
projecten wel zin hebben. Ik dank je zeer voor alle samenwerking. 
Jan Walburg, mijn baas en directeur van het Trimbos-instituut, heeft me zeer 
gestimuleerd om te promoveren. De combinatie met een leidinggevende functie 
vond hij geen bezwaar en toen ik aankondigde dat ik na de promotie direct een 
jaar naar het buitenland wilde, was hij daar ook helemaal voor. Jan, jouw 
bevlogenheid voor kennisverspreiding en kwaliteitsverbetering in de GGZ heeft me 
geïnspireerd tijdens het schrijven van dit proefschrift. Ik wil je hartelijk bedanken 
voor je leiderschap en voor de mogelijkheden die het instituut me heeft geboden 
om mezelf op vele verschillende fronten te ontwikkelen.   
 Ook bedank ik graag enkele van mijn voormalige leidinggevenden, Giel 
Hutschemaekers en Lourens Henkelman, die mij in het Trimbos-instituut hebben 
aangenomen en in de posities hebben gezet die tot het proefschrift hebben geleid. 
Ik was Giels hulpje in 1999, toen het Trimbos-instituut begon met het ontwikkelen 
van de richtlijnen. Giel zette in dat jaar de visie neer voor een evidence-based 
GGZ, en die is sindsdien leidend geweest bij ons werk. Was ik in 1999 nog de 
persoon die na elke vergadering van de Landelijke Stuurgroep bedankt werd voor 
de koffie, nu heb ik de eer om het richtlijnprogramma zelf mede aan te sturen in 
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partnership met de beroepsgroepen en patiëntenorganisaties. Die positie dank ik 
vooral aan Lourens Henkelman, met wie ik 5 jaar lang heel plezierig heb gewerkt 
en die het mogelijk maakte dat ik een promotietraject kon realiseren in het 
Trimbos-instituut, hetgeen niet voor de hand liggend is. Hij vertrok in 2007 en ik 
was zeer vereerd toen hij mij vroeg om hem op te volgen.  
Een aantal hoogleraren heeft mij op onderdelen van het proefschrift geadviseerd 
en tijd in mijn werk geïnvesteerd. Ik bedank Christina van der Feltz-Cornelis, 
hoogleraar sociale psychiatry, voor het opnemen van de Doorbraakstudie in het 
grote Depressie Initiatief en haar leiderschap in dat programma. Ik bedank Brenda 
Penninx, hoogleraar psychiatrische epidemiologie, voor de betrokkenheid bij het 
oorspronkelijke design van de trial waar NESDA data voor gebruikt zouden 
worden. De dataverzameling liep helaas anders dan gepland, maar gelukkig 
hebben we toch het kosteneffectiviteitsartikel met elkaar kunnen schrijven. Dat dat 
lukte kwam voornamelijk door de begeleiding en input van Filip Smit, hoogleraar 
evidence-based public mental health, die geheel belangeloos en op zijn 
vriendelijke wijze kritische suggesties deed voor verbetering van dit artikel. Ik 
bedank ook Peter Verhaak, hoogleraar GGZ binnen de huisartsvoorziening, die 
mij adviseerde over het gebruik van LINH gegevens en bij dit artikel co-auteur 
was. Dank ook aan Jan Spijker, hoogleraar chronische depressie, lid van de 
richtlijnwerkgroep depressie en expert bij de Doorbraak-projecten. Maar vooral 
was hij de laatste jaren mijn opgewekte buurman in het Trimbos-instituut. Ook 
dank ik Ton van Balkom, hoogleraar psychiatrie en al vele jaren voorzitter van de 
richtlijnwerkgroep depressie en angststoornissen. Hij is als vooraanstaand lid van 
de Nederlandse Vereniging voor Psychiatrie zeer belangrijk geworden voor de 
ontwikkeling van GGZ-richtlijnen in ons land, de stepped care aanpak van angst 
en depressie en de implementatie daarvan. En dan last but not least, Jan 
Swinkels, hoogleraar richtlijnen in de gezondheidszorg, die ik al vanaf 1999 in vele 
projecten tegenkom. Ik dank je Jan, voor je kennis over en  bevlogenheid voor 
praktisch alles wat met kwaliteit van zorg te maken heeft. Maar net zo belangrijk 
voor me is je Amsterdamse directheid en de lol die ik heb bij onze ontmoetingen.  
Advisering en begeleiding door hoogleraren is cruciaal bij promoveren, maar het 
zijn overwegend anderen die helpen bij het uitvoerend werk. De meeste van hen 
waren medewerkers van het Trimbos-instituut. Ik ben hen zeer erkentelijk voor de 
kwaliteit die ze leverden, hun inzet en hun humeur dat immer goed bleef, ook bij 
de tachtigste email van mij. De volgende personen wil ik hierbij zeer bedanken 
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voor hun werk aan de verschillende hoofdstukken. Hans Kroon hielp bij 
beoordelen van de artikelen uit het review (hoofdstuk 3) en Jacomine de Lange en 
Lex Hulsbosch bij de analyses van de Doorbraakdata (hoofdstuk 4). Jacomine en 
Matthijs Oud waren sterk betrokken bij de kwalitatieve studie over het 
Doorbraakproject Depressie (hoofdstuk 5). Harrie van Haastrecht en Yvonne Drost 
verzorgden het datamanagement bij de Doorbraak Depressie studie (hoofdstuk 6). 
Danielle Volker en Cristina Majo voerden de kosteneffectiviteitsanalyse uit
(hoofdstuk 7). Met Danielle van Duin werkte ik nauw samen aan het hoofdstuk 
over het Doorbraakproject Schizofrenie (hoofdstuk 8). Veel dank gaat uit naar Jan 
Koetsenruijter van IQ healthcare die hielp bij de analyses van de studies uit 
hoofdstuk 6 en 8. Tot slot bedank ik all co-auteurs die hier nog onvermeld bleven 
voor de plezierige en productieve samenwerking: Rob Drake, Mark van der Gaag, 
Jeremy Grimshaw, Jako Burgers, Jolanda Meeuwissen, Peter Niesink, Henny 
Sinnema, Cees Slooff, Jaap van Weeghel.  
In de publicatiefase van de artikelen en het boekje werd ik zeer geduldig en 
professioneel geholpen door Toine Ketelaars, Joris Staal, Nelleke van Zon en 
Jolanda van Haren van IQ healthcare. Jolanda, ik ben je zeer erkentelijk voor de 
zorg die jij in de eindfase droeg voor de promotie en het boekje. Nelleke, jouw hulp 
strekt veel verder dan de promotie en ik kan je eigenlijk niet genoeg bedanken 
voor jouw professionele, pro-actieve en zeer prettige ondersteuning van mij de 
laatste jaren. Mede omdat ik veel aan jou heb kunnen overlaten, is het gelukt om 
dit boekje nu van de pers te laten rollen.  
Als hoofd van het team Zorginnovatie van het Trimbos-instituut ben ik mijn 
(oud)teamleden dank verschuldigd voor hun geduld en steun bij het tot stand 
komen van het proefschrift. Ik ben me ervan bewust dat ik vooral het laatste jaar 
vaak thuis aan het werk was en er voor jullie niet altijd fysiek kon zijn. Peter van 
Splunteren, Jolanda Meeuwissen, Ina Boerema, Daniëlle van Duin, Henny 
Sinnema, Matthijs Oud, Geurt van de Glind, Marleen Hermens, Bob van 
Wijngaarden, Daniëlle Meije, Simone van de Lindt, Annemieke van den Bosch, 
Laura Shields en Harriët van Wetten, ik ben zeer trots op de prestaties van ons 
team en dank jullie enorm voor je inzet. Hedda van ’t Land ben ik erkentelijk voor 
het feit dat ze mij dit jaar als leidinggevende van dit team op zeer energieke wijze 
vervangt.  
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Zonder de vele hulpverleners en hun patiënten die aan de studies hebben 
bijgedragen was dit proefschrift uiteraard nooit tot stand gekomen. Ik noem Betty 
Steenkamer en Marieke van den Heuvel van ROS Robuust bij naam, omdat zij in 
Zuid Nederland het Doorbraakstokje hebben doorgegeven aan een grote groep 
huisartsen en andere eerstelijns hulpverleners die nu nog steeds met het 
depressiemodel werkt, gestimuleerd door verzekeraars. Het is zeer bemoedigend 
om te weten dat al het implementatiewerk niet alleen voor dit boekje is verricht. 
Ook in de langdurende zorg zijn de effecten van de Doorbraakprojecten nog 
steeds aanwezig, zo horen we terug.  
Met die boodschap durf ik dan wel thuis te komen, na zeven jaar afwezigheid op 
etentjes en avondjes, weekjes Frankrijk, zeilvakanties, tennispartijtjes, Luba 
loopjes, etcetera. Dit brede thuisfront heb ik bij tijd en wijle tekort gedaan, dat 
realiseer ik me goed. Gelukkig is iedereen er nog. Mijn lieve ouders bijvoorbeeld, 
die me al mijn hele leven van dichtbij volgen. Ik vind het zeer bijzonder en 
ontroerend om hen nog om me heen te hebben nu ik promoveer. Mijn beide 
paranimfen, Rolande en Elske-Tine, zijn al twintig jaar geleden op hun posities 
benoemd en waren dus zo langzamerhand wel gewend om rustig en opgewekt het 
moment af te wachten waarop er iets ging gebeuren. Ik vind het een fijn idee dat 
zij op dat ene moment dan eindelijk naast me staan. En dan mijn broers, 
schoonfamilie en vrienden, ik dank jullie allen zeer voor de steun en interesse 
maar jullie kunnen nu ophouden mij te confronteren met de vraag: ‘is het 
proefschrift al af?’
Het proefschrift is af en opgedragen aan Marijke Hoen, my working week and my 
Sunday rest. 
Amsterdam, oktober 2012 
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In de Geestelijke Gezondheidszorg bestaat een grote kloof tussen de beschikbare 
kennis over werkzame behandelingen (wat men weet) en de dagelijkse praktijk (wat 
men krijgt). In Nederland ontvangt slechts 25-50% van de patiënten met psychische 
problematiek bewezen effectieve zorg. Richtlijnen worden gezien als hulpmiddelen 
om beschikbare kennis in de praktijk te implementeren en daarmee zowel de zorg als 
de gezondheid van patiënten te verbeteren.
De hoofdstukken uit dit boekje vormen een proefschrift over de implementatie 
van aanbevelingen uit de landelijke multidisciplinaire richtlijnen voor depressie en 
schizofrenie.  De methode die hiervoor werd gebruikt is de uit Amerika overgenomen 
Doorbraakmethode. Groepen hulpverleners uit huisartspraktijken en GGZ instellingen 
werden begeleid om in ruim een jaar tijd richtlijnen in hun  praktijken in te voeren. In 
diverse studies werd nagegaan of dit doel werd bereikt, of patiënten ervan profiteerden 
en of investeringen in dergelijke implementatie projecten lonen.
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